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This thesis describes the preparation and characterisation of a number of 
homochiral coordination and metallosupramolecular assemblies. These species 
were formed from the reaction of chiral pyridine and quinoline containing ligands 
and metal ions. The combination of traditional coordination chemistry and 
supramolecular interactions led to a range of polymeric and network structures 
being formed. 
 
The ligands used in this thesis can be divided into two broad categories: 
alkaloids and ligands derived from them, and amino acid-based ligands. In the 
first category three new ligands were synthesized, and a variety of routes 
towards alkaloid-based homochiral ligands were investigated. The second 
category focused on three ligand motifs, and resulted in the preparation of 16 
ligands. These two categories of ligands were reacted with a range of metal salts 
to investigate their coordination and supramolecular chemistry. 
 
The structure of twenty complexes was determined by single crystal X-ray 
crystallography. The complexes had a range of structures, with discrete and 
polymeric species being formed. Hydrogen bonding was an important feature in 
the supramolecular chemistry of the complexes, playing a different role in 
different series of complexes. 
 
Two chiral coordination polymers and one chiral coordination network were 
synthesized. All three of these structures possessed directionality to some 
degree: in the coordination network and one of the polymers the directionality is 
counterbalanced by the opposite directionality being present in the crystal, while 
the second coordination polymer is generated by the screw axis present and has 
a high degree of overall directionality.  
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Introduction 




In transition metal coordination chemistry one of the most important classes of 
ligands is the nitrogen heterocycles.1, 2 The most widely studied of these are 
pyridine, 2,2’-bipyridine and 2,2’:6’,2”-terpyridine (see Figure 1.1). Due to 
interactions between the π* antibonding orbitals of the ligand and the d-orbitals 
of a metal ion, strong coordinate bonds are formed, resulting in stable 
complexes. Other related ligands that have been extensively employed in 
coordination chemistry are the five membered nitrogen heterocycles pyrazole 












Figure 1.1: From left to right, pyridine, 2,2’-bipyridine, 2,2’:6’,2”-terpyridine, pyrazole and 
imidazole. 
 
The incorporation of two or more of these donors into a single molecule can 
result in species which can bridge between two metal centres, chelate to a single 
metal centre, or a combination of both these motifs. Chelation to a metal centre 
increases the stability of the complex, and so is desirable for inclusion into the 
design of ligands. The bridging of metal centres by a ligand can result in 
communication between the metal centres, as well as resulting in higher order 
molecular architectures. These include discrete species, such as molecular 
squares, cubes and cages, and polymeric species such as chains, ladders, 




Chirality is an extremely common feature in molecules, and can be defined as a 
molecule which is not superimposable on its mirror image. The most common 
and well-studied type of chirality is that of the tetrahedral carbon atom, which has 
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been recognized since 1874.3 Other types of chirality in organic chemistry 
include planar chirality, atropisomerism and molecules with stereochemical axes. 
These molecules have non-superimposable mirror images that are not based on 
a tetrahedral carbon atom with four different substituents.  
 
Chirality in coordination chemistry is a relatively more complex subject. With a 
wide range of coordination numbers and coordination geometries at the chiral 
centre (often, but not always the metal centre), there is a greater range of types 
of chirality in coordination compounds.  
 
There are two extremes in synthesizing a chiral complex: to attach a chiral ligand 
to an achiral complex and to synthesize a metal centre that is chiral. These can 
be viewed as two extremes of a continuum, with cases occurring in which both of 
these occur, as well as many in which this type of description would be an 
oversimplification.  
 
Two of the best studied in inorganic systems are the ∆ and Λ- forms of tris-
bidentate substituted octahedral centres, and the P- and M- forms of helicates. In 
any typical synthesis of coordination compounds it is possible that all the 
stereoisomers can form, as with organic syntheses, although external factors can 
more significantly affect these syntheses to favour one product over another. 
 
When a metal complex is synthesized with an aim to create a chiral metal centre 
there are two possible methods. These mirror to some extent the synthesis of 
chiral organic molecules. The first is synthesis of a single stereoisomer, which 
would have to involve some sort of stereoselective synthesis. Potential methods 
for this type of synthesis are the use of chiral anions during the synthesis, the 
use of a chiral auxiliary to direct the synthesis, or use of a chiral ligand (which 
would have to be synthesized itself, see below). The other method is to 
synthesize multiple stereoisomers and then separate them. One example of a 
method of separation is fractional crystallization with a chiral anion. The 
aforementioned separation is a specific example of the method generally used to 
separate these types of complexes: these separations involve the temporary or 
permanent formation of diastereoisomers; these have different physical 
 - 4  
 
properties and so may be separated by a number of methods. One example is 
the work of Fletcher and Keene,4 which involved the separation of 
diastereomeric diruthenium complexes by chromatography. They demonstrated 
that intelligent selection of the anion used for elution would result in separation of 
the diastereoisomers. 
 
The other extreme in the synthesis of chiral complexes is to attach a chiral ligand 
to an achiral metal centre, resulting in a chiral complex. Although this method 
seems simpler than the previous method, it moves the origin of chirality further 
up the synthetic chain. The synthesis of a chiral ligand then becomes an 
important step towards the synthesis of a chiral coordination compound.  
 
As with the synthesis of a chiral metal centre, there are three methods of 
obtaining a chiral ligand. The first is the synthesis of a chiral centre, with a 
stereoselective synthesis resulting in a single stereoisomer. The second method 
is synthesis of two stereoisomers, followed by separation. The final method is to 
start with a single stereoisomer and use that in the synthesis of the chiral ligand. 
This is the approach used in this thesis.  
 
Chiral ligands play an important role in coordination chemistry, and have been 
used extensively in catalysis.5 A wide range of phosphorus containing ligands is 
known, and have found widespread use in enantioselective catalytic processes.6 
Nitrogen containing heterocycles have not been utilized as extensively, although 
a number are known.7 
 
Four common sources of chiral materials in nature, which are part of the chiral 
pool, are carbohydrates, amino acids, terpenes and alkaloids. Each of these 
classes has been incorporated into chiral heterocyclic ligands for use in 
coordination chemistry. Carbohydrates, a common example of which is glucose 
(see Figure 1.2), have been the least utilized in this context. Terpenes are the 
most commonly used chiral starting material, due to their ease of incorporation in 
synthesis. Examples such as the pinenes5 and camphor8 (see Figure 1.2) have 
been widely incorporated into heterocyclic ligands. 














Figure 1.2: α-(D)-Glucose, a carbohydrate, and (1R)-(+)-camphor, a monoterpene. 
 
Amino acids have mainly been used in the synthesis of amino alcohols, for 












Figure 1.3: Two examples of chelating oxazolines synthesized from amino acids. 
 
Alkaloids are a class of compounds isolated from plants, in which their function is 
largely unknown, and thousands have been structurally characterized. Alkaloids 
have found little use in coordination chemistry, or indeed in organic chemistry. 
The notable exception to this is the ligands used in the asymmetric Sharpless 
dihydroxylation,11 which are derived from the cinchona alkaloids.  
 
1.3 Supramolecular Chemistry 
 
Supramolecular chemistry12, 13 is defined as “chemistry beyond the molecule, 
bearing on the organized entities of higher complexity that results from the 
association of two or more species held together by intermolecular forces.”13, 14 
Traditional chemistry relies on covalent bonds between atoms to hold molecules 
together, and, as such, atoms are the building blocks of molecules. One of the 
key concepts of supramolecular chemistry is that the molecules themselves are 
the building blocks of larger aggregates. 
 
In traditional chemistry covalent bonds hold the atoms together to form 
molecules, and these bonds typically have strengths in the region of 350 kJ 
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mol-1. In supramolecular chemistry a range of weaker interactions is considered; 
examples include hydrogen bonding, ion-dipole, dipole-dipole and π-π Stacking. 
Hydrogens bonds are relatively common in chemistry, and occur when a 
hydrogen atom is bonded to an electronegative or electron deficient atom and is 
in close proximity to an acceptor atom which is electron rich. Hydrogen bonds 
are defined as the sharing of the hydrogen nucleus, or proton, between the 
donor and acceptor. Hydrogen bonds typically have strengths in the 5-50 kJ mol-
1 range,15 which is significantly less than  a covalent bond. π-π stacking is 
another common interaction considered in supramolecular chemistry, and a 
number of different types exist.16 The strength of this type of interaction has a 
typical range of 0-20 kJ mol-1.  
 
“Metallosupramolecular chemistry” was a term first introduced by Constable,17 
and refers to aggregates formed by the combination of organic molecules and 
metal ions. Similar to supramolecular chemistry (of which it is a subset), this area 
also considers interactions other than the covalent bond. Combinations of weak 
interactions lead to complex structures, and the introduction of metal atoms has 
led to a range of interesting new topologies, such as macrocyclic polyhedra,18 
helicates,19 and numerous types of coordination polymers and networks.20, 21 
 
A key concept in supramolecular chemistry is self assembly. This refers to the 
self-organisation of materials resulting in a single supramolecular species. The 
choice of starting materials and their ratios have a significant effect on the 
products. The use of weak interactions, rather than covalent bonds, allows 
continual breaking and reforming to occur, resulting in thermodynamic control. 
The outcome of self-assembly is that the thermodynamically most stable product 
will eventually be formed. An alternative description of this process is “error 
checking”. 
 
In metallosupramolecular chemistry the choice of building blocks is an important 
feature of the process. Transition metals have a wide range of coordination 
numbers and geometries, and with extension to the lanthanides, this can 
increase even more. Additional properties of the metal ions can be used to 
obtain different results. The lability of the metal ion chosen can be used to tune 
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the self-assembly process, while luminescence, and other spectroscopic and 
electronic properties can be incorporated by choice of an appropriate metal 
centre.  
 
The other building blocks in metallosupramolecular chemistry are the organic 
ligands. There is a wide range of different potential geometries available, and 




Coordination complexes, supramolecular and metallosupramolecular aggregates 
are investigated in a wide range of areas. Beyond general coordination 
chemistry1 they are of interest in areas such as new materials research, host-
guest chemistry and solid state reactions. 
 
Chiral complexes are of particular interest in materials science. For example, the 
use of chiral coordination polymers is important in the area of non linear optics.22 
 
1.5 Thesis Coverage 
 
Nicotine and the cinchona alkaloids are readily available, homochiral, aromatic 
heterocycles. They make an ideal starting point for the investigation of chiral 
coordination and metallosupramolecular species. In Chapter 2 the coordination 
and metallosupramolecular chemistry of the unmodified alkaloids is explored. In 
Chapter 3 the modification of nicotine and the cinchona alkaloids towards the 
synthesis of new homochiral aromatic heterocycles is investigated. Chapter 4 
extends from alkaloids to incorporating amino acids into chiral ligands. Chapter 5 
reports the coordination and metallosupramolecular chemistry of the ligands 
synthesized in the previous chapter. 
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Metal Complexes of Alkaloids 




In this chapter the coordination and metallosupramolecular chemistry of two 
members of the alkaloid family of compounds, namely nicotine and quinine, are 
described. As outlined in Chapter 1, these compounds are homochiral ligands, 
consisting of only one enantiomer, and hence can be expected to result in pure 




Nicotine (see Figure 2.1) consists of a pyridine ring, substituted at the 3-position 
with an N-methyl-pyrrolidine ring. Nicotine is extracted from the Nicotiana 
tabacum plant, although it is found in smaller amounts amongst other plants of 
the Solanaceae family. Previous work on the coordination chemistry of nicotine 
has been limited to a few studies, and only a limited number of crystal structures 





Figure 2.1: Nicotine 
 
Original work on the coordination chemistry of nicotine was carried out by 
Smith,23 who investigated the synthesis of nicotine “double salts” of various 
metal salts. Some of these complexes have been synthesized and their three-
dimensional structures explored via X-ray crystallography; this is described in 
Section 2.2.1 of this chapter.  
 
Prior to commencement of this work, only three crystal structures of metal 
complexes of nicotine had been reported, although a number of iodide salts of 
nicotine had also been determined by X-ray crystallography.24 The first crystal 
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structure of a metal complex of nicotine was determined by Udupa and Krebs,25 
and describes a structure in which nicotine acts as a bridging ligand between 
tetrahedral Hg(II) centres, forming a one-dimensional coordination polymer. 
Subsequently an investigation by Haendler,26 detailed the crystal structure of a 
complex in which four nicotine molecules are coordinated to an interesting 
Cu4Cl6O core (see Figure 2.2). In this structure nicotine acts a monodentate 
ligand, coordinated via the pyridine nitrogen. The most recent of these three 
crystal structures was an investigation by Peulecke and co-workers.27 In this 
study nicotine acts as a monodentate ligand, coordinated via the pyridine 
nitrogen to a zirconium complex.  
 
Figure 2.2: A perspective view of the crystal structure determined by Haendler, showing 
the Cu4Cl6O core and the pendant nicotine molecules. Hydrogen atoms are omitted for 
clarity. 
 
After this project had commenced, four more X-ray crystal structures were 
published which use nicotine as a ligand. A paper by Guan and Fischer28 
reported three related complexes, each consisting of a lanthanide metal 
coordinated to three indenyl ligands and a single, pyridine linked, nicotine 
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molecule. More recently, Meyer and co-workers29 reported a silver(I) complex 
identical to complex 9 reported in this chapter (see Section 2.2.2). 
 
Comparison of all previous X-ray crystal structures reveals that only two of the 
possible three bonding modes of nicotine (see Figure 2.3) have been observed; 
coordination of the pyridine nitrogen, and coordination of both the pyridine and 















Figure 2.3: The three possible coordination modes of the nicotine molecule. From left to 
right: monodentate coordination via the pyridine nitrogen, monodentate coordination via 
the pyrrolidine nitrogen, bridging bidentate coordination via both nitrogens. 
 
2.1.2 Quinine and the Cinchona Alkaloids 
 
Quinine is the best-known member of the cinchona family of alkaloids. These 
alkaloids all have the same basic form (see Figure 2.4), with two different 
subsets related by the change from a methoxy-substituent to a hydrogen atom. 
There are five different stereocentres within the quinine molecule, however only 
2 of these vary between different members of the family. Having only two 
variable stereocentres (at C9 and C10 – see Figure 2.4) means that there are 
four different diastereoisomers. As the other stereocentres do not vary, there are 
no true pairs of enantiomers amongst the family; however, due to chemical 
similarity of these different diastereoisomers, they have sometimes been dubbed 
“pseudo-enantiomers”. An example of this is quinine and quinidine. 
 
Quinine (and the related cinchona alkaloids) possesses four possible 
coordination sites. The most obvious is the quinoline nitrogen, and this has been 
 










Figure 2.4: A schematic representation of the cinchona alkaloids.  
 
reported in the work of Oleksyn and co-workers,30 and Beck,31 and the work of 
Xue and co-workers.32, 33 The amine nitrogen is the second obvious donor site; 
this site has not been observed to coordinate in any complexes with quinine as a 
monodentate donor. The third site is the alcohol oxygen, and again, this site has 
not been observed in any complexes with quinine as a monodentate donor. 
However these two donor sites can coordinate in a cooperative fashion, with 
quinine acting as a bidentate chelating ligand. This coordination mode has been 
observed in the work of Hubel, Polborn and Beck,31 as well as Missling and co-
workers.34 The final coordination mode is via the vinyl group; this coordination 
mode has been observed in the work of Hubel, Polborn and Beck,31 and by Xie 
and co-workers.32 It should be noted that the work of Xie and co-workers32 
involves the synthesis of coordination networks formed by copper(I)-halide 
clusters and bridging cinchona alkaloids, with coordination to both quinoline 
nitrogen and the alkene group. The work of Hubel, Polborn and Beck31 involves 
discrete complexes utilising each of the three coordination modes above, as well 
as a discrete complex that involves coordination to both the quinoline nitrogen 
and the chelating bidentate donor set. 
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2.2 Complexes of Nicotine 
 
2.2.1 Complexes of Nicotine: M(SCN)4(Nicotine.H)2 Series 
 
Initial investigation of transition metal complexes of nicotine involved the 
repetition of syntheses from the work of Smith.23 This paper detailed the 
synthesis and elemental analysis of a number of nicotine-transition metal 
complexes, although no further structural elucidation was attempted. 
 
Synthesis of the Complexes 
 
All the complexes were prepared by reacting an aqueous solution of an 
appropriate metal salt and ammonium thiocyanate with an ethanolic solution of 
nicotine. Slow evaporation of the solution generally furnished crystals suitable for 
X-ray crystallography. Cobalt(II) (1), nickel(II) (2), copper(II) (3), and cadmium(II) 
(4) complexes were all synthesized in this manner, with yields of 88%, 98%, 29% 
and 75%, respectively.  
 
Synthesis of an iron(II) complex (5) required the use of deoxygenated solvents 
under an inert atmosphere (N2), and resulted in a small number of low quality 
crystals, as well as a large amount of non-crystalline by-products. Although the 
crystals appeared of high quality, and even gave apparently high quality data, a 
solution to the crystal structure could not be found. The crystal system and space 
group were readily identified, and were in close agreement with other complexes 
in this series (see Table 2.1). However the lack of a structural solution makes the 
exact nature of this complex uncertain. The most that can be said is that this 
complex resembles others in the series. 
 
Synthesis of a manganese(II) complex (6) involved the same deoxygenated 
solvent/inert atmosphere conditions as that of the iron complex, as well as the 
use of freshly recrystallized manganese(II) acetate. This complex crystallized as 
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a large number of poor quality crystals, which were relatively unstable to the 
presence of oxygen. The low crystal quality meant that although the crystal 
structure could be solved, with the same motif observed as in the previous 
structures, it could not be refined satisfactorily. The instability of the product to 
oxygen precluded any further analysis, as the submitted product was invariably 
contaminated with manganese(IV) oxide. 
 
The copper(II) complex (3) could also be synthesized in an alternative manner to 
that detailed above. An attempt was made to synthesize a copper(I)-nicotine-
thiocyanate complex by combining a solution of tetrakis(acetonitrile)copper(I) 
tetrafluoroborate in acetonitrile with a solution of nicotine in 40% aqueous  
calcium thiocyanate solution. Slow evaporation of the solution provided crystals 
suitable for X-ray crystallography, which proved identical to those provided by 
the earlier synthesis. 
 
Initial synthesis of the nickel(II) complex (2) was also different to that detailed 
above, and resulted in more than one crystalline product being formed. Reaction 
of hexa(aqua)nickel(II) perchlorate dissolved in water with a solution of nicotine 
in ethanol was followed by addition of a solution of sodium thiocyanate in water. 
Upon addition of the final solution a pale blue precipitate formed. After further 
standing for ~3 days two different crystalline products had formed, pale blue 
crystals (2) (which ultimately were identical to those synthesized using the 
method detailed above) and purple crystals (7- see Section 2.2.3). The purple 
and pale blue crystals were separated by manual sorting under a microscope. 
 
Structure of 1 
 
Complex 1 crystallizes in the monoclinic space group C2, as a 2:1 ligand:metal 
complex. Hydrogen bonding between adjacent complexes forms a two-
dimensional network in the xy plane. The asymmetric unit consists of a cobalt 
centre on the 2-fold axis, coordinated to a nicotine molecule via the pyridine 
nitrogen, as well as two N-bound thiocyanates. Generation of the symmetry 
equivalent thiocyanates and nicotine reveal the octahedral geometry of the 
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cobalt centre, with the nicotine molecules having a trans relationship (see Figure 
2.5). The charge balance of the complex is accounted for by protonation of the  
 
 
Figure 2.5: A perspective view of 1, with symmetry equivalent nicotine and thiocyanates 
denoted by the suffix A. Hydrogen atoms and the minor component of the disordered 
thiocyanate sulfur atoms are omitted for clarity. Selected bond length (Å) and angle (°): 
Co(1)-N(1) 2.180(2), Co(1)-N(20) 2.134(2), Co(1)-N(21) 2.088(2), N(1)-Co(1)-N(1A) 179.59(11), 
N(1)-Co(1)-N(20) 91.11(8), N(1)-Co(1)-N(20A) 88.59(8), N(1)-Co(1)-N(21) 92.42(7), N(1)-Co(1)-
N(21A) 87.86(7), N(20)-Co(1)-N(20A) 85.33(11), N(20)-Co(1)-N(21) 89.84(8), N(20)-Co(1)-
N(21A) 175.09(8), N(21)-Co(1)-N(21A) 95.00(11). 
 
Figure 2.6: A perspective view of the (4,4) hydrogen bonding network looking down the z-
axis. Hydrogen atoms and minor components of the disordered sulfur atoms are omitted 
for clarity.  
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amine nitrogen of the nicotine molecule. This proton was located from the 
electron density difference map, and then placed in a calculated position. Both 
the terminal sulfur atoms of the thiocyanates are disordered over two positions. 
Two of the four thiocyanates (symmetry equivalent to each other) are hydrogen 
bonded to the protonated amines of an adjacent cobalt unit, to form a two-
dimensional network. This (4,4) network extends in the xy-plane (see Figure 2.6). 
 
Structure of 2 
 
The structure of 2 (see Figure 2.7) is isostructural with that of 1; it crystallizes in 
the monoclinic space group C2, as a 2:1 ligand:metal complex. It possesses the 
same intra- and inter-molecular structural features, including an identical 
hydrogen bonding network. 
 
 
Figure 2.7: A perspective view of complex 2. Hydrogen atoms and the minor component of 
the disordered thiocyanate sulphurs are omitted for clarity. Selected bond lengths (Å) and 
angles (°): Ni(1)-N(1) 2.125(3), Ni(1)-N(20) 2.066(3), Ni(1)-N(21) 2.097(3), N(1)-Ni(1)-N(1A) 
179.72(18), N(1)- Ni (1)-N(20) 92.28(13), N(1)-Ni(1)-N(20A) 87.91(13), N(1)-Ni(1)-N(21) 
91.03(13), N(1)-Ni(1)-N(21A) 88.76(13), N(20)-Ni(1)-N(20A) 93.40(19), N(20)-Ni(1)-N(21) 
90.43(14), N(20)-Ni(1)-N(21A) 176.06(14), N(21)-Ni(1)-N(21A) 85.7(2). 
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Structure of 3 
 
Complex 3 crystallizes in the monoclinic space group P21, as a 2:1 ligand:metal 
complex. Hydrogen bonding between adjacent complexes forms a one-
dimensional polymer along the y-axis. As opposed to the previous two 
structures, 3 crystallizes with the entire copper unit in the asymmetric unit. The 
copper centre has a square pyramidal geometry, with three nitrogen bound 
thiocyanates (one in the apical position), and two pyridine bound nicotines, trans 
to each other. Both nicotine molecules are protonated at the amine nitrogen, and 
the charge balance is accounted for by a non-coordinated thiocyanate anion, 
which is hydrogen bonded to one of the amine protons via the nitrogen terminus 
(see Figure 2.8). The bond distances between the copper and the ligands are 
typical of such complexes, ranging from 1.980(3) to 2.044(3) Å for the basal 
ligands, and 2.223(3) Å for the apical thiocyanate, showing the expected Jahn- 
 
Figure 2.8: The asymmetric unit of complex 3. Hydrogen atoms and the minor component 
of the disordered thiocyanate sulfur atom are omitted for clarity. The hydrogen bond 
between N(8) and N(43) is shown as a dashed line. Selected bond lengths (Å) and angles 
(°): Cu(1)-N1 2.044(3), Cu(1)-N(21) 2.057(2), Cu(1)-N(40) 2.001(3), Cu(1)-N(41) 1.980(3), 
Cu(1)-N(42) 2.223(3), N(1)-Cu(1)-N(21) 172.99(12), N(1)-Cu(1)-N(40) 90.82(12), N(1)-Cu(1)-
N(41) 87.91(11), N(21)-Cu(1)-N(40) 88.18(12), N(21)-Cu(1)-N(41) 91.15(12), N(21)-Cu(1)-N(42) 
91.55(12), N(40)-Cu(1)-N(41) 164.14(13), N(40)-Cu(1)-N(42) 96.13(14), N(41)-Cu(1)-N(42) 
99.72. 
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Teller distortion. The copper centre is displaced from the basal plane slightly 
towards the axial thiocyanate, with apical-basal angles of 99.72(14) (N41-Cu1-
N42), 96.13(14) (N40-Cu1-N42), 95.45(12) (N1-Cu1-N42) and 91.55(12)° (N21- 
Cu1-N42). The empty site which would complete an octahedral donor set has a 
weak (3.358 Å) interaction to the hydrogen bonded thiocyanate of an adjacent 
complex. The extended structure results from the hydrogen bonding of an amine 
proton to the terminal sulfur of the thiocyanate of an adjacent copper unit. The 
hydrogen bonding extends as a zigzag one-dimensional polymer along the y-
axis. Examination of the packing in the yz plane reveals that the one-dimensional 
polymers pack together in such a way as to mimic the two-dimensional network 
of the previous two complexes (see Figure 2.9). The different planes in which the 
packing and network occur (xy and yz respectively) is due to the differing space 
groups of the two complexes – space group C2 constrains the x- and z-axes, 
while space group P21 follows standard crystallographic practices, in which the 
shorter axis is designated the x-axis. 
 
Figure 2.9: A packing diagram of complex 3 looking down the x-axis. On the left-hand 
side, with solid bonds, is a hydrogen bonded chain. On the right-hand side is another 
hydrogen bonded chain, which demonstrates how the two chains pack together, similar to 
the two-dimensional networks of the earlier complexes. 
 




Complex 4 crystallizes in the monoclinic space group C2, as a 2:1 ligand:metal 
complex. Similar to structures 1 and 2, hydrogen bonding to adjacent cadmium 
units extends to a two-dimensional (4,4) network in the xy plane. The asymmetric 
unit consists of a cadmium centre located on the 2-fold rotation axis, coordinated 
to a nicotine molecule via the pyridine nitrogen, and coordinated to two 
thiocyanate anions, one via the nitrogen terminus and one via the sulfur 
terminus. The larger size of the (second row transition metal) cadmium atom 
means that there is space for the larger sulfur donor to coordinate (see Figure 
2.10), a difference from the smaller metals in the previous complexes. In the 
same manner as the structures of 1 and 2, generation of the symmetry 
equivalent thiocyanates and nicotine units reveals the octahedral geometry of the 
complex. The charge balance is again accounted for by protonation of the 
nicotine molecules at the amine nitrogens. The hydrogen bonding network is 
similar to that of 1 and 2, but with hydrogen bonding to the sulfur-bound 
thiocyanates, via the nitrogen terminus. Obviously this mode is not available in 
the other structures where the thiocyanates are all nitrogen-bound with only the 
sulfur terminus available for hydrogen bonding. 
 
Figure 2.10: A perspective view of complex 4. Hydrogen atoms are omitted for clarity. 
Selected bond lengths (Å) and angles (°): Cd(1)-N(1) 2.349(3), Cd(1)-S(20) 2.7479(13), 
Cd(1)-N(21) 2.302(5), N(1)-Cd(1)-N(1A) 178.1(3), N(1)-Cd(1)-S(20) 85.72(12), N(1)-Cd(1)-
S(20A) 95.54(12), N(1)-Cd(1)-N(21) 90.69(18), N(1)-Cd(1)-N(21A) 88.06(18), S(20)-Cd(1)-
S(20A) 95.19(6), S(20)-Cd(1)-N(21) 84.98(13), S(20)-Cd(1)-N(21A) 173.77(14), N(21)-Cd(1)-
N(21A) 95.5(3). 




Complex 6 crystallizes in the monoclinic space group C2, and has a structure 
very similar to that of the previous complexes that crystallized in this space group 
(see Figure 2.11). The quality of the crystals was such that initially the structure 
could only be solved in triclinic space group P1 and the correct higher symmetry 
space group and crystal system could not be determined. The initial cell used to 
solve the crystal structure was anorthic, although it was apparent from the 
structure that the complex should be isomorphous with the earlier structures. 
Eventually a monoclinic cell was found, and the structure solved in space group 
C2. When compared to other complexes in this series, the unit cell is slightly, but 
significantly, smaller (see Table 2.1). The effect of this on the structure of the 
complex is observed in the packing effects; there is an additional hydrogen bond 
to the thiocyanate of an adjacent molecule. This hydrogen bond does not affect 
the overall packing, which remains the same (see Figure 2.12), but does affect 
the description of the network. The network can now be described as a (2,8)  
 
Figure 2.11: A perspective view of complex 6. Hydrogen atoms and disordered sulfur 
atoms of thiocyanates are omitted for clarity. Selected bond lengths (Å) and angles (°): 
Mn(1)-N(1) 2.292(6), Mn(1)-N(20) 2.150(12), Mn(1)-N(21) 2.220(12), N(1)-Mn(1)-N(1A) 179.2(6), 
N(1)-Mn(1)-N(20) 86.9(3), N(1)-Mn(1)-N(20A) 92.6(3), N(1)-Mn(1)-N(21) 88.9(4), N(1)-Mn(1)-
N(21A) 91.7(4), N(20)-Mn(1)-N(20A) 96.0(6), N(20)-Mn(1)-N(21) 89.5(4), N(20)-Mn(1)-N(21A) 
174.3(5), N(21)-Mn(1)-N(21A) 85.0(6). 
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Figure 2.12: A packing diagram of complex 6 looking down the z-axis. The additional 
hydrogen bonds change the description of the network, but do not change the overall 
packing of the structure. 
 
network, as opposed to the (4,4) network, which describes the previous 
complexes. 
 
Comparison of the M(SCN)4(Nicotine.H)2 Series 
 
This series of compounds can be readily compared and contrasted in a number 
of different ways; some of these comparisons have been noted above for the 
individual compounds. One section not fully explored previously is the 
comparison of the unit cell parameters of the different complexes (see Table 
2.1). Comparison of these parameters reveals a number of features which can 
be explained or related to features within the structures themselves. Overall 
consideration of the unit cell lengths reveals, unsurprisingly, that they are all of 
similar dimensions. The two “most similar” structures, those of 1 and 2, have  
 - 22 - 
 
 a (Å) b (Å) c (Å) β (°) V (Å3) R1 (%) 
1 19.059(9) 10.772(5) 7.434(3) 107.09(3) 1458.9(11) 2.63 
2 18.94(2) 10.805(13) 7.435(9) 106.88(4) 1456(3) 4.55 
3† 18.236(6) 10.850(4) 7.478(2) 97.757(4) 1466.0(8) 4.00 
4 19.505(4) 10.818(2) 7.4438(16) 106.141(2) 1508.8(5) 3.95 
6 18.514(7) 10.606(4) 7.321(3) 93.943(3) 1434.2(9) 11.39 
5 19.288(2) 10.757(1) 7.454(1) 107.260(1) 1476.9(5) NA 
Table 2.1: A comparison of the unit cell parameters of the M(SCN)4(Nicotine.H)2 series of 
compounds. The R1 value is included for comparison. † The a- and c-axes for B6 have 
been inverted for ease of comparison. 
 
extremely similar unit cell parameters, and will be used as a baseline for 
comparison and contrast. 
 
 
Complex 3 has a shorter a-axis, but a less obtuse β-angle which means that the 
cell volume is slightly larger than that of the two baseline complexes. This 
difference can be attributed to this being the only complex of this series to 
crystallize in a space group other than C2 (P21). The structural difference of the 
complex, with a non-coordinated thiocyanate molecule, is the cause of this. It 
could be considered surprising that the cell parameters are still so similar, and 
that this complex maintains a packing arrangement so similar to the others in the 
series. 
 
Complex 4 has a longer a-axis, and larger cell volume than the baseline 
complexes. This is due to the use of a (larger) metal, as opposed to the first row 
transition metals used for the baseline complexes. As noted above, this leads to 
one of the two thiocyanates, in the asymmetric unit, coordinated via the sulfur 
terminus as opposed to the nitrogen terminus. Again, this change does not 
significantly alter the overall packing of the complex, which is almost identical to 
that of the baseline complexes. An interesting feature is that when both sulfur 
and nitrogen termini of thiocyanate are available as hydrogen-bond acceptors, 
the nitrogen is bonded in preference. 
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Complex 6 is smaller in all dimensions, with a similar β-angle when compared 
with the baseline complexes. This is unsurprising when the structure is taken into 
account; the increased intermolecular interactions (an increased number of 
hydrogen bonds), makes the packing of this complex tighter, hence the reduced 
size of the unit cell. For this series, the overall packing is still extremely close to 
that of the baseline complexes.  
 
Although the cell determination of 5 was of high quality, and the data were highly 
internally consistent (post absorption correction Rint of 2.13%), no solution could 
be obtained, probably due to some sort of twinning. Simple examination of the 
unit cell parameters shed little light beyond the obvious on the nature of the 
structure. The parameters are consistent with a complex closely related to the 
previous ones, however, the parameters are larger than those for both 
complexes 6 (manganese) and 1 (cobalt), which reside to either side of 5 (iron) 
in the periodic table. This indicates that there is some sort of structural variation, 
in all probability not yet explored in the previous complexes. One possibility, 
consistent with the red colour of the crystals, is that only a single nicotine 
molecule is protonated, and the iron exists in the Fe(III) oxidation state. 
 
Another feature that can be compared between different complexes in this series 
is the relative orientation of the pyrrolidine ring with respect to the pyridine ring. A 
related detail is the relative conformation of the methyl group; whether a cis or 
trans relationship to the pyridine ring exists. Earlier work by Whidby and co-
workers, on the basis of computational work, NMR and one X-ray crystal 
structure, as well as some knowledge of related systems, concluded that there is 
a perpendicular relationship between the pyrrolidine and pyridine rings35, 36 and 
that the methyl group had a trans relationship to the pyridine ring.37 If we 
compare the orientation of the nicotine rings amongst this series, by overlaying 
the nicotine molecules from the five different complexes for which crystal 
structures were obtained, we can see that all the nicotine molecules have very 
similar geometry (see Figure 2.13). This can further be compared to the 
perpendicular orientation suggested by Whidby and co-workers, and it is 
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apparent that the original conformation proposed is very close to that observed in 
this series of compounds in the solid state (see Figure 2.14). 
 
Figure 2.13: A representation of how the different nicotine molecules from complexes 1, 2, 
3, 4 and 6 compare. All complexes have been fitted with the pyridine ring in a constant 
position, showing the difference in relative configuration of the pyrrolidine rings. 
 
 
Figure 2.14: A comparison of the original conformation proposed by Whidby and co-
workers (left), and the conformation of the nicotine molecule in complex 1 (right) 
 
2.2.2 Complexes of Nicotine: Silver Complexes 
 
Silver(I) has been used extensively for the synthesis of coordination and 
metallosupramolecular complexes, both by this group and others.8, 21, 38, 39 
Silver(I) has a wide variety of coordination modes, ranging from 2- to 6-
coordinate, and has flexible coordination geometry. For these reasons it was 
attractive as a metal centre in this study.  
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Investigation of the coordination chemistry of nicotine with silver(I) involved the 
reactions with various silver(I) salts. Reaction of one equivalent of nicotine with 
one equivalent of silver nitrate, followed by the slow diffusion of diethyl ether into 
the reaction mixture resulted in 8 depositing from solution as crystals suitable for 
X-ray crystallography in a yield of 56%. Analysis of this complex by 1H-NMR 
revealed contact induced shifts for the aromatic protons. Analysis by 
electrospray mass-spectroscopy showed the major component in solution was a 
1:1 silver(I):nicotine species, although more complex mixtures of silver(I), 
nicotine, nitrate and acetonitrile (the solvent used for the procedure) were 
observed. The crystals were suitable for X-ray crystallography, and the structure 
of the complex was determined by this method. 
 
Further investigation into the coordination of nicotine with silver(I) involved both 
different ratios of silver:nicotine and the use of different counter ions. Reaction of 
three equivalents of nicotine with one equivalent of silver nitrate under the same 
conditions as for synthesis of the 1:1 complex yielded a crystalline complex 
suitable for X-ray crystallography. Elemental analysis revealed a 1:2 
silver:nicotine ratio, and complex 9 was produced in a yield of 74%. Analysis of 
the complex by 1H-NMR again revealed contact induced shifts, although smaller 
that those of the 1:1 complex. The structure of the complex was determined by 
X-ray crystallography, and the 1:2 silver:nicotine ratio confirmed. 
 
The third silver-nicotine complex investigated involved the use of a different 
counter ion. Reaction of a 1:1 mixture of silver tetrafluoroborate and nicotine 
under the same conditions as the previous complexes resulted in a crystalline 
product suitable for X-ray crystallography. The complex (10) was synthesized in 
72% yield. Elemental analysis of this complex showed a 1:1 silver 
tetrafluoroborate:nicotine ratio. It is believed that solvent is lost from the complex 
in the process of analysis, as the crystal structure revealed solvent molecules in 
the complex. 
 
The contact induced shift of proton resonances in the silver-nicotine complexes 
is smaller than that with more inert metal centres (see Table 2.2). This is  
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Molecule δ(H2) ppm δ(H4) ppm δ(H5) ppm δ(H6) ppm 
Nicotine 8.61 7.40 7.81 8.54 
8 8.70 7.56 7.99 8.55 
9 8.69 7.36-7.40 7.82-7.85 8.54 
8-nicotine +0.09 +0.16 +0.18 +0.01 
9-nicotine +0.08 -0.02 (av.) +0.025 (av.) +0.00 
Table 2.2: A comparison of the chemical shifts of the pyridine ring protons of nicotine, 8 
and 9.  
 
probably due to the weak silver-nicotine bond and a rapid equilibrium between 
coordinated and non-coordinated nicotine molecules. 
 
Structure of 8 
 
Complex 8 is a three-dimensional network, with both the nicotine molecule and 
the nitrate counter ion acting as bridges between different silver(I) atoms. The 
complex crystallizes in the orthorhombic space group P212121. The deceptively 
 
Figure 2.15: The coordination sphere of 8. Atoms N(8A) and O(12A) are symmetry 
equivalents of N(8) and O(12) respectively. Hydrogen atoms have been omitted for clarity. 
Selected bond lengths (Å) and angles (°): Ag(1)-N(1) 2.301(2), Ag(1)-N(8A) 2.381(2), Ag(1)-
O(11) 2.579(2), Ag(1)-O(12A) 2.451(2), N(1)-Ag(1)-O(11) 85.22(6), N(1)-Ag(1)-N(8A) 125.35(6), 
N(1)-Ag(1)-O(12A) 127.85(7), O(11)-Ag(1)-N(8A) 102.81(7), O(11)-Ag(1)-O(12A) 123.47(7), 
N(8A)-Ag(1)-O(12A) 92.48(7). 
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Figure 2.16: A perspective view of the silver-nicotine-silver motif along the z-axis. 
Hydrogens and nitrate counter ions have been omitted for clarity. 
 
Figure 2.17: The three-dimensional coordination network of 8. 
 
simple asymmetric unit consists of a single silver centre coordinated to a nicotine 
through the pyridine nitrogen, and to a nitrate through an oxygen. The 
coordination sphere (see Figure 2.15) of the silver atom is completed by 
coordination of a symmetry equivalent nicotine through the amine nitrogen, and 
the oxygen of a symmetry equivalent nitrate. The geometry around the silver 
atom is a distorted tetrahedron, with angles ranging from 85.22(6) to 127.85(7)°. 
The silver-nicotine-silver motif forms a one-dimensional helical polymer, 
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propagating via the 21 screw axis in the z-direction (see Figure 2.16). These 
polymers are also directional, as the nicotine is asymmetric, so the two ends of 
the polymer are distinct from each other. A consequence of the space group in 
which the complex crystallized is that polymers going in both directions coexist in 
the same crystal. These one-dimensional chains are cross-linked by the nitrates 
to form the three-dimensional network (see Figure 2.17). Pairs of silver atoms 
bridged by the nicotine molecules are separated by 7.886 Å, while those bridged 
by nitrate anions are 5.715 Å apart. 
 
Structure of 9 
 
Complex 9 crystallizes as a one-dimensional coordination polymer in the 
monoclinic space group P21, with one of two nicotine molecules acting as the 
bridging ligand between silver centres. The asymmetric unit consists of a silver 
centre coordinated by two nicotine molecules via pyridine nitrogens, as well as 
an oxygen coordinated nitrate. The coordination sphere is completed by the 
symmetry equivalent amine nitrogen of one of the nicotine molecules, while the 
other remains hypodentate (see Figure 2.18). The geometry around the silver 
centre is again distorted tetrahedral, with angles ranging from 91.01(7) to 
120.14(8)°, a less severe distortion than in complex 8. The silver-nicotine-silver 
motif propagates via the 21 screw axis in the y-direction. Again this is a helical, 
directional coordination polymer, and when compared to the silver-nicotine-silver 
motif from complex 8 (ignoring additional ligands) is almost identical (see Figure 
2.19). The distance between silver atoms bridged by nicotine molecules in this 
case is 8.019 Å. A consequence of the space group in this case is that the entire 
crystal consists of polymer chains all having the same direction, so overall the 
crystal is unidirectional. The pendant nicotine molecules interdigitate into cavities 
within the adjacent polymer chain in the z-direction (see Figure 2.20). 
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Figure 2.18: The coordination sphere of the silver centre in 9. N(8A) is the symmetry 
equivalent of N(8). Hydrogen atoms have been omitted for clarity. Selected bond lengths 
(Å) and angles (°): Ag(1)-N(1) 2.323(2), Ag(1)-N(21) 2.298(2), Ag(1)-N(8A) 2.405(2), Ag(1)-
O(41) 2.500(2), N(1)-Ag(1)-N(21) 120.14(8), N(1)-Ag(1)-N(8A) 117.93(7), N(1)-Ag(1)-O(41) 
91.01, N(21)-Ag(1)-N(8A) 106.76(8), N(21)-Ag(1)-O(41) 116.05(8), N(8A)-Ag(1)-O(41) 
103.19(7). 
 
Figure 2.19: A perspective view of the silver-nicotine-silver motif along the y-axis. 
Hydrogens, nitrate counter ions, and the pendant nicotine molecules have been omitted 
for clarity. 
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Figure 2.20:  A view of the packing in the yz-plane, showing how the pendant nicotines 
interdigitate. 
 
Structure of 10 
 
Complex 10 crystallizes in the monoclinic space group P21, as a one-
dimensional coordination polymer, in which nicotine acts as a bridge between 
silver centres. The asymmetric unit of the complex consists of a silver centre 
coordinated to two acetonitrile molecules and a nicotine via the pyridine nitrogen, 
as well as a non-coordinated, disordered, tetrafluoroborate counter ion (see 
Figure 2.21). The coordination sphere of the silver is completed by the amine 
nitrogen of a translationally related nicotine molecule. The geometry around the 
silver centre is again distorted tetrahedral, with angles ranging from 86.5(1) to 
127.9(1)°, a similar distortion to 8. The silver-nicotine-silver motif propagates 
along the x-direction, with a silver-silver distance of 7.602 Å, the length of the a-
axis. The polymer chains in this complex are generated by translation, which 
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Figure 2.21: The asymmetric unit of 10. Hydrogen atoms and the minor component of the 
tetrafluoroborate counter ion are omitted for clarity. Selected bond lengths (Å) and angles 
(°): Ag(1)-N(1) 2.334(3), Ag(1)-N(21) 2.572(4), Ag(1)-N(31) 2.329(3), Ag(1)-N(8A) 2.326(3), 
N(1)-Ag(1)-N(21) 86.49(11), N(1)-Ag(1)-N(31) 99.70(11), N(1)-Ag(1)-N(8A) 127.93(9), N(21)-
Ag(1)-N(31) 113.75(13), N(21)-Ag(1)-N(8A) 94.54(12), N(31)-Ag(1)-N(8A) 126.3(1). 
 
Figure 2.22: The packing of complex 10 in the xz-plane. Hydrogens and the minor 
component of the counter ion have been omitted for clarity. 
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differs to those in 8 and 9, which are generated by a screw axis. Again, this 
polymer is directional, due to the asymmetric nature of the bridging ligand. 
Polymer chains going in opposite directions exist in each crystal, so overall they 
are not directional (unlike 9). The tetrafluoroborate counter ions occupy the voids 
between polymer chains (see Figure 2.22). 
 
Comparison of Silver Complexes 
 
As with the previous section, there are further comparisons that can be made 
between the different complexes. In this case comparing the overall cell 
characteristics does not reveal any trends, however comparison of the 
conformation of the different nicotine molecules is still useful. The four nicotine 
molecules from three different structures all have very similar relative ring 
conformations (see Figure 2.23). Again this conformation is very similar to that 
proposed originally by Whidby and co-workers (see Section 2.2.1 for more 
details). The three complexes described in this section were published together 
under the title “Chiral Heterocyclic Ligands. XI. Self-assembly and X-Ray Crystal 
Structures of Chiral Silver Coordination Polymers of (S)-(-)-Nicotine”.40 
 
Figure 2.23: The relative conformations of the 4 different nicotine molecules in complexes 
8, 9 and 10. Pyridine rings have been fitted as being coincident to compare the relative 
conformations of the pyrrolidine rings of different molecules. 
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2.2.3 Complexes of Nicotine: Other Metal Complexes 
 
A number of other coordination complexes were synthesized in the course of this 
project, for a variety of reasons. Complex 7, for example, was synthesized as a 
by-product in the synthesis of another complex (2).  
 
Ruthenium complexes are widely studied for a variety of reasons. They have 
been studied extensively in this group,39, 41 with their electrochemical and 
structural properties being of interest. Ruthenium tris(bipyridyl) complexes have 
inherent chirality, and are generally synthesized as a mixture of two enantiomers. 
Synthesis of a bis-nicotine adduct would provide the complex as a mixture of two 
diastereoisomers, which could potentially be separated, and could have 
interesting properties. This provided the incentive for the synthesis of 11. 
 
A method of avoiding the inherent chirality of the ruthenium bis(bipyridyl) system 
is to use a ruthenium terpyridine bipyridine system; in this case the central metal 
atom is achiral, and all of the chirality comes from the monodentate substituent. 
The use of nicotine (which is supplied as a single enantiomer) in the synthesis of 
such a complex (12) would result in a chiral ruthenium complex which is achiral 
at the metal centre. 
 
Synthesis of a complex in which nicotine acted only as a monodentate ligand, 
and was not protonated was targeted. One method of achieving such geometry 
is the use of a square-planar metal centre coordinated to a terpyridine, leaving 
only one possible coordination site. This approach led to 13. 
 
Synthesis of the Complexes 
 
Complex 7 was synthesized as detailed in Section 2.2.1, with a yield of 18%. A 
number of crystals were trialled for X-ray crystallography before a suitable one 
was found, however this crystal was still of low quality, and the X-ray crystal 
structure was also of low quality. 
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An attempt was made to synthesize a ruthenium bis-bipyridyl, bis-nicotine 
complex (11 – see Figure 2.24). Bis(2,2’-bipyridine)dichlororuthenium(II) was 
reacted with several equivalents of nicotine and the product was isolated with a 
yield of 56% following workup. Examination of the complex by 1H-NMR showed 
that only one chloride had been displaced and the mono-chloro, mono-nicotine 
complex (12) had been synthesized. Attempts were made to synthesize the bis-
nicotine complex via removal of the chloride with silver salts, as well as using a 
ruthenium complex with more readily replaced counter ions (in this case triflate). 
Neither method resulted in the desired bis-nicotine complex 11. Following the 
synthesis of the original complex, a microwave reactor became available (a 
domestic microwave adapted for chemical synthesis). The synthesis of 11 was 
attempted via this method as well. Bis(2,2’-bipyridine)dichlororuthenium(II) and 
several equivalents of nicotine were dissolved in ethylene glycol, with a drop of 
water added. The solution was heated by ten consecutive exposures in the 
microwave reactor for 30 seconds each at 600 watts, interspersed by careful 
swirling of the solution. Initial examination of the product by 1H-NMR following 
workup indicated that 12 had again been synthesized, so this method was 









Figure 2.24: The attempted synthesis of 11, which results in 12. 
 
After the attempted synthesis of 11, it was decided to attempt the synthesis of a 
similar complex that would not possess any chlorides, namely a ruthenium 
terpyridine bipyridine complex. (2,2’-Bipyridine)chloro(2,2’:6’,2”-
terpyridine)ruthenium(II) hexafluorophosphate was synthesized by literature 
methods,42 with a yield of 53%. This precursor was reacted with nicotine in 1:1 
ethanol:water, and isolated in a manner identical to 12. Purification by column 
chromatography provided an orange solid. Examination of this solid by 1H-NMR 
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confirmed the identity as the desired product (13). Numerous attempts failed to 
recrystallize this complex. 
 
After the successful synthesis of 13, in an attempt to crystallize a structure in 
which the nicotine molecule acts as a monodentate ligand, synthesis of a 
copper-terpyridine-nicotine complex (14) was attempted. Hexa(aqua)copper(II) 
perchlorate was reacted with a slight excess of nicotine and subsequently with 
half that amount of 2,2’:6’,2”-terpyridine. The solid formed was removed by 
filtration, and the desired product obtained in a yield of 53% by the slow diffusion 
of diethyl ether into the filtrate. 
 
Structure of 7 
 
Complex 7 crystallizes in the monoclinic space group P21, as a 4:1 ligand:metal 
complex. The asymmetric unit contains two complexes, which each consist of a 
central octahedral nickel atom coordinated to four nicotine molecules through the  
 
 
Figure 2.25: A perspective view of a single molecule of complex 7. Hydrogen atoms are 
omitted for clarity. 
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Figure 2.26: A perspective view of the contents of the asymmetric unit of complex 7. 
Hydrogen atoms and the minor component of the disordered thiocyanate sulfur atom are 
omitted for clarity. Selected bond lengths (Å), and angles (°): Ni(1)-N(1) 2.044(6), Ni(1)-N(2) 
2.051(6), Ni(1)-N(21) 2.115(5), Ni(1)-N(41) 2.158(5), Ni(1)-N(61) 2.130(5), Ni(1)-N(81) 2.141(5), 
N(1)-Ni(1)-N(2) 177.6(3), N(1)-Ni(1)-N(21) 90.9(2), N(1)-Ni(1)-N(41) 91.6(3), N(1)-Ni(1)-N(61) 
91.1(2), N(1)-Ni(1)-N(81) 88.4(2), N(2)-Ni(1)-N(21) 88.4(2), N(2)-Ni(1)-N(41) 91.6(3), N(2)-Ni(1)-
N(61) 89.8(2), N(2)-Ni(1)-N(81) 89.3(3), N(21)-Ni(1)-N(41) 90.3(2), N(21)-Ni(1)-N(61) 175.6(2), 
N(21)-Ni(1)-N(81) 93.3(2), N(41)-Ni(1)-N(61) 85.7(2), N(41)-Ni(1)-N(81) 176.4(2), N(61)-Ni(1)-
N(81) 90.7(2), Ni(2)-N(3) 2.056(6), Ni(2)-N(4) 2.039(6), Ni(2)-N(121) 2.119(5), Ni(2)-N(141) 
2.131(6), Ni(2)-N(161) 2.127(5), Ni(2)-N(181) 2.131(6), N(3)-Ni(2)-N(4) 176.9(3), N(3)-Ni(2)-
N(121) 88.9(2), N(3)-Ni(2)-N(141) 91.2(2), N(3)-Ni(2)-N(161) 91.1(2), N(3)-Ni(2)-N(181) 87.9(2), 
N(4)-Ni(2)-N(121) 89.5(2), N(4)-Ni(2)-N(141) 91.5(2), N(4)-Ni(2)-N(161) 90.6(2), N(4)-Ni(2)-
N(181) 89.6(2), N(121)-Ni(2)-N(141) 90.9(2), N(121)-Ni(2)-N(161) 177.1(3), N(121)-Ni(2)-N(181) 
92.6(2), N(141)-Ni(2)-N(161) 86.2(2), N(141)-Ni(2)-N(181) 176.4(2), N(161)-Ni(2)-N(181) 90.3(2). 
 
pyridine nitrogen in equatorial positions, with two thiocyanates coordinated 
through the nitrogen terminus in axial positions (see Figure 2.25 for an example 
of one molecule). Each complex has a half-occupied water molecule associated 
with it (see Figure 2.26 for the asymmetric unit), in an appropriate position to 
hydrogen bond to the amine nitrogen of one of the coordinated nicotine 
molecules; unfortunately the hydrogen atoms of the water molecules could not 
be located in the electron-density difference map, and so were not assigned in 
the structure. Beyond this possible hydrogen bond there are no further hydrogen 
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bonds in or between the molecules. The two molecules are related by a pseudo-
c-glide plane; however the use of chiral substituents (nicotine) precludes this.43 
In each molecule the nicotine pyridines exhibit a propeller-like relationship 
around the central nickel atom. Interestingly, the pyrrolidine rings of the nicotine 
are not arranged in a typical alternating up-down-up-down arrangement with 
respect to each other and the equator. Instead they are arranged in an up-up-
down-down fashion. The extended structure exhibits no notable intermolecular 
interaction between adjacent molecules, and the packing overall is 
unremarkable. 
 
Comparison of the relative conformation of the nicotine molecules by overlaying 
shows that they all very similar (see Figure 2.27). Interestingly the relative 
position of the pyridine nitrogen is different in this structure, rotated 180° when 
compared to the position in previous complexes in this chapter. However the 
relative conformation of the two rings is still perpendicular. 
 
Figure 2.27: An overlay off the eight different nicotine molecules present in complex 7. 
 
Structure of 14 
 
Complex 14 crystallizes in the triclinic space group P1, as a discrete 1:1 
ligand:metal complex. The asymmetric unit (see Figure 2.28) consists of two 
copper(II)-terpyridine-nicotine units, each with a square planar geometry. Both 
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units have a long copper-perchlorate bond in one axial site (2.424 and 2.458 Å 
for molecules 1 and 2 respectively) and a longer copper-perchlorate interaction 
in the second axial site (2.745 and 2.742 Å for molecules 1 and 2 respectively). 
The internal angles between adjacent pyridines of the terpyridines are less than 
the ideal right angle (ranging from 79.9(5) to 81.6(5)°) due to the constrained 
geometry of the molecule; consequently the angles between the nicotines and 
outer pyridines are greater than 90° (ranging from 97.6(5) to 101.5(5)°). The 
angles between the nicotines and outer pyridines are however exaggerated by  
 
Figure 2.28: A perspective view of the asymmetric unit of complex 14. Hydrogen atoms are 
omitted for clarity. Selected bond lengths (Å) and angles (°): Cu(1)-N(1) 2.074(13), Cu(1)-
N(8) 1.924(12), Cu(1)-N(14) 2.100(12), Cu(1)-N(31) 2.026(11), Cu(1)-O(11) 2.424(11), N(1)-
Cu(1)-N(8) 79.9(5), N(1)-Cu(1)-N(14) 160.1(5), N(1)-Cu(1)-N(31) 98.2(5), N(8)-Cu(1)-N(14) 
80.2(5), N(8)-Cu(1)-N(31) 171.7(6), N(8)-Cu(1)-O(11) 91.3(5), N(14)-Cu(1)-N(31) 101.5(5), 
N(14)-Cu(1)-O(11) 86.6(4), N(31)-Cu(1)-O(11) 96.8(5), Cu(2)-N(41) 2.018(13), Cu(2)-N(48) 
1.951(13), Cu(2)-N(54) 1.984(13), Cu(2)-N(61) 1.944(12), Cu(2)-O(31) 2.458(13), N(41)-Cu(2)-
N(48) 81.4(5), N(41)- Cu(2)-N(54) 163.0(5), N(41)-Cu(2)-N(61) 97.6(5), N(41)-Cu(2)-O(31) 
96.9(4), N(48)-Cu(2)-N(54) 81.6(5), N(48)-Cu(2)-N(61) 172.6(6), N(48)-Cu(2)-O(31) 93.1(5), 
N(54)-Cu(2)-N(61) 99.3(5), N(54)-Cu(2)-O(31) 83.6(4), N(61)-Cu(2)-O(31) 94.3(5). 
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Figure 2.29: A packing diagram of complex 14. The interdigitation of the nicotine 
pyrrolidine groups can clearly be seen, while the limited π-stacking is less obvious. 
 
Figure 2.30: An overlay of the two different nicotine molecules in complex 14. 
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the slight out of plane position of the central copper atom (~0.09 and ~0.07 Å out 
of plane for molecules 1 and 2 respectively) – it is distorted towards the attached 
perchlorate anion, despite the Jahn-Teller lengthening of this bond. The two 
molecules in the asymmetric unit are related by a pseudo-inversion centre (see 
Figure 2.28); however, the complex cannot be solved in the space group P-1 as 
the use of a chiral substituent precludes this.43 There are only a limited number 
of longer range effects in this structure which affect the packing: in the y-direction 
nicotine molecules interdigitate, while there is weak π-stacking between the 
terpyridines of adjacent molecules along the z- axis (see Figure 2.29). 
Unfortunately this complex exhibited poor crystal quality, 
and so the crystal structure could not be satisfactorily refined. Anisotropic 
refinement results in a small number of non-positive-definite atoms, as well as 
some with large thermal displacement factors, which do not represent any 
coherent disorder. 
 
Comparison of the two nicotine molecules in the structure by overlaying the 
pyridine rings (see Figure 2.30), reveals that the two nicotine molecules have 
comparatively different relative conformations. Both molecules are still 
reasonably close to the conformation proposed by Whidby and co-workers, but 
packing effects have enforced a rotation, in opposite directions, resulting in an 
obvious difference between the two. 
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2.3 Complexes of Quinine 
 
Syntheses of the Complexes 
 
Complex 15 was synthesized by the reaction of quinine with copper(II) chloride in 
a 2:1 mixture of methanol and acetonitrile. Crystals suitable for X-ray 
crystallography formed overnight in a yield of 80%. The complex was analysed 
by elemental analysis to confirm the solid state structure. An attempt to analyse 
the solution state of the complex by mass-spectroscopy was inconclusive due to 
complete dissociation of the complex. 
 
The analogous copper(II) bromide complex, 16 was synthesized in a similar 
manner as 15, with a yield of 67%, and the same analysis performed. Again, 
attempts to probe the solution state of the complex by mass-spectroscopy were 
inconclusive due to dissociation of the complex. 
 
Complex 17 was synthesized by the reaction of cobalt(II) chloride with quinine in 
methanol.  Crystals suitable for X-ray crystallography were obtained overnight. 
After the structure was identified as closely related to previously published work 
(see below for details), no further analysis was attempted. 
 
Structure of 15 
 
Complex 15 crystallizes in the monoclinic space group P21, with one molecule in 
the asymmetric unit. The molecule consists of a Cu2O2 square, with each copper 
coordinated to both oxygen atoms of different quinine molecules. The 
coordination sphere of each copper atom is completed by a chloride counter ion, 
and a quinuclidine nitrogen from one of the quinine molecules; this means that 
each copper atom has a monodentate quinine and a chelating bidentate quinine 
coordinated (see Figure 2.31). The asymmetric unit is completed by two solvent 
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acetonitrile molecules. One of these acetonitrile molecules has a long (2.988 Å) 
interaction to Cu(1), while the other has no intermolecular interactions. The 
copper-copper distance in this complex is 2.9644(10) Å, too long to be 
considered a bond, but probably some sort of longer range interaction would 
exist. The geometry of the copper atoms is distorted square planar, with angles 
between adjacent substituents ranging from 75.64(11) to 100.83(10)°, the 
distortion imposed by the 5-membered chelate ring on the bidentate quinine 
molecule. There is a pseudo-2-fold rotation axis in the middle of the Cu2O2 
square. However, the quinuclidine section of the quinine molecules are not truly 
coincident with respect to this axis. The acetonitriles also do not conform to the  
 
Figure 2.31: A perspective view of the asymmetric unit of complex 15. Hydrogen atoms 
and solvent molecules have been omitted for clarity. Selected bond lengths (Å) and angles 
(°): Cu(1)-Cl(1) 2.2017(14), Cu(1)-O(2) 1.921(3), Cu(1)-O(32) 1.915(3), Cu(1)-N(32) 2.003(3), 
Cu(2)-Cl(2) 2.1956(15), Cu(2)-O(2) 1.902(3), Cu(2)-O(32) 1.925(3), Cu(2)-N(2) 2.006(3), Cl(1)-
Cu(1)-O(2) 98.82(9), Cl(1)-Cu(1)-O(32) 172.73(9), Cl(1)-Cu(1)-N(32) 100.83(10), O(2)-Cu(1)-
O(32) 75.64(11), O(2)-Cu(1)-N(32) 158.83(12), O(32)-Cu(1)-N(32) 84.09(12), Cl(2)-Cu(2)-O(2) 
175.02(10), Cl(2)-Cu(2)-O(32) 100.15(9), Cl(2)-Cu(2)-N(2) 99.61(10), O(2)-Cu(2)-O(32) 
75.85(11), O(2)-Cu(2)-N(2) 84.41(12), O(32)-Cu(2)-N(2) 160.24(12). 
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Figure 2.32: A packing diagram looking down the x-axis showing the acetonitrile 
molecules in the voids between adjacent stacks of the complex. 
 
2-fold axis, and so the complex does not crystallize in a higher symmetry space. 
There are no notable intermolecular interactions between adjacent molecules; 
the acetonitrile molecules sit in channels between the quinoline parts of the 
ligand and adjacent molecules (see Figure 2.32). 
 
Structure of 16 
 
Complex 16 was synthesized and crystallized in the same manner as complex 
15. Upon determination of the unit cell it was observed that 16 had almost 
identical parameters to 15 (see Table 2.3). This observation, in conjunction with 
the elemental analysis, which confirmed the stoichiometry as identical to that of  
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Complex a (Å) b (Å) c (Å) β (°) V (Å3) 
15 10.490(4) 15.167(6) 13.510(5) 99.477(5) 2120.1(14) 
16 10.5(3) 15.2(2) 13.5(3) 99.5(9) 2120(120) 
Table 2.3: A comparison of unit cell parameters for complexes 15 and 16. Although there 
is high error on the parameters for 16 (due to the limited amount of data used for cell 
determination), the parameters are remarkably similar. 
 
15 lead to the assumption that 16 would have an almost identical structure to 15, 
and so full X-ray determination was not carried out. 
 
Structure of 17 
 
Complex 17 crystallizes in the tetragonal space group P41, with two molecules in 
the asymmetric unit. Although the two molecules are related by a pseudo rotation 
axis, the inclusion of a molecule of methanol and one of water break the 
symmetry, resulting in the reported space group. Both cobalt centres have  
 
Figure 2.33: A perspective view of one molecule of complex 17. Hydrogens are omitted for 
clarity. Selected bond lengths (Å) and angles (°): Co(1)-Cl(1) 2.265(8), Co(1)-Cl(2) 2.228(8), 
Co(1)-Cl(3) 2.319(8), Co(1)-N(1) 2.06(2), Cl(1)-Co(1)-Cl(2) 116.5(3), Cl(1)-Co(1)-Cl(3) 106.5(3), 
Cl(1)-Co(1)-N(1) 100.7(7), Cl(2)-Co(1)-Cl(3) 107.5(3), Cl(2)-Co(1)-N(1) 111.0(6), Cl(3)-Co(1)-
N(1) 114.9(6). 
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tetrahedral geometries, and are coordinated to three chloride ligands and the 
quinoline nitrogen of a quinine molecule (see Figure 2.33), with angles ranging 
from 101.7(7) to 117.8(3)°. Observation that the crystals were pink, indicating 
divalent cobalt centres, led to the charge balance being accounted for by 
protonation of the quinuclidine nitrogen of each quinine. This type of complex 
has previously been synthesized by Oleksyn and co-workers,30 although all 
previous complexes were crystallized in lower symmetry space groups. As the 
complex has no new features when compared with the previous work, and with 
poor quality crystals (Rint of 81.8%), the decision was made not to fully refine this 
structure. 




This chapter has described the coordination and metallosupramolecular 
chemistry of the alkaloids nicotine and quinine. These chiral heterocyclic 
compounds have been used directly, without synthetic modification, to 
coordinate to transition metals salts to form a number of complexes. The majority 
of these complexes were examined by X-ray crystallography, as well as other 
standard experimental techniques. 
 
The reaction of nicotine with transition metals thiocyanates resulted in the 
synthesis of a number of related coordination compounds. A common structural 
motif ran through these complexes, and could be seen in the structure of the 
complexes themselves, as well as the network formed by hydrogen bonds 
between different complexes. Comparison of the conformation of the nicotine 
molecule confirmed the previous computational work, with a perpendicular 
relationship between the two rings of the nicotine molecule. 
 
Reaction of nicotine with silver(I) salts resulted in three different complexes. In all 
cases nicotine acts as a bridging ligand, and in one case also as a monodentate 
ligand coordinated via the pyridine nitrogen. Due to the difference between the 
two donor sites on the nicotine molecule, this bridging bidentate ligand aligns 
itself in a regular fashion in the formation of these polymeric products. This leads 
to the chiral coordination polymers which are directional. Amongst these 
complexes the conformation of the nicotine molecules is very similar to that in 
the previously described complexes, and again compares favorably with the 
earlier computational work.  
 
A smaller number of coordination complexes of quinine were synthesized than of 
nicotine. Coordination of quinine was observed via three of the possible four 
binding domains within the different complexes.  
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Alkaloid Organic Chemistry 




This chapter focuses on the attempted synthesis of potential ligands, using 
nicotine and the cinchona alkaloids as starting materials. These alkaloids are 
readily available as single enantiomers, which makes them attractive building 
blocks for the synthesis of chiral ligands. Total synthesis of nicotine- and 
cinchona alkaloid-based molecules which involve stereoselective synthesis of 




The organic chemistry of nicotine has been surprisingly unexplored. Only one 
paper has investigated the synthesis of nicotine derivatives as potential chiral 
coordination ligands. Schmidt and Neitemeier44 reported the synthesis of 6-(2’-
pyridyl)nicotine (18) and bis-6,6’-nicotine (19), via the synthesis of 6-
chloronicotine (20) (see Scheme 3.1). 6-Chloronicotine was a key intermediate 
















19 18N  
Scheme 3.1 
 
There has been sparse research over the last century into the derivatisation of 
nicotine for a variety of aims. As early as 1924 Chichibabin was investigating the 
amination of nicotine, employing the method named for him.45 Another area 
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which has been investigated is the direct alkylation of nicotine by various 
methods.46 A wide range of modifications of nicotine were investigated by 
Acheson, Ferris and Sinclair,47 unfortunately few of these had any potential use 
in the synthesis of new ligands for coordination chemistry. There has been more 
recent interest in the synthesis of nicotine derivatives and analogues due to their 
pharmacological applications.48-50 
 
3.1.2 Quinine and the Cinchona Alkaloids 
 
Quinine and the cinchona alkaloids have been more extensively investigated as 
the basis for ligands for coordination chemistry, largely due to their use in the 
Sharpless Dihydroxylation catalysts.11 The organic chemistry of this family of 
compounds has also been more widely investigated due to the use of quinine for 
the treatment and prevention of malaria. A recent review by Hoffman and 
Frackenpohl51 covers the majority of work in this area, as well as detailing some 
of the chemical history of the cinchona alkaloids. 
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Initial efforts in this area focused around the synthesis of 6-chloronicotine (20), 
as an intermediate towards the synthesis of ligands with a greater number of 
donor sites. Prior to this thesis 20 had been synthesized a number of times. A 
synthesis was reported in 1996 by Damaj and co-workers;52 their synthesis is via 
6-aminonicotine (21), synthesized by a Chichibabin method45 (see Figure 3.1). 
Unfortunately this method racemizes the nicotine molecule, resulting in a mixture 
of (S)- and (R)-6-aminonicotine, and so is not useful in the synthesis of 
homochiral ligands. A more recent paper by Roduit, Wellig and Kiener53 details 
the functionalisation of nicotine via microbial action. Unfortunately this method 
was unavailable. The most recent synthesis of 20 prior to the beginning of this 
thesis was the work of Schmidt and Neitemeier,44 which involved the synthesis of 
nicotine-N1-oxide (22), and subsequent chlorination. This method was the one 













21 22  
Figure 3.1: From left to right: (S)-6-chloronicotine (20), 6-aminonicotine (21), and (S)-
nicotine-N1-oxide (22). 
 
Following the commencement of this thesis a number of other syntheses of 
nicotine derivatives appeared in the literature. The synthesis of 20 via reaction of 
22 with a trialkyl amine in the presence of an electrophile to produce a cationic 
radical, which could subsequently be reacted with a nucleophile to produce a 
6-substituted nicotine derivative, was detailed by Johansson and Svensson49 in a 
patent application. This method was also attempted in this thesis and is detailed 
below. More recently (after this area of research had largely been abandoned) in 
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the work of Comins and co-workers50, a more attractive synthesis of 20 
appeared, which detailed the use of n-butyllithium and lithium 
dimethylaminoethanoate, followed by reaction with hexachloroethane.  
 
The desire for the synthesis of 20 relates to the ease of synthesis of derivatives 
from such a precursor. Previous work in this group had involved the synthesis of 
ligands with chelating donor pockets, an increased number of binding pockets, 
as well as a combination of these two methods. It was intended to mimic this 



















Figure 3.2: Examples of ligands that could be synthesized from nicotine, counter-
clockwise: a ligand with a chelating donor site, a ligand with bridging donor sites, a ligand 
with multiple chelating donor sites (only one arm shown). 
 
Although the synthesis of 20 was the primary starting target for the synthesis of 
nicotine based ligands, a number of other synthetic routes to derivatives of 
nicotine were explored. Synthesis of cotinine (23 – see Figure 3.3) was one route 










23 24  
Figure 3.3: Cotinine (23) and nornicotine (24). 
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known as a metabolite of nicotine produced in the human body. Synthesis of 
nornicotine (24 – see Figure 3.3), another known metabolite of nicotine, was also 
attempted, as potential precursor to new nicotine based ligands. 
 
3.2.2 Synthesis of 6-Chloronicotine and Related Reactions 
 
A variety of methods were attempted for the synthesis of 6-chloronicotine (20). 
Initially, known methods were focused on, and later alternative syntheses were 
attempted. 
 
The first method attempted in the synthesis of 20 was that of Schmidt and 
Neitemeier44 (see Scheme 3.2). The initial step in this process is the synthesis of 
nicotine-di-N-oxide (25) via literature procedures.55 This synthesis was carried 
out without problems, and provided the desired product in high yield. The next 
step was chemoselective reduction to the pyridine mono-N-oxide (22). In the 
original synthesis by Taylor and Boyer55 this was done by reaction of the 22 with 
gaseous sulfur dioxide bubbled through water. Schmidt and Neitemeier adjusted 
this method, using a mixture of 40% aqueous sodium bisulphite solution, acetic 





















(a) CH3COOH, H2O, H2O2; (b) SO2(g), H2O or NaHSO3, 
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with a low yield. This method had to be abandoned due to a lack of access to 
gaseous sulfur dioxide in sufficient quantities. The method utilized by Schmidt 
and Neitemeier was also attempted, and met with mixed success, with yields 
ranging from low (10%) to moderate (60%) in small scale reactions (~100mg 
scale). Attempts to upscale this reaction invariably led to yields at the low end of 
the scale (10-20%), and isolation via column chromatography was less 
successful than that of Schmidt and Neitemeier in this case. Synthesis of 20 by 
the method of Schmidt and Neitemeier was then attempted, but unfortunately did 
not yield any of the desired products. This reaction was attempted both in the 
presence and absence of diisopropyl amine (as detailed in the original paper), 
but neither method was successful despite repeated attempts. 
 
Following on from the above work was the synthesis of cotinine (23) as an 
intermediate in the synthesis of a substituted nicotine derivative. This was 
attractive for a number of reasons; in contrast to the amine subunit of nicotine 
the amide of 23 cannot be N-oxidized, resulting in a one step synthesis of the 
pyridine-N-oxide (27), as no reduction is required. There is a further advantage in 
the chlorination step; Schmidt and Neitemeier in their work noted the synthesis of 
both 2-chloronicotine (26 – see Scheme 3.3) and 20 when reacting 22 with 
phosphorus oxychloride. They attributed the chlorination of the more sterically 
hindered 2-position to interaction between the amine nitrogen and the 
phosphorus species placing the chlorine in the closer position. Addition of 
diisopropyl amine to compete with the substrate for this interaction suppressed 
this pathway, resulting in only the formation of 20. In the case of cotinine, it was 
thought that the amide would not interact with the phosphorus species in the 































(a) H2O2, CH3COOH  
Scheme 3.4 
 
The synthesis of 23 was performed by literature methods54, then N-oxidized by 
adapting the procedure for the synthesis of 25. Cotinine was reacted with 
hydrogen peroxide in acetic acid to provide cotinine-N-oxide (27) in excellent 
yield (99%). Compound 27 was then reacted with refluxing phosphorus 
oxychloride. Following workup, NMR spectroscopy revealed some interesting 
features; the aromatic region remained the same as in the starting material, with 
four peaks being visible, while the spectrum for the five-membered ring was 
significantly different. This indicated that the five-membered ring was unstable to 
reaction with phosphorus oxychloride, and had possibly undergone ring-opening. 
Following this result, 23 was also reacted with phosphorus oxychloride. Analysis 
by NMR revealed that in this case also, the five-membered ring had undergone 
some sort of reaction, possibly ring-opening. A further probe of the reactivity of 
the N-oxides was the reaction of 25 with phosphorus oxychloride. After removal 
of the reagent by vacuum distillation, and neutralisation of the residue, no 
products could be extracted, indicating either complete destruction or 
polymerization of the starting material. To test whether this was due to the 
presence of the amine-N-oxide, or both, nicotine-N’8-oxide (28 – see Scheme 
3.5) was synthesized by the method of Taylor.55 Compound 28 was reacted with 
phosphorus oxychloride at reflux, which was subsequently removed by vacuum 
distillation. No products could be extracted from the residue, again indicating 
either complete destruction or polymerization of the starting material.  
 
 









Another series of reactions was the attempted acylation of the N-oxides by acetic 
anhydride at elevated temperatures.56 This reaction was attempted with all three 
N-oxides (22, 27 and 28) as well as 23. After workup a variety of results were 
observed. Nicotine N-oxides 22 and 28 displayed no reaction, with only the 
starting material observed by NMR. The reactions of 23 and 27 were both 
unsuccessful as well, although in these cases analysis by NMR showed similar 
spectra to those from the reaction of these compounds with phosphorus 
oxychloride, possibly indicating some sort of ring opening of the five-membered 
ring. 
 
Another route to 6-substituted nicotine derivatives investigated was through the 
work of Johansson and Svensson.49 This involves the reaction of nicotine-N1-
oxide with a trialkylamine in the presence of an electrophilic compound to 
produce 6-substituted nicotine species, which can be readily substituted by 
nucleophiles to produce the desired nicotine derivative (see Scheme 3.6). The 
original method reported the use of dry gaseous trimethylamine in the reaction. 
This was unavailable, and so triethylamine was used in its place. Unfortunately, 
after workup, analysis by NMR showed none of the desired product. The original 
report claims the use of multiple trialkyl and triaryl amines, but only gives details 


















(a) NR3, AX (b) Nu  
Scheme 3.6 
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An alternative method pursued towards the synthesis of 20 was via N1-
methylnicotin-6-one (29). Synthesis of 29 was achieved by the method of 
Acheson, Ferris and Sinclair,47 involving initial synthesis on N1-methyl nicotinium 
iodide (30), followed by oxidation with basic ferricyanide (see Scheme 3.7). 
Reaction of 29 with refluxing phosphorus oxychloride resulted in 20 in varying 
yields. On a small scale (~30mg) this reaction would proceed in 30-60% yield, 
which appeared to be related to the solubility of 29 in the solvent. On a larger 
scale the yield of 20 decreased, to 5-10%, and significant amounts of the starting 
material were observed. It was observed that most of the starting material was 
not dissolved in the solvent (phosphorus oxychloride), and simply adhered to the 
walls of the reaction vessel. On a small scale, there was significant agitation 
possible by the magnetic stir bar, which appeared to force more of the starting 
material into solution. On the larger scale, such agitation was not possible, and 

























Various attempts were made to increase the solubility of the starting material; 
one avenue of investigation was through the use of different solvents. As 
phosphorus oxychloride is highly reactive, only chlorinated solvents were used in 
the reactions. The first solvents trialled were chloroform and 1,2-dichloroethane; 
unfortunately both these solvents have lower boiling points than phosphorus 
oxychloride, and no reaction occurred at reflux. The next solvent trialled was 1,2-
dichlorobenzene, which has a significantly higher boiling point (180 °C). 
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Reactions were attempted at both ~105 °C and at 180 °C. With low amounts of 
phosphorus oxychloride (half to one equivalents), no reaction, or only a trace of 
20 was observed. As the amount of phosphorus oxychloride was increased it 
was noted that the solubility of 29 in the solvent decreased, and it adhered to the 
walls of the vessel. Unfortunately the desired 20 was still not obtained. Due to 
the low yields and difficulty in scaling, this method had to be abandoned for the 
preparation of 20. 
 
After the above method had been abandoned, a number of other synthetic 
procedures were attempted with 29 to try and access nicotine derivatives that 
would be useful synthetically.  
 
The first pathway investigated was the demethylation of 29 in an attempt to 
synthesize nicotin-6-one (31 – see Scheme 3.8), which is tautomeric with 6-
hydroxynicotine. This type of pyridone is much more readily substituted than N-
alkyl derivatives. A number of methods were attempted for this transformation. 
Catalytic hydrogenation, using palladium on carbon in dry dichloromethane was 
attempted; after workup the NMR showed only starting material. This was 
repeated using Pearlman’s Catalyst (palladium hydroxide on carbon) as the 
catalyst; unfortunately again, NMR showed only starting material after workup. 
Boron tribromide, a well known demethylation/dealkylation agent was used; 













29 31  
Scheme 3.8 
 
The other synthetic pathway explored was the attempted synthesis of 6-
bromonicotine (32) from 29. A number of methods were explored in the 
attempted synthesis of 32 from 29. The first method tried was simply the reaction 
of 29 with phosphorus tribromide. Initially this reaction was tried in dry 
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chloroform, and after workup NMR showed no product present. The reaction was 
repeated in neat phosphorus tribromide; unfortunately this was also unsuccessful 
with only the starting material observed by NMR following workup. The second 
method attempted followed the work of Kato and co-workers,57 which recognizes 
the mechanism of reactions of phosphorus oxytrihalides. This mechanism 
involves reaction of the phosphorus species with the N-substituent, activating the 
2-position towards substitution; subsequent reaction by a halide present in 
solution results in the desired product being formed. Recognising this 
mechanism, Kato proposed to substitute phosphorus oxyhalide with a mixture of 
phosphorus pentoxide and a tetraalkylammonium halide. Reaction of 29 under 
these conditions, followed by workup, unfortunately showed only the starting 
material present by NMR. The final method attempted was from the work of 
Sugimoto, Mori and Tanji,58 and was originally intended as a method of synthesis 
via 31. Reaction of 29 with N-bromosuccinimide and triphenylphosphine in 
dioxane, followed by workup, showed only the starting material present by NMR. 
 
Following on from the unsuccessful synthesis of 6-halonicotines from N-
methylnicotine-6-pyridone, either by direct halogenation, or by demethylation 
then halogenation, another route was investigated. This involved the preparation 
of other N-substituted nicotin-6-one derivatives, with an aim to access 31. A 























Br NO2 OMe  
Scheme 3.9 
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The first substituent investigated was a simple benzyl group. N-Benzylnicotinium 
bromide (33) was synthesized by the reaction of nicotine with benzyl bromide in 
acetic acid, in moderate yield (42%). Reaction of 33 with basic ferricyanide 
provided the desired N-benzylnicotine-6-pyridone (34) in moderate yield (60%). 
Although this compound was intended for debenzylation in the synthesis of 31, a 
number of other reactions were attempted on it. 
 
Chlorination of 34 was attempted by the method used for the chlorination of 29, 
namely reaction of 34 with refluxing phosphorus oxychloride. Following workup, 
analysis of the products by NMR revealed only the starting material. The 
bromination reactions attempted on 29 were also trialled on 34 (see above for 
details). Unfortunately all three of these methods failed, returning only starting 
material.  
 
The debenzylation of 34 was attempted by a number of different methods. 
Initially reaction with boron tribromide was attempted; following workup only 
starting material was observed by NMR. Catalytic hydrogenation was also 
attempted by a number of related methods. Compound 34 was stirred in acetic 
acid with palladium on carbon as a catalyst under a hydrogen atmosphere. 
Following workup only the starting material was observed by NMR. Repetition of 
this method with Pearlman’s Catalyst in place of palladium on carbon, with 
trifluoroacetic acid in place of acetic acid, and both these adjustments at the 
same time were all performed; in all cases analysis by NMR following workup 
revealed only the starting material.  
 
Following the failed debenzylation of 34 the synthesis of a number of other 
N-substituted nicotine derivatives was attempted. Reaction of nicotine with 2-
bromoethanol failed to produce an N-substituted derivative. Reaction with 
chloromethyl methyl ether also failed to produce an N-substituted derivative. 
Reaction with both 1-bromomethyl-4-nitrobenzene and 1-bromomethyl-4-
bromobenzene resulted in the desired respective nicotinium species 35 and 36. 
When the syntheses of the respective pyridone species 37 and 38 were 
attempted, the nicotinium species were insoluble in the reaction mixture. 
Attempts to solubilize the starting materials by changing from an aqueous 
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system to a mixture of water and methanol did not alleviate this problem; if the 
mixture was adjusted sufficiently for the dissolution of the nicotinium species, 
invariably the iron species precipitated out of solution. Reaction of nicotine with 
both 1-chloromethyl-4-methoxybenzene and 1-bromomethyl-4-methylbenzene 
resulted in the desired nicotinium species 39 and 40. Synthesis of the respective 
pyridone species, 41 and 42, was attempted, and again the nicotinium species 
were insoluble in the reaction mixture. For these two reactions, dissolution of the 
nicotinium species while maintaining the solubility of the iron(III) cations was 
achieved. Following workup NMR analysis of the products in both cases 
revealed nicotine; the nicotinium species were not robust enough to withstand 
the high pH in the reaction mixture, and had hydrolysed back to nicotine. 
 
3.2.3 Other Reactions of Nicotine 
 
A number of other approaches were investigated towards the synthesis of 
nicotine derivatives as potential ligands for use in coordination and 
metallosupramolecular chemistry. These approaches are reported below. 
 
The demethylation of nicotine to 24 was one approach investigated. Compound 
24, although a potential ligand itself, is attractive because it could be readily 
substituted onto the type of cores that have been extensively studied by this 
group,59 to prepare a range of related ligands with differing numbers and 
arrangements of donor groups (see Scheme 3.10). Previous work on the 
preparation has focussed on a number of different ways of preparing 24: most 
recent work has reported the stereoselective synthesis of 24 from other chiral 
starting materials or in the presence of chiral auxiliaries.60 Prior to this many 
syntheses relied on resolution of a mixture of both enantiomers of 24 (or of  
 













diastereomeric salts),61 while the least explored method is the synthesis directly 
from nicotine by demethylation.62, 63 The syntheses directly from nicotine were 
either too low yielding to be of synthetic use,62 or were by methods unavailable 
to us.63 In this thesis the direct demethylation of nicotine was investigated, with 
four different methods being investigated. Reaction of nicotine with boron 
tribromide returned only starting material, as did reaction with refluxing 
trifluoroacetic acid. Catalytic hydrogenation of nicotine in acetic acid with either 
palladium on carbon, or Pearlman’s Catalyst also returned only starting material. 
 
Another route to 6-substituted nicotine derivatives was the synthesis of 21, a 
known reaction originally reported by Chichibabin.45 This reaction was 
successfully performed, and the 2- and 6-aminonicotine were separated by 
column chromatography. Shortly thereafter, a more complete translation of the 
original paper was obtained, which revealed that this synthetic method resulted 
in racemisation of the nicotine molecule. As the aim of this thesis was the 
synthesis of homochiral ligands, this approach was then abandoned. 
 
The reaction of nicotine with alkyl halides had been explored earlier, when 
attempting to synthesize 20. These reactions were performed in acetic acid, and 
it can be assumed that initially both nitrogen atoms are protonated. The amine 
nitrogen in these cases is too strongly basic to be deprotonated, and so 
alkylation only occurs at the pyridine nitrogen. Another avenue of exploration 
would be the linking two or more molecules of nicotine together with an alkyl 
linker to create a cationic ligand with multiple donor sites. Ideally the amine 
nitrogens would be linked together, as the pyridine nitrogen atom of nicotine is 
the preferred donor. Investigation of the literature revealed the work of 
Yoshizawa and co-workers,64 where nicotine is reacted with benzyl bromide in 
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acetone, synthesising N’8-benzyl nicotinium bromide (43 – see Scheme 3.11). 
This reaction was successfully repeated, and then attempts were made to adapt 
it to other alkyl halides. The reaction of nicotine with 1,4-bisbromomethylbenzene 
was the first investigated; reaction in acetone followed by workup provided a 
brown tar-like product. Analysis by NMR in deuterium oxide revealed that several 
species were present in the product mixture. The reaction of alkyl halides with 
the amine nitrogen of nicotine locks the position of the methyl group of the 
pyrrolidine ring; prior to reaction the molecule can equilibrate between two 
possible orientations. After substitution a new stereocentre is formed. The large 
number of peaks observed indicated that both chiralities were being formed in 
the reaction; as more than one nicotine molecule was being attached to the alkyl 
linker, there was a large possible mix of diastereomeric molecules present. 
There are three possible combinations of stereocentres possible: (S,S,S,S), 
(S,R,S,S) and (S,R,R,S). This does not account for the larger number of peaks 
observed in the spectra, and so it was postulated that in this case the pyridine 
nitrogen was also reacting, adding further possible products that could be 
observed. Separation was not attempted as there was no major product, and the 
mixture was only soluble in strongly polar solvents. The reaction with both the 
1,2- and 1,3-bisbromomethylbenzenes was also explored, and had the same 











An adjustment to this proposal was reacting nicotine with picolyl chloride, 
attempting to synthesize N’8-picolylnicotinium chloride (44 – see Scheme 3.12), 
a potential bridging ligand. Although the reaction with bisbromomethylbenzenes 
had failed, it was hoped that the smaller molecule, similar to benzyl bromide 
would not encounter such problems. Unfortunately this was not the case, and 
after workup analysis by NMR revealed multiple products present. It appeared in  
  















this case that there were more than three products, indicating that substitution 
onto attached picolyl nitrogens may have been occurring. 
 
After the attempted synthesis of 44 failed, a variation of this theme was 
investigated. As the synthesis of pyridine-N-substituted nicotines molecules 
could be carried out successfully, it was decided to attempt the synthesis of N1-
picolylnicotinium chloride (45 – see Scheme 3.13), which could subsequently be 
oxidized by basic ferricyanide to N1-picolylnicotine-6-pyridone (46). Compound 
46 could potentially chelate a metal centre by coordination of picolyl nitrogen and 
the pyridone oxygen, while still having the amine nitrogen available for further 
coordination. Compound 45 was successfully synthesized by the reaction of 
nicotine with picolyl chloride in acetic acid in a yield of 94%. Oxidation by basic 
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A range of different chemistry was investigated in this area, focusing around the 
derivatisation of the cinchona alkaloids at the C9 position. 
 
The synthesis of quininone (47) or cinchonidinone (48) was the target as an 
intermediate on the route to the preparation of potential ligands. An example of 
the type of chemistry that would be attempted is the reaction of one of these 
ketones with 2-aminopyridine to synthesize 49 (see Scheme 3.14). This 
molecule would have a bi- or possibly tri-dentate binding pocket, as well as 
additional coordination sites at the quinoline nitrogen and vinyl group. These 
factors would make ligands of this type ideal for the synthesis of chiral 
coordination polymers and/or mixed-metal complexes. There is a wide range of 
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Bromination of cinchona alkaloids at the C9 position was also explored. These 
derivatives would be readily substituted onto the range of multi-armed 
heterocyclic cores previously utilized in this group (see Scheme 3.15).59 
 
The final route investigated in this area was the synthesis of 9-amino-(9-
deoxy)epi-cinchona alkaloids. These molecules, potentially ligands themselves,

















R = OMe, H  
Scheme 3.15 
 
could be readily substituted in a number of ways to produce derivatives with 
greater numbers of donor sites and/or greater denticity. One example, 
complementary to 49, is the reaction of a 9-amino-(9-deoxy)epi-cinchona alkaloid 
with pyridine-2-carboxyaldehyde (see Scheme 3.16). This would result in a 
potential ligand (50) with similar properties to 49 and would be interesting for 
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pyridine-methyl halides, to add further donor sites, or with poly-bromomethyl 
benzenes to link multiple amine moieties together. 
 
3.3.2 Cinchona Alkaloid Organic Chemistry 
 
The synthesis of cinchonidinone (48) from cinchonidine was investigated, as a 
precursor to potential new ligands. The synthesis of quininone (47) from quinine 
by Woodward, Wendler and Brutschy65 was used as a template for the synthesis 
of 48, although some details of the synthesis were adjusted (see Experimental 
Section). Analysis by NMR following synthesis revealed twice the number of 
expected signals. Crystals of the product were also obtained shortly after 
synthesis, and were suitable for X-ray crystallography. Compound 48 crystallizes 
in space group C2 with two molecules in the asymmetric unit (see Figure 3.4), 
which differ from each other in the conformation of the vinyl group. There are no 
significant long range packing effects between molecules of 48 in the crystal 
structure. Consideration of the NMR results indicates that two related products 
were formed from the reaction. When the reaction conditions for the synthesis of 
48 were examined it became obvious that the synthesis has resulted in both 48 
and cinchoninone (51). After the formation of 48, in the reaction mixture in the 
presence of base, it exists in equilibrium with enolate 52, which can convert to 
both 48 and 51 (see Scheme 3.17). The equilibrium results in the epimerisation 
of the variable stereocentre. Within the cinchona alkaloids there are only two 
 
Figure 3.4: The asymmetric unit of 48 (hydrogen atoms are omitted for clarity). 
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48 52 48 + 51  
Scheme 3.17 
 
variable stereocentres of the five that exist in the molecule (see Section 2.1.2 for 
further details). This ultimately means that this is not a viable route to the 
synthesis of homochiral ligands for coordination chemistry. 
 
The second avenue towards synthesising new ligands from the cinchona 
alkaloids was based on the bromination of quinine at C9 to synthesize 9-bromo-
(9-deoxy)epi-quinine (53), as reported by Hoffman and co-workers.66 This 
synthesis was repeated using cinchonidine in the place of quinine to synthesize 
9-bromo-(9-deoxy)epi-cinchonidine (54). Initial analysis of the product by 1H 
NMR spectroscopy suggested that the synthesis of 54 had been successful. 
Analysis by mass spectroscopy however revealed the major product to have a 
mass of 613, significantly more that the 386 expected. Analysis by 13C NMR 
spectroscopy revealed that the signal for C9, expected at around 30 ppm was 
absent, and an unexpected peak was present at 71 ppm. The unexpected peak 
was consistent with an ether carbon atom, and this, in conjunction with the close 
to doubling of the molecular weight from the starting material, led to the 
conclusion that two quinine molecules had been joined together. It is believed 
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that the reaction takes place via synthesis of 54, and then in situ reaction with 
cinchonidine leads to the formation of 55. The synthesis of 54 involves an 
inversion at C9, due to the SN2 reaction mechanism; the reaction to form 55 is 
thought to proceed by re-inversion at C9 of 54 (again with an SN2 reaction 
mechanism), resulting in identical stereochemistry in both halves of the 
molecule. This result is consistent with the NMR results, which have signals for 
only half the molecule – this is a result of two-fold symmetry of some kind, and 
as three stereocentres remain unchanged during the reaction this symmetry 
cannot be an inversion or mirror plane. The similarity of the NMR spectra to that 
of the starting material, along with consideration of the reaction mechanism, 





















54 55  
Scheme 3.18 
 
The next route explored for the modification of cinchona alkaloids was the 
synthesis of 9-amino-(9-deoxy)epi-quinine (56). The synthesis of 56 has been 
previously reported by Brunner, Buegler and Nuber,67 and was repeated. It 
employs a Mitsunobu reaction,68 which directly converts a primary or secondary 
alcohol to an amine. Initially the reaction was repeated as reported in the original 
paper, but increasing the amount of hydrazoic acid approximately three and a 
half fold, using anhydrous solvents, and performing the reaction in an inert 
atmosphere increased the ratio of product:starting material from 2:1 to 10:1. The 
original report does not give complete details on how 56 was purified, simply 
stating the purification was done by column chromatography. Repeated attempts 
were made to remove the starting material using a variety of solvent systems, as 
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well as both alumina and silica columns, all resulting in loss of product and an 
increase in the amount of starting material. It appears that the amine either 
adheres permanently to the column or is unstable to column chromatography. 
One interesting feature of this compound is the 1H NMR spectrum. In the original 
report the aromatic region of the spectra is reported as a multiplet spanning 0.8 
ppm and a single identified peak at 8.60 ppm. When the proton NMR of the 
product (the 10:1 mixture) was examined, it became obvious that there were 
some interesting features. The broadening of the signals for H3 and H5 indicated 
that intramolecular hydrogen bonding, or some other type of NH2-CH interaction 
was occurring. Synthesis of the analogous amine (57) from cinchonidine by this 
method was unsuccessful. 
 
Although 56 could not be purified, two reactions were attempted to probe the 
usefulness of the unpurified material. Compound 56 was dissolved in 
dichloromethane and reacted with an equimolar amount of palladium dichloride 
bisbenzonitrile. This led to an immediate yellow precipitate that could not be 
filtered. The solution was reduced in vacuo and water added, after which the 
solid was removed by filtration. The melting point of this product was greater 
than 330 °C, which is significantly higher than the starting materials or the 
quinine present. The product was insoluble in all common laboratory solvents 
except DMSO and DMF, so analysis by NMR was performed in d6-DMSO. The 
NMR spectrum appears to indicate coordination of the palladium centre to both 
amine nitrogens of 56. The attempted recrystallisation by slow diffusion of 


















56 58  
Scheme 3.19 
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The second reaction to probe the usefulness of unpurified 56 was the reaction 
with pyridine-2-carboxaldehyde to form imine 58 (see Scheme 3.19). Although 
58 was successfully synthesized, it could not be separated from the quinine 
present.  
 
After the synthesis of 56 by the method of Brunner, Beugler and Nuber67 was 
abandoned, because the starting material could not be removed from the product 
mixture, another route to 56 (and to the analogous 57) was investigated. 
Preparation of the mesylate (59 and 60, respectively), followed by conversion to 
an azide (61 and 62, respectively), then reduction would result in the desired 
amine (see Scheme 3.20). The appropriate alkaloid was reacted with methane 
sulphonic acid, in the presence of triethylamine in anhydrous THF under an inert 
atmosphere. In the case of quinine this reaction failed, and none of the desired 


























R = OMe, H R = OMe 59
R = H 60
R = OMe 61
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R = OMe 56
R = H 57
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(b)
(a) MeSO3H, Et3N, THF
(b) NaN3, DMF  
Scheme 3.20 
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Unfortunately all attempts at synthesis of 62 failed, so this route was not pursued 
any further. It appeared that 60 was too unstable to substitution, as invariably 
cinchonidine was isolated from all attempts at this conversion. 
 




This chapter reports the investigation of the organic chemistry of nicotine and the 
cinchona alkaloids directed towards the synthesis of new ligands for coordination 
and metallosupramolecular chemistry.  
 
6-Chloronicotine (20) was identified as a key intermediate towards the synthesis 
of more substituted nicotine derivatives. A number of methods for the synthesis 
of 20 were investigated. Unfortunately all methods ultimately had to be 
abandoned due to a variety of factors. The aim of synthesising nicotine 
derivatives via 20 went unachieved. 
 
Other routes towards the synthesis of nicotine derivatives were investigated. The 
synthesis of nornicotine (24) was investigated by several unsuccessful methods. 
The syntheses of cationic ligands by the reactions of nicotine with poly-
bromomethylbenzenes, as well as picolyl chloride, were investigated. It was 
intended to quarternize the amine nitrogen, with the pyridine nitrogen left free to 
coordinate to metal centres. The synthesis of a related ligand, N-picolylnicotin-6-
one (46) was successful. 
 
Derivatisation of the cinchona alkaloids focused around reactions at the C9 
position. Three different derivations were investigated. Synthesis of the C9-
ketones had to be abandoned, as the synthesis resulted in epimerisation of the 
adjacent chiral centre, defeating the aim of synthesising homochiral derivatives. 
The synthesis of 9-amino-(9-deoxy)epi-quinine (56) was successful. 
Unfortunately this compound could not be purified, and was not further pursued. 
Finally bromination of cinchonidine was investigated, but resulted in dimerisation 
to form ether 55. 
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Amino Acid Organic Chemistry 




The organic chemistry of amino acids has been widely studied. As such amino 
acids are an obvious choice for incorporation into ligands for coordination and 
metallosupramolecular chemistry. One area where amino acids have been 
extensively utilized for this purpose is the synthesis of amino alcohols, which are 
in turn incorporated in homochiral, chelating bis-oxazolines.10 The aim of this 
chapter was to utilize known chemistry for the synthesis of new (and some 
known) homochiral ligands for coordination and metallosupramolecular 
chemistry. 
 
The reaction of amino acids with halomethylpyridines and the coordination 
chemistry of the derived ligands has been extensively studied.69, 70 The prior 
work in this area provides a valuable stepping stone towards the synthesis of 
some new ligands. 
 
The synthesis of an amide bond is one of the most important reactions in amino 
acid chemistry. Although the synthesis of pyridyl-based ligands via this route 
have been extensively reported in the literature, there are surprisingly only two 
reports of metal complexes of these types of ligands.71 
 
Although the synthesis of imines from amino acids has been studied in the past, 
and the study of metal complexes of imines is relatively common, the study of 
the intersection of these two areas is less common than would be expected. 
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A simple reaction often employed in the synthesis of molecules for use as 
ligands is the reaction of an amine with an alkyl halide to form an alkyl amine. 
Interestingly this technique has seldom been applied to the synthesis of ligands 
from amino acids. One of the simplest of these types of ligands would by N,N-
bis(2-pyridylmethyl)-L-alanine (63). As an illustrative example, 63 could act as a 
ligand with a number of different bonding modes: the two pyridine sites could 
chelate to a single metal centre, the two pyridines could bridge different metal 
centres, the carboxylate group adds an extra possible bridging interaction (see 
Figure 4.1). There is also precedence for the trisubstituted amine to acts as an 

















Figure 4.1: The different possible bonding modes of 63, from left to right: chelating a 
single metal centre, bridging two metal centres, additional chelation by the amine 





Two different methods were investigated towards the synthesis of these types of 
molecules: the direct synthesis, reacting the amino acid with an alkyl halide, and 
the reductive alkylation of the amine using an aldehyde and a reducing agent.73  
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The first method examined was the direct alkylation of amino acids with an alkyl 
halide. An example of this is the synthesis of 63. An aqueous solution of picolyl 
chloride hydrochloride was added to an aqueous solution of L-alanine and 
sodium hydroxide, and the mixture refluxed overnight. The product was isolated 
by two different techniques (see Experimental Section for details), and the 
identity of the product confirmed by comparison of the NMR spectra to literature 
values.70  
 
The second method employed for the synthesis of 63 is that of Levadala and co-
workers.73 This method involves the use of an aldehyde and a reducing agent to 
reductively alkylate the amine. Compound 63 was successfully synthesized by 
this method, using pyridine-2-carboxyaldehyde and sodium 
tris(acetoxy)borohydride. This method is more powerful than the first method, 
allowing the synthesis of trisubstituted amines with different alkyl groups 
attached. However, it is technically more complex than the first method, and so 
was not employed for the synthesis of ligands beyond the initial exploration into 
the synthesis of 63. 
 
A number of different ligands were synthesized in this series. Compound 63, 
mentioned already, was the first to be synthesized. The related compound N,N-
bis(2-pyridylmethyl)-L-valine (64) was synthesized by the same method (see 





















65 66 67  
Scheme 4.1 
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these would be different to ligands synthesized from primary amino acids. Using 
the same method as for the synthesis of 63, N-(2-pyridylmethyl)-L-proline (65) 
was synthesized in good yield (96%). Additionally the related compounds,  
N-(3-pyridylmethyl)-L-proline (66) and N-(4-pyridylmethyl)-L-proline (67), by 
replacing the picolyl chloride hydrochloride used in the reaction with 3- and 
4-chloromethylpyridine hydrochloride respectively (see Scheme 4.1).  
 
The last potential ligand synthesized in this series was based on the artificial 
amino acid (S)-(-)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid (68). The 
molecule synthesized from 68 is related to 65, but has a larger ring size, as well 
as a more constrained geometry, both effects it was hoped would aid in the 
synthesis of different complexes to those synthesized from 65. The ligand (69) 
was prepared in the same manner as 65, by reaction of the amino acid with 
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One of the most common reactions in peptide chemistry is the formation of an 
amide bond. This section focuses on the synthesis of ligands from amino acids 
by formation of amide bonds to attach pyridine rings. The simplest ligand of this 
type is L-alanine picolinamide (70), which has been previously prepared.74, 75 
The obvious extension of this is to add an additional pyridine ring to the other 
terminus of the molecule to add a further binding site (71), or to link together two 





































The first molecule targeted for synthesis was 70; the coordination chemistry of 
this molecule has only been cursorily studied by Reddy and coworkers,74 so this 
is an attractive target. The synthetic route to 70 must involve the use of a 
protected acid group to prevent reaction of the amino acid with itself in any 
amide synthesis reaction. The starting material chosen in this case was 
commercially available L-alanine methyl ester, which was reacted with picolinic 
acid using a mixed carboxylic-carbonic acid anhydride method.76 The desired 
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product, L-alanine methyl ester picolinamide (72), was isolated in high yield 
(93%) as a pale yellow oil. Hydrolysis of 72 to 70 was achieved by reaction with 
5% lithium hydroxide solution in 3:1 methanol:water, which provided the desired 
product in near quantitative yield. Slow evaporation of a dichloromethane 
solution of 70 provided crystals suitable for X-ray crystallography.  
 
Structure of 70 
 
Compound 70 crystallizes in orthorhombic space-group P212121, with one 
molecule in the asymmetric unit. There is an intramolecular interaction between 
the pyridine nitrogen (N6) and the amide hydrogen (H3A) which dictates the 
orientation of the pyridine ring (see Figure 4.3). The extended structure of 70 
features a one-dimensional hydrogen bonded polymer along the y-axis, the 21 
screw axis growing the polymer. The polymer can be viewed as the polar core 
where the hydrogen bonding occurs, with the non-polar parts of the molecules 
forming the outside. The difference in size between the methyl and pyridine 
groups creates pockets, into which the pyridine rings of the polymer chain 
adjacent in the z-direction interdigitate. The pyridine rings have edge to face 
interactions with adjacent pyridine rings, extending to a plane of such 
interactions (see Figure 4.4). 
  
Figure 4.3: A perspective view of the compound 70. The intramolecular hydrogen bond 
between the pyridine nitrogen and amide is shown as a dashed line. Hydrogen atoms are 
shown as spheres of arbitrary radius. 
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Figure 4.4: A packing diagram showing the π-stacking and hydrogen bonding between 
molecules of 70. 
 
To test whether this method could be extended to other amino acids, the 
analogous valine-based molecule was also synthesized. Synthesis of the 
analogous L-valine methyl ester picolinamide (73 – see Scheme 4.3) was 
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The previous two sections of this chapter have investigated the synthesis of 
ligands from amino acids using two possible derivatisation routes, the alkylation 
of the amine, and the synthesis of an amide from the amine. This section 
investigates a third route to the synthesis of ligands from amino acids, again 
focusing on derivatisation at the amine terminus: the reaction of an amine with 
an aldehyde to form an imine (see Scheme 4.4). Ligands used to coordinated 
metal ions are based on this motif are less common than the previous two types, 
and there are only two reports77 in the literature of crystal structures of 














Although the synthesis of imine-based ligands was the aim of this section, during 
the synthesis of these ligands and of complexes from these ligands, another 
class of ligands was encountered and investigated. The reaction of cysteine with 
pyridine-2-carboxaldehyde results in the unexpected synthesis of 2-(2-pyridyl)-4- 
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reaction, and this compound,78-81 as well as some related ones,79, 81, 82 has been 





The ligands in this chapter were synthesized exclusively in solution at the 
desired concentration, then used directly in the attempted synthesis of 
complexes, without isolation. Typically the formation of the desired ligand can be 
monitored by the uptake of the amino acid into a solvent in which it is not 
normally soluble, indicating reaction has taken place. When complete 
reaction/dissolution of the amino acid has occurred, the solution is stirred for a 
further 30 minutes, and then used directly to react with solutions of metal salts.  
 
The simplest ligand in this series is (S)-2-(2-iminomethylpyridine)-propanoic acid 
(76), and is synthesized from the reaction of pyridine-2-carboxaldehyde with L-
alanine in methanol. The solution was used directly for the synthesis of metal 
complexes. Analogues of this ligand using L-valine (77) and L-leucine (78) were 














76 77 78  
Scheme 4.6 
 
Originally it was intended to synthesize a ligand based on cysteine in this series 
(79 – see Scheme 4.7). Instead, as mentioned above, thiazolidine 75 resulted. 
This lead to a new series of ligands being synthesized, by varying the aldehyde 
used in the synthesis. Aldehydes used in this way, beyond pyridine-2- 
  























































carboxaldehyde, were quinoline-2-carboxaldehyde and pyridine-2,6-
dicarboxaldehyde to synthesize ligands 80 and 81 (see Scheme 4.7). 
 




In this chapter the synthesis of amino acid based ligands for coordination and 
metallosupramolecular chemistry was reported. Three different approaches 
towards this aim were investigated. 
 
N-Alkylation of the amine terminus of the amino acids was studied. The reaction 
of amino acids with halomethylpyridines resulted in the preparation of a variety of 
ligands, with a range of donor numbers and configurations. 
 
A more classical approach to amino acid organic chemistry was the synthesis of 
amide bonds. Again the amine terminus of the amino acid was targeted, and 
amino acid-picolinamide ligands were synthesized. 
 
The final approach was the in situ preparation of imine based ligands. Reaction 
of the amine with a range of aldehydes led to a number of imine based ligands. 
The unexpected synthesis of thiazolidine based ligands from cysteine expanded 
the range and number of ligands explored. 
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Metal Complexes of Amino 
 Acid Derived Ligands 




In this chapter the coordination and supramolecular chemistry of some amino 
acid based ligands is described. The synthesis of these homochiral ligands was 
described in the previous chapter. 
 
5.1.1 Thiazolidine-based ligands 
 
Thiazolidines are well known compounds, having been synthesized as early as 
the 1940s.83 (2R,4R)-2-(2-Pyridyl)-4-thiazolidinecarboxylic acid (75) has only 
been reported twice in the literature,78, 81 and in both cases was used in 
asymmetric catalysis. The catalytic species was not identified in either report, but 
was purported to be a complex of rhodium and 75. No crystal structures of 75 or 
complexes of 75 have been reported in the literature, although a crystal structure 
of the ethyl ester of 75 has been reported.84 
 
5.1.2 Amide-based ligands 
 
Although a range of ligands based on this concept have been crystallized,85 only 
a small number of complexes have been examined by X-ray crystallography.86 
No complexes of 72 or the hydrolyzed derivative 70 have been reported in the 
literature. 
 
5.1.3 N-Alkyl-based Ligands 
 
No complexes of ligand 65 have been previously reported in the literature, 
although Bernauer and co-workers87 have reported extensively on a related C2 
symmetric ligand (see Figure 5.1). This ligand is similar to 65 in that it has a 
proline ring with an attached pyridylmethyl, however in the work of Bernauer a 
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second proline ring is attached on the other side of the pyridine ring, so the 










Figure 5.1: The ligand synthesized by Bernauer and co-workers on the left, and ligand 65 
on the right. 




5.2.1 Complexes of Thiazolidine-based ligands 
 
Synthesis of the Complexes 
 
Complexes 82, 83, 84, 85 and 86 were all synthesized in the same manner. A 
solution of ligand 75 in 2:1 methanol:water was added to a solution of half an 
equivalent of the appropriate metal salt in water. Crystals were formed upon 
standing of the solution. Complex 82 was synthesized with a yield of 20%, with 
hexa(aqua)cobalt(II) nitrate as the metal salt. Complex 83 was synthesized with 
cobalt(II) bromide as the metal salt with a yield of 23%. Complex 84 was 
synthesized in a yield of 55%, with hexa(aqua)nickel(II) nitrate as the metal salt. 
Complex 85 was synthesized using hexa(aqua)nickel(II) sulfate as the metal salt 
with a yield of 55%. Complex 85 could also be isolated from the reaction of a 
number of other nickel(II) metal salts. An example of this is the reaction of 
nickel(II) bromide trihydrate; the majority of the crystals isolated from this 
reaction had the same unit cell as 85, and so were not further analysed. A small 
rosette of crystals, with a different morphology, had a different unit cell, and 
proved to be a different complex: complex 86 was isolated with a yield of 14%. 
 
The synthesis of a number of other complexes related to these was attempted. 
Reaction of a range of metal salts with ligands 80 and 81 was attempted. 
Unfortunately neither of these ligands led to crystalline products.  
 
Structure of 82 
 
Complex 82 crystallizes in monoclinic space group P21, as a 2:1 ligand:metal 
complex. Each ligand is coordinated to the cobalt centre through the pyridine 
nitrogen, amine nitrogen and an oxygen of the carboxylate, with a facial 
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arrangement of the donors (see Figure 5.2). The pyridines of the two different 
ligands have a trans relationship, while both the amine and carboxylate have a 
cis relationship to each other. The cobalt centre is in the 3+ oxidation state, with 
two anionic ligands coordinated. The charge balance is accounted for by a non-
coordinated nitrate anion. The asymmetric unit is completed by three water 
solvate molecules. Both the ligands have the same R,R stereochemistry. The 
presence of 3 water molecules, as well as both hydrogen bonding acceptors and 
donors being present on the complex itself, leads to 10 unique hydrogen bonds 
 
Figure 5.2: A perspective view of complex 82, water molecules, the nitrate anion and 
hydrogens are omitted for clarity. Selected bond lengths (Å) and angles (°): Co(1)-N(3) 
1.9539(13), Co(1)-N(21) 1.9257(13), Co(1)-O(42) 1.8923(11), Co(1)-N(3’) 1.9568(13), Co(1)-
N(21’) 1.9356(14), Co(1)-O(42’) 1.8991(11), N(3)-Co(1)-N(21) 83.46(6), N(3)-Co(1)-O(42) 
87.20(5), N(3)-Co(1)-N(3’) 96.45(5), N(3)-Co(1)-N(21’) 96.24(5), N(3)-Co(1)-O(42’) 175.86(5), 
N(21)-Co(1)-O(42) 89.58(5), N(21)-Co(1)-N(3’) 93.36(5), N(21)-Co(1)-N(21’) 177.23(6), N(21)-
Co(1)-O(42’) 94.50(5), O(42)-Co(1)-N(3’) 175.55(6), O(42)-Co(1)-N(21’) 93.16(5), O(42)-Co(1)-
O(42’) 89.18(5), N(3’)-Co(1)-N(21’) 83.94(6), N(3’)-Co(1)-O(42’) 87.25(5), N(21’)-Co(1)-O(42’) 
85.97(5). 




Figure 5.3: A packing diagram of complex 82. Two layers of the complex can be seen here, 
with the intermediate water molecules and nitrate anion hydrogen bonded between the 
layers. Non-hydrogen bonding hydrogen atoms are omitted for clarity. 
 
being present in the structure. This large number of hydrogen bonds leads to a 
complicated three dimensional hydrogen bonding network. Although this network 
is difficult to describe clearly in detail, a simplified representation is of layers in 
the xy-plane of the cobalt complex, hydrogen bonded to each other, separated 
by layers of hydrogen bonded water molecules and nitrate anions (see Figure 
5.3). The two layers are also hydrogen bonded to each other, extending the 
hydrogen bonding network in three dimensions. 
 
Structure of 83 
 
Compound 83 crystallizes in orthorhombic space group P21212 as a 2:1 
ligand:metal complex. Each ligand is coordinated to the cobalt centre through the 
pyridine nitrogen, amine nitrogen and an oxygen of the carboxylic acid (see 
Figure 5.4). This complex has the same facial arrangement of donors as the 
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previous complex, as well as the same arrangement of donors between the two 
ligands. The cobalt centre is in the 3+ oxidation state, with two anionic ligands 
coordinated and a non-coordinated, disordered bromide anion, which is 
hydrogen bonded to one of the amine groups. The hydrogen bonding in this 
complex is simpler than that of the previous complex. Each complex has a 
hydrogen bond to the bromide anion, as well as the symmetry related bromide of 
an adjacent complex, both from the same amine group. The complementary 
 
Figure 5.4: A perspective view of complex 83. Non-hydrogen bonded hydrogens and the 
minor component of the bromide disorder are omitted for clarity. The dashed line 
represents a hydrogen bond. Selected bond lengths (Å) and angles (°): Co(1)-N(3) 
1.904(11), Co(1)-N(7) 1.957(9), Co(1)-O(13) 1.926(9), Co(1)-N(23) 1.938(7), Co(1)-N(27) 
1.958(9), Co(1)-O(33) 1.905(8), N(3)-Co(1)-N(7) 84.4(4), N(3)-Co(1)-O(13) 87.9(5), N(3)-Co(1)-
N(23) 97.8(5), N(3)-Co(1)-N(27) 96.1(5), N(3)-Co(1)-O(33) 173.6(4), N(7)-Co(1)-O(13) 89.7(4), 
N(7)-Co(1)-N(23) 92.9(4), N(7)-Co(1)-N(27) 176.5(4), N(7)-Co(1)-O(33) 91.9(4), O(13)-Co(1)-
N(23) 173.9(5), O(13)-Co(1)-N(27) 93.8(4), O(13)-Co(1)-O(33) 86.9(4), N(23)-Co(1)-N(27) 
83.6(3), N(23)-Co(1)-O(33) 87.5(3), N(27)-Co(1)-O(33) 87.9(4). 
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Figure 5.5: A packing diagram of complex 83, showing the (6,3) hydrogen bonding 
network in the xy-plane. 
 
hydrogen bonds to the amine of the adjacent complex form a dimeric structure. 
These are linked to adjacent dimeric structures by hydrogen bonding of the other 
amine present in the complex to one of the carboxylate oxygens of another 
adjacent complex. The combination of these two hydrogen bonding interactions 
results in a two-dimensional (6,3) hydrogen bonded network in the xy-plane (see 
Figure 5.5). There is no notable interaction between adjacent planes. 
Unfortunately this may not represent the true hydrogen bonding situation within 
the structure. Due to poor crystal quality and a high level of background electron 
density, believed to be due to disordered solvent molecules, the SQUEEZE 
routine from PLATON88 was applied. This removes the residual electron density 
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from disordered solvent molecules within the structure, which may mask any 
further hydrogen bonding within the structure. 
 
Structure of 84 
 
Complex 84 crystallizes in monoclinic space group P21, as a 2:1 metal:ligand 
complex. Each ligand is coordinated to the nickel centre through the pyridine 
nitrogen, amine nitrogen and an oxygen of the carboxylic acid (see Figure 5.6). 
This complex has the same facial arrangement of donors as the previous  
 
 
Figure 5.6: A perspective view of the nickel complex in structure 84. Hydrogen atoms and 
the nitrate anion are omitted for clarity. Selected bond lengths (Å) and angles (°): Ni(1)-
N(3) 2.0890(18), Ni(1)-N(21) 2.0566(19), Ni(1)-O(42) 2.0927(16), Ni(1)-N(3’) 2.0960(18), Ni(1)-
N(21’) 2.0517(19), Ni(1)-O(42’) 2.0902(16), N(3)-Ni(1)-N(21) 81.35(8), N(3)-Ni(1)-O(42) 
82.07(7), N(3)-Ni(1)-N(3’) 97.18(7), N(3)-Ni(1)-N(21’) 99.55(7), N(3)-Ni(1)-O(42’) 173.22(7), 
N(21)-Ni(1)-O(42) 86.20(7), N(21)-Ni(1)-N(3’) 99.07(7), N(21)-Ni(1)-N(21’) 178.93(8), N(21)-
Ni(1)-O(42’) 92.26(7), O(42)-Ni(1)-N(3’) 174.53(7), O(42)-Ni(1)-N(21’) 93.35(7), O(42)-Ni(1)-
O(42’) 99.88(6), N(3’)-Ni(1)-N(21’) 81.41(8), N(3’)-Ni(1)-O(42’) 81.50(6), N(21’)-Ni(1)-O(42’) 
86.86(7). 
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Figure 5.7: The one-dimensional hydrogen bonded polymer present in structure 85. Non-
hydrogen bonded hydrogen atoms are omitted for clarity. 
 
Figure 5.8: A packing diagram of structure 84 showing the hydrogen bonding between 
nitrate anions and chains to form two-dimensional networks in the yz-plane and stacking 
in the x-direction. 
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complexes, as well as the same arrangement of donors between the two ligands. 
There is one nitrate anion present in the structure, with the nickel in the 2+ 
oxidation state, meaning one of the carboxylates is protonated. When attempts 
were made to determine which carboxylate group the proton was located on by 
examining the electron density difference map, both had peaks of equal height in 
close proximity with an appropriate geometry. Initially the proton was assigned 
as being disordered over both sites, although it soon became apparent that this 
was a simplistic representation of the situation. Examination of the hydrogen 
bonding in the structure reveals a one dimensional chain, which is formed by 
hydrogen bonding between symmetry equivalent complexes along the y-axis 
(see Figure 5.7). The alternating complexes are related by the 21 screw axis, 
with hydrogen bonding between adjacent carboxylic acid groups. The proton is 
disordered between the two carboxylic acids in the asymmetric unit, which leads 
to it being disordered between those of adjacent complexes as part of the 
hydrogen bonding network. The amines of each complex are both hydrogen 
bonded to the same nitrate anion and there is an additional hydrogen bond to an 
adjacent chain, linking them together to form a two-dimensional hydrogen 
bonded network in the yz plane. These networks stack in the x-direction (see 
Figure 5.8) 
 
Structure of 85 
 
Complex 85 crystallizes in orthorhombic space group P212121, as a 2:1 
ligand:metal complex. The arrangement of donors and ligands is identical to that 
of the previous three structures (see Figure 5.9). In this structure both 
carboxylate groups are deprotonated, and there is no other anion present; the 
nickel is in the 2+ oxidation state. The asymmetric unit is completed by a water 
molecule, which is hydrogen bonded to one of the carboxylate groups of the 
complex. There is further hydrogen bonding between adjacent complexes and 
water molecules which lead to the extended hydrogen bonding network. Each 
complex is hydrogen bonded to the four adjacent complexes in the xy-plane. All 
four of these complexes are related by translation, and the hydrogen bonds  
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Figure 5.9: A perspective view of complex 85. Hydrogen atoms and the water molecule are 
omitted for clarity. Selected bond lengths and angles: Ni(1)-N(3) 2.093(2), Ni(1)-N(21) 
2.0683(18), Ni(1)-O(42) 2.0658(16), Ni(1)-N(3’) 2.1418(19), Ni(1)-N(21’) 2.0890(18), Ni(1)-O(42’) 
2.0454(16), N(3)-Ni(1)-N(21) 81.70(8), N(3)-Ni(1)-O(42) 80.41(7), N(3)-Ni(1)-N(3’) 104.37(8), 
N(3)-Ni(1)-N(21’) 93.34(7), N(3)-Ni(1)-O(42’) 174.19(7), N(21)-Ni(1)-O(42) 90.54(7), N(21)-Ni(1)-
N(3’) 94.97(7), N(21)-Ni(1)-N(21’) 172.51(8), N(21)-Ni(1)-O(42’) 96.00(7), O(42)-Ni(1)-N(3’) 
173.16(7), O(42)-Ni(1)-N(21’) 94.18(7), O(42)-Ni(1)-O(42’) 94.31(7), N(3’)-Ni(1)-N(21’) 80.77(7), 
N(3’)-Ni(1)-O(42’) 81.11(7), N(21’)-Ni(1)-O(42’) 89.45(7).  
 
are between the amine hydrogens and carboxylate oxygens. This forms a (4,4) 
net in this plane (see Figure 5.10). The water molecule (hydrogen bonded to one 
carboxylate group) is further hydrogen bonded via the other hydrogen to an 
adjacent symmetry equivalent complex via one of the sulfur atoms. The 
interaction between the complexes is not limited to hydrogen bonding: there is π-
stacking between the pyridine rings of the layers. The pyridine rings interdigitate, 
but are offset in the z-direction, not fully overlapping (see Figure 5.11). The rings 
are also not parallel, with the distances between adjacent rings ranging from 
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Figure 5.10: The (4,4) net formed from hydrogen bonding between the complexes and 
water molecules in the xy-plane. 
 
3.706 to 4.837 Å. These two layers form a bilayer which is not hydrogen bonded 
any further in the z-direction. The interaction with adjacent bilayers is restricted 
to π-stacking; similar to the intra-bilayer π-stacking, the interdigitating pyridine 
rings are offset in the z-direction and are not parallel. The π-stacking in this case 
is tighter, with ring to ring distances ranging from 3.585 to 3.734 Å. 
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Figure 5.11: A perspective view showing how the hydrogen bonded networks stack in the 
z-direction. The π-stacking between pyridine rings of adjacent networks can clearly be 
seen here. 
 
Structure of 86 
 
Complex 86 crystallizes in monoclinic space group P21, as a 2:1 ligand:metal 
complex. Again the arrangement of donors and ligands is identical to that of the 
previous structures (see Figure 5.12). In this structure there is one bromide 
anion, so it is assumed that only one of the ligands is anionic. The hydrogen 
atom could not be located in the electron density difference map, and so was not 
initially assigned. Examination of the extended structure reveals an 
intermolecular relationship between molecules almost identical to that observed 
in complex 85, indicating a one-dimensional hydrogen bonded chain along the y-
axis. This would indicate that the protons are disordered between the 
carboxylate groups of adjacent complexes, as in complex 84, accounting for the 
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Figure 5.12: A perspective view of 86. Hydrogen atoms and the counter ion are omitted for 
clarity. Selected bond lengths (Å) and angles (°): Ni(1)-N(3) 2.080(7), Ni(1)-N(21) 2.038(7), 
Ni(1)-O(42) 2.094(6), Ni(1)-N(3’) 2.079(7), Ni(1)-N(21’) 2.039(7), Ni(1)-O(42’) 2.079(6), N(3)-
Ni(1)-N(21) 81.7(3), N(3)-Ni(1)-O(42) 81.8(3), N(3)-Ni(1)-N(3’) 98.2(3), N(3)-Ni(1)-N(21’) 
100.4(3), N(3)-Ni(1)-O(42’) 172.9(3), N(21)-Ni(1)-O(42) 86.0(2), N(21)-Ni(1)-N(3’) 99.7(3), N(21)-
Ni(1)-N(21’) 177.4(3), N(21)-Ni(1)-O(42’) 91.4(3), O(42)-Ni(1)-N(3’) 174.3(3), O(42)-Ni(1)-N(21’) 




Figure 5.13: A packing diagram showing how the bromide anions sit in channels between 
the complexes. All hydrogens are omitted for clarity. 
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charge balance. Similar to the position of the nitrate in complex 84, the bromide 
anion is hydrogen bonded to both amine hydrogens of the complex. The bromide 
anions sit in channels between adjacent polymer chains in the z-direction (see 
Figure 5.13). 
 
5.2.2 Complexes of Pyridyl-Amide-based ligands 
 
Synthesis of the Complexes 
 
Complex 87 was synthesized by reacting two equivalents of ligand 72 dissolved 
in acetonitrile with one equivalent of copper nitrate trihydrate, also dissolved in 
acetonitrile. The solution immediately darkened. The solution was divided up and 
a range of non-polar solvents diffused into the different solutions to crystallize the 
product. Slow diffusion of diethyl ether into the solution provided crystals suitable 
for X-ray crystallography in a yield of 80%. Initial synthesis of the silver complex 
88 was almost identical the synthesis of complex 87, however the solution was 
kept light free, and in this case the solvent which resulted in eventual 
crystallisation was ethyl acetate. This complex required almost complete 
evaporation of all solvent before the two crystals were formed. Unfortunately 
there was insufficient amount of this complex to study it beyond X-ray 
crystallography. 
 
Structure of 87 
 
Complex 87 crystallizes in monoclinic space group P21, as a 2:1 ligand:metal 
complex. The asymmetric unit consists of only the metal centre, coordinated to 
two ligands and two nitrate anions (see Figure 5.14). Both ligands chelate the 
copper centre through the pyridine nitrogen and the amide oxygen, with a bite 
angle of 82.57(11)°. Both ligands are coordinated in the same plane, with the 
nitrate anions occupying the axial positions. The copper oxygen bonds to the 
nitrate anions are Jahn-Teller distorted as is expected in such complexes: 
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2.405(3) and 2.425(3) Å compared to the 1.970(3)-1.991(2) Å for the equatorial  
 
 
Figure 5.14: A perspective view of complex 87. Hydrogen atoms are omitted for clarity. 
Selected bond lengths (Å) and angles (°): Cu(1)-N(1) 1.970(3), Cu(1)-O(7) 1.991(2), Cu(1)-
N(21) 1.970(3), Cu(1)-O(27) 1.988(2), Cu(1)-O(41) 2.405(3), Cu(1)-O(51) 2.425(3), N(1)-Cu(1)-
O(7) 82.57(11), N(1)-Cu(1)-N(21) 179.01(14), N(1)-Cu(1)-O(27) 97.88(11), N(1)-Cu(1)-O(41) 
96.77(10), N(1)-Cu(1)-O(51) 84.61(12), O(7)-Cu(1)-N(21) 96.73(11), O(7)-Cu(1)-O(27) 
179.54(13), O(7)-Cu(1)-O(41) 91.25(9), O(7)-Cu(1)-O(51) 89.06(10), N(21)-Cu(1)-O(27) 
82.82(11), N(21)-Cu(1)-O(41) 83.94(11), N(21)-Cu(1)-O(51) 94.68(12), O(27)-Cu(1)-O(41) 
88.63(9), O(27)-Cu(1)-O(51) 91.05(10), O(41)-Cu(1)-O(51) 178.61(12). 
 
Figure 5.15: The one-dimensional hydrogen bonded polymer along the x-axis. 
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Figure 5.16: The packing of the hydrogen bonded polymers. 
 
ligands. The relative conformation of the two ligands is different (see Figure 
5.14), so although there is a rotational relationship between them, they are not 
related by any true symmetry. Each complex has four hydrogen bonds; these are 
between each amide hydrogen and the nitrate anion of an adjacent complex, as 
well as the complementary hydrogen bond from the nitrates to the amide protons 
of the adjacent complexes (see Figure 5.15). The complexes are related by 
translation in the x-direction, with the polymer chains stacking in the y- and z-
directions (see Figure 5.16). 
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Structure of 88 
 
Complex 88 crystallizes in orthorhombic space group P212121, as a 2:1 
ligand:metal complex. The asymmetric unit consists of the metal centre chelated 
by the pyridine nitrogen and amide oxygen of both ligands, and is completed by 
the perchlorate counter ion, which is hydrogen bonded to the complex (see 
Figure 5.17). The geometry of the silver centre is distorted tetrahedral, with the 
bite angles of the chelate rings being 71.15(5) and 71.44(5)°, while the other 
angles around the silver centre range from 105.73(4) to 151.11(5)°. This wide 
range is due to the constrained geometry of the chelate ring, which in turns 
causes the other angles to widen. In this complex the bonds between the 
pyridine nitrogens and the silver centre (2.2147(15) and 2.2280(15) Å) are 
shorter than those between the amide oxygens and the silver centre (2.4520(12) 
and 2.4741(13) Å). The hydrogen bonding of the perchlorate anion to an 
adjacent complex leads to a one-dimensional hydrogen bonded chain (see  
 
Figure 5.17: The asymmetric unit of 88. The hydrogen bonding proton is represented by a 
sphere of arbitrary radius. Other hydrogens are omitted for clarity. Selected bond lengths 
(Å) and angles (°): Ag(1)-N(1) 2.2280(15), Ag(1)-O(7) 2.4741(13), Ag(1)-N(1’) 2.2147(15), 
Ag(1)-O(7’) 2.4520(12), N(1)-Ag(1)-O(7’) 71.44(5), N(1)-Ag(1)-N(1’) 151.11(5), N(1)-Ag(1)-O(7’) 
125.32(5), O(7)-Ag(1)-N(1’) 131.13(5), O(7)-Ag(1)-O(7’) 105.73(4), N(1’)-Ag(1)-O(7’) 71.15(5). 
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Figure 5.18: The one-dimensional hydrogen bonding chain along the y-axis. 
 
Figure 5.19: A perspective view of 88 looking down the y-axis showing the π-stacking 
present in the complex. 
 
Figure 5.18). The complexes of the chain are related by translation along the y-
axis. Along the x-axis there is π-stacking interactions between adjacent, screw-
axis related, complexes. Each pyridine ring has an offset π-stacking interaction 
with the pyridine ring of an adjacent complex; distances between the pyridine 
rings are approximately 3.4 Å (see Figure 5.19). The other adjacent complex 
does not π-stack with the pyridine ring; instead the amino acid tail is positioned 
over the pyridine ring. Along the z-axis the complexes stack simply, with the 
amino acid tail groups filling the gaps between adjacent complexes in this 
direction. 
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5.2.3 Complexes of N-Pyridyl-Amino Acid-based Ligands 
Synthesis of the complexes 
 
Only one complex was synthesized from this series of ligands, despite a large 
array of attempted syntheses with different metal salts and solvent systems. The 
reaction of two equivalents of ligand 65 in methanol with one equivalent of 
cobalt(II) bromide in acetonitrile resulted in an orange solution. Slow evaporation 
of the solution furnished thin needle-like crystals of complex 89 suitable for X-ray 
crystallography. Although the structure could be identified it could not be fully 
refined as it was of poor quality due to twinning of the crystal. Numerous crystals 
were examined in an attempt to find a high quality one, and several were 
 
 
Figure 5.20: A perspective view of the cobalt complex 89. Hydrogen atoms, the bromide 
counter ion and the water molecule are omitted for clarity. Selected bond lengths (Å) and 
angles (°): Co(1)-N(1) 2.028(8), Co(1)-N(6) 1.964(7), Co(1)-O(21) 1.895(6), N(1)-Co(1)-N(6) 
83.6(3), N(1)-Co(1)-O(21) 85.0(3), N(1)-Co(1)-N(1A) 105.9(4), N(1)-Co(1)-N(6A) 94.0(3), N(1)-
Co(1)-O(21A) 168.7(3), N(6)-Co(1)-O(21) 90.2(3), N(6)-Co(1)-N(6A) 176.0(4), N(6)-Co(1)-
O(21A) 92.7(3), O(21)-Co(1)-O(21A) 84.3(4). 
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mounted for preliminary X-ray examination before settling on a very narrow 
crystal (dimensions 0.44 x 0.09 x 0.04 mm3) to try and avoid twinning. Despite 
these precautions the structure was still of low quality. 
 
Structure of 89 
 
Complex 89 crystallizes in tetragonal space group P42212 as a 2:1 ligand:metal 
complex. The asymmetric unit consists of a cobalt atom, located on the two-fold 
rotation axis, coordinated to a deprotonated ligand through the pyridine nitrogen, 
amine nitrogen and a carboxylate oxygen in a facial arrangement. The 
coordination sphere is completed by a symmetry equivalent ligand generated by 
the two-fold rotation axis (see Figure 5.20). The remainder of the asymmetric unit 
consists of a half-occupied bromide anion and a quarter-occupied water 
molecule. There are no notable interactions between adjacent complexes, 
however they do stack in columns along the z-axis, with channels between the 




Figure 5.21: A packing diagram of complex 89 showing the bromide anions and water 
solvate molecules occupying channels between the stacks of complexes. 
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5.3 Comparison of the Complexes 
 
5.3.1 Complexes of Thiazolidine-based Ligands 
 
The most obvious place to start when comparing these complexes is the metal 
centres themselves. When the complexes are overlaid, fitting the central metal 
atom and the three donor atoms, it becomes obvious that the complexes are 
very similar (see figures 5.22 and 5.23). Unsurprisingly the geometry of the 
ligand is constrained by the coordination to the metal centre, and as the cobalt 
and nickel centres are very similar in size and arrangement of donors, there is 
little difference between the five complexes. The largest variation is in the 
thiazolidine ring, with differences in the sulfur position visible. This is not a 
particularly important feature; some of the complexes exhibit disorder in the 
thiazolidine ring, and not all disorder components were included in this 
comparison. This reflects a small amount of flexibility in the thiazolidine ring.  
 
Figure 5.22: An overlay diagram of the five complexes of ligand 75. 
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Figure 5.23: A diagram showing the other side of the five overlaid complexes of ligand 75. 
 
When the 10 ligands are themselves directly compared (see Figure 5.24), they 
are all relatively similar, as would be expected from the overlay of the 
complexes. The geometry of the ligands is enforced by coordination to the metal 
centre. In the diagram there appears to be a larger variation in the positions of 
the pyridine ring and carboxylate group. This is caused by, in this case, fitting the 
centre thiazolidine ring. This ring, as noted above, has a flexible backbone, and 
in some cases disorder, so fitting this ring exaggerates the variations of the 
pyridine and carboxylate groups. 
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Figure 5.24: An overlay diagram comparing the 10 ligands present amongst the 
structures.  
 
The hydrogen bonding networks of the different structures are not directly 
comparable. The networks are influenced by the anions and water molecules 
present in the structures, and as all have different amounts of these species, 
none are directly comparable. The complexes themselves have as many as six 
possible hydrogen bond acceptors, as well as two hydrogen bond donors, which 
gives them a large amount of flexibility for forming hydrogen bonds. This factor 
combined with large variation in the other species present leads to a variety of 
hydrogen bonding networks. 
 
5.3.2 Complexes of N-(picolinamide)-alanine-based Ligands 
 
Comparison of the four different ligands from complexes 87 and 88 shows that 
the head region of the ligands, which coordinates to the metal centre is, 
unsurprisingly, almost identical throughout the complexes. The tail region of the 
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ligands, which are not coordinated, show much more variation. This is 
unsurprising; the conformation of the tail regions is affected by the steric 
environment surrounding the complex, rather than coordination to the metal 
centre, which influences the conformation of the head section (see Figure 5.25). 
The complexes cannot be compared with respect to the extended structure: not 
only does different geometry around the metal centre significantly affect the 
directions in which supramolecular interaction can occur, but one complex has 
an additional species present, while the other exist as a discrete complex. 
 
Figure 5.25: A diagram showing the different conformations of the tail units of the four 
different ligands present in complexes 87 and 88. 




This chapter has described the coordination and supramolecular chemistry of a 
range of ligands synthesized from amino acids. A range of substituted 
thiazolidine-based ligands were synthesized (see Chapter 4), however only 
complexes of 75 were successfully crystallized and reported here. Two 
complexes of ligand 72 are also reported here. Although 72 was a precursor to 
70, no complexes of this ligand were successfully crystallized. Finally a single 
cobalt complex of ligand 65 was reported. Interestingly this series (see Section 
4.2) resulted in the most isolated ligands, but these ligands led to only a single 
crystalline complex. 
 
The five thiazolidine complexes reported in this chapter all have an almost 
identical coordination geometry around the metal centre. A consequence of this 
is that the relative conformations of the thiazolidine ligands are all very similar. 
The variation in conformations is due to the central thiazolidine ring; the sulfur-
carbon backside of the ring has some flexibility. The supramolecular chemistry 
between the complexes in this series is extremely varied, and largely dependant 
on the ancillary species present in the structures. 
 
The two complexes of ligand 72 reported in this chapter are relatively different. 
The two different metal centre geometries mean the complexes can not be 
directly compared. Comparison of the conformation of the ligands reveals that 
the coordinated head of the molecules are all very similar, while the non-
coordinated tails of the molecules show considerable variance. This is 
unsurprising, as steric effects and supramolecular effects are largely responsible 
for these conformations, and they differ between the two complexes. 
 
The complex of ligand 65 cannot be directly compared to any other complexes. It 
is interesting to note the relative similarity of complex 89 to the thiazolidine 
complexes previously examined in this chapter.  
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Conclusions 





This thesis has described the formation of a number of homochiral coordination 
complexes and supramolecular assemblies. The ligands utilized were from the 
alkaloid class of compounds, derivatives thereof, or derived from amino acids. A 
range of metal atoms with a variety of coordination numbers and geometries, as 
well as steric sizes was used in the formation of complexes. These factors, in 
combination with other supramolecular interactions led to a range of 
supramolecular polymeric and network structures, as well as some discrete 
species. 
 
The reaction of alkaloids with transition metals resulted in the formation of a 
number of coordination complexes with interesting structural features. Nicotine 
formed a number of different complexes, acting as either a monodentate ligand 
through the pyridine nitrogen, or as a bridging bidentate ligand through both 
pyridine and amine nitrogens. The conformation of the nicotine molecules was 
found to be similar to earlier work, and was consistent throughout all the 
complexes. The stable conformation of the nicotine molecule appeared to have 
an effect on the supramolecular chemistry, which was observed as consistent 
structural motifs between different complexes appearing. The other alkaloids 
studied in this thesis, the cinchona alkaloid family, were involved in three 
complexes; these were all examples of previously known coordination modes of 
this family of compounds.  
 
The synthesis of new homochiral ligands from alkaloids was an area of major 
work in this thesis. A wide range of synthetic routes were investigated, with three 
new ligands synthesized. The reaction of these ligands with a range of metal 
salts did not result in any complexes being isolated or characterized.  
 
The synthesis of homochiral ligands from amino acids was the other area of 
organic chemistry investigated in this thesis. These ligands were divided into 
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three separate areas: amine-based ligands, amide-based ligands and 
thiazolidine-based ligands. Six potential ligands designed on the first concept 
were synthesized. These ligands had three to four possible binding sites, and a 
range of possible coordination modes. Four potential ligands using the second 
concept were synthesized. The methyl ester forms of these ligands can act as 
chelating bidentate ligands, while the hydrolysed derivatives have the potential 
for an additional bridging interaction. The thiazolidine-based ligands were 
exclusively chelating ligands (with three to five potential donors), but also 
possessed additional functionality that could readily be involved in hydrogen 
bonding. 
 
The coordination chemistry of the amino acid-based ligands was investigated in 
this thesis. From the thiazolidine-based ligands five complexes were prepared. 
The complexes all had the same coordination geometry around the central metal 
atom, but different counter ions and solvate molecules resulted in different 
supramolecular chemistry in all five crystal structures. The amide-based ligands 
resulted in two complexes, both of the same methyl ester ligand (72). The amine-
based ligands resulted in only a single crystal structure, in which the ligand (65) 
coordinates in a chelating tridentate fashion. 
 
Hydrogen bonding was important in the extended three-dimensional structure of 
many of the complexes described in this thesis. These interactions had a range 
of effects, from being an important link between molecules in a robust 
supramolecular motif in one series of complexes, to completely defining the 
supramolecular chemistry in another series of complexes. Other interactions 
which were less important in defining extended three-dimensional structure were 
π-stacking and long range copper(II)-donor interactions. 
 
In summary this thesis has described the synthesis of nineteen homochiral 
ligands. Chiral coordination complexes of some of these ligands, as well as the 
parent compounds, were prepared. Twenty of these complexes were 
characterized by X-ray crystallography. These complexes exhibited a range of 
structural motifs, some of which were robust and observed across a series of 
complexes.  
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The ligands prepared in this thesis have potential applications in asymmetric 
catalysis and materials research, in which their homochiral nature is important. 
Similarly, the homochiral coordination complexes prepared in this thesis have 
potential in these areas, with the chiral, directional coordination polymers 
prepared in Chapter 2 of interest in non-linear optics. 
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Experimental
7.1 General Experimental 
 
NMR spectra were recorded on Varian Unity 300 or Varian INOVA 500 
spectrometers at 23 °C with a 3 mm probe and operating at 300 and 500 MHz 
for 1H spectra, respectively, and at 75 MHz for 13C spectra (Unity 300 only). 1H-
NMR spectra recorded in CDCl3 were referenced to the internal standard Me4Si, 
while other solvents were referenced to residual solvent signal. 13C-NMR spectra 
recorded in CDCl3 were referenced against the solvents signal at 77.0 ppm. 
When required 1H:1H-COSY, 1-D TOCSY, HSQC and CIGAR experiments were 
performed using the standard pulse sequences available with the Varian INOVA 
500 system. Unless otherwise stated the value of the chemical shift is given to 
the centre of the multiplet. 
 
Electron Impact (EI) mass spectra were recorded using a Kratos MS80FRA 
mass spectrometer with a Mach 3 data system. Spectra were obtained at 70 eV 
with a source temperature of 250 °C. Electrospray mass spectra were recorded 
using a Micromass LCT TOF mass spectrometer, with the probe operating at 
3200 V and a cone voltage of 30 V. Samples were dissolved in 1:1 
acetonitrile:water, and spectra acquired using source and desolvation 
temperatures of 80 and 150 °C, respectively. 
 
Melting points were determined using an Electrothermal melting point apparatus 
and are uncorrected. The Campbell microanalytical laboratory, University of 
Otago, Dunedin, performed elemental analyses. 
 
Unless otherwise stated, reagents were obtained from commercial sources and 
used as received. Solvents were purified by standard literature procedures. 
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7.2 Chapter 2 Experimental 
1 
Cobalt(II) acetate tetrahydrate (100 mg, 0.4 mmol) and ammonium thiocyanate 
(122 mg, 1.6 mmol) were dissolved in water (2 mL) to give a red solution. After 
addition of a solution of nicotine in ethanol (2 mL, 0.4 M) the solution went 
purple. Slow evaporation of the solution provided red crystals suitable for X-ray 
crystallography. Yield 217 mg (88 %). M.p. 196-198 °C. Anal. Found: C, 46.45; 
H, 4.83; N, 18.23. Calc for C24H30CoN8S4: C, 46.66; H, 4.89; N, 18.14. IR (KBr 
mull): 2957, 2721, 2081, 1603, 1454, 1402, 1007, 916, 810, 704, 640 cm-1. 
UV-vis 196 nm (62615 M-1cm-1), 327 nm (7586 M-1cm-1), 624 nm (1705 M-1cm-1). 
 
2 & 7 
Hexa(aqua)nickel(II) perchlorate (146 mg, 0.4 mmol) was dissolved in water 
(2 mL), then nicotine in ethanol solution (2 mL, 0.4 M) followed by sodium 
thiocyanate in aqueous solution (5 mL, 0.4 M) was added. On addition of the 
thiocyanate solution a pale blue precipitate formed. After standing over the 
weekend two different crystalline products had formed, pale blue crystals and 
purple crystals, both of which were suitable for X-ray crystallography. Purple 
crystals: Yield 62 mg (18 %). M.p. 243-248 °C. Anal. Found: C, 58.33; H, 6.44; 
N, 16.44. Calc for C42H56N10NiS2.1½H2O: C, 59.29; H, 6.99; N, 16.46. IR (KBr 
mull): 2968, 2941, 2777, 2077, 1603, 1433, 1317, 1111, 1045, 905, 812, 777, 
644, 629 cm-1. 
 
An alternative synthesis of only the pale blue crystals involved dissolving 
nickel(II) acetate tetrahydrate (50 mg, 0.2 mmol) and ammonium thiocyanate (61 
mg, 0.8 mmol) in 1:1 ethanol/water (2 mL) and adding a solution of nicotine in 
ethanol (1 mL, 0.4 M). Blue block-shaped crystals, suitable for X-ray 
crystallography, formed overnight. Yield 242 mg (98 %). M.p. 270-273 °C. Anal. 
Found: C, 46.70; H, 4.76; N, 18.22. Calc for C24H30N8NiS4: C, 46.68; H, 4.90; N, 
18.15. IR (KBr mull): 2957, 2723, 2091, 1605, 1454, 1402, 1209, 810, 704, 644 
cm-1. 




Tetrakis(acetonitrile)copper(I) tetrafluoroborate (126 mg, 0.4 mmol) was 
dissolved in acetonitrile (2 mL) and a solution of nicotine (130 mg, 0.8 mmol) 
dissolved in 40% calcium thiocyanate solution (1 mL) was added. A white 
precipitate formed, which immediately redissolved. Slow evaporation of the 
solution provided green crystals suitable for X-ray crystallography. An alternative 
preparation directly from copper(II) was also performed: Copper(II) acetate 
hydrate (40 mg, 0.2 mmol) and ammonium thiocyanate (61 mg, 0.8 mmol) were 
dissolved in 1:1 ethanol/water (2 mL). Upon addition of a solution of nicotine in 
1:1 water/ethanol (1 mL, 0.4 M) the solution went green and a brown suspension 
formed. Upon standing for a long period green crystals suitable for X-ray 
crystallography formed. Yield 42 mg (29 %). M.p. 251-254 °C. Anal. Found: 
C, 45.00; H, 4.96; N, 18.81. Calc for C24H30CuN8S4.7/4(H2O).3/2(MeCN): 
C, 45.33; H, 5.35; N, 18.60. IR (KBr mull): 3115, 2962, 2722, 2065, 1608, 1457, 
1400, 1208, 1097, 1009, 963, 900, 810, 701, 653 cm-1.  
 
4 
Cadmium(II) acetate dihydrate (107 mg, 0.4 mmol) and ammonium thiocyanate 
(122 mg, 1.6 mmol) were dissolved in 1:1 water/ethanol and a solution of 
nicotine in ethanol was added (1 mL, 0.4 M). Slow evaporation of the solution 
provided crystals suitable for X-ray crystallography. Yield 101 mg (75 %). 
M.p. 201.5-202 °C. Anal. Found: C, 42.63; H, 4.48; N, 16.30. Calc for 
C24H30CdN8S4: C, 42.94; H, 4.50; N, 16.30.  
5 
Iron(II) sulphate (61 mg, 0.4 mmol) and ammonium thiocyanate (61 mg, 0.8 
mmol) were dissolved in deoxygenated water under N2. A solution of nicotine in 
water (1 mL, 0.4 M) was deoxygenated and then added to the iron(II) solution. 
An immediate green precipitate formed, as well as a number of small orange 
crystals on the side of the vial. These crystals were suitable for X-ray 
crystallography, although only identification of the compound was possible, as 
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crystal quality was too low for complete refinement. Unfortunately these crystals 
were too unstable in air for any other analyses to be carried out. 
 
6 
Freshly recrystallized manganese(II) acetate tetrahydrate (49 mg, 0.2 mmol) and 
ammonium thiocyanate (61 mg, 0.8 mmol) were dissolved in deoxygenated 
water (2 mL) under N2. A solution of nicotine in ethanol (1 mL, 0.4 M) 
deoxygenated with N2 was added. Slow evaporation of the solvent under N2 
provided crystals suitable for X-ray crystallography, although only identification of 
the compound was possible, as crystal quality was too low for complete 




A solution of nicotine in acetonitrile (0.4 M, 1 mL) was added to a solution of 
silver(I) nitrate (66 mg, 0.4 mmol) in acetonitrile (1 mL). A crystalline product was 
obtained by the diffusion of ether into the solution. Yield 74 mg (56 %). 
M.p. 149-151 °C (dec.). Anal. Found: C, 35.98; H, 4.29; N, 12.91. Calc for 
C10H14AgN3O3: C, 36.17; H, 4.25; N, 12.65. 
1H-NMR (500 MHz, CD3CN): 
δ 8.70 (1H, d, H2), 8.55 (1H, dd, H6),  7.99 (1H, dt, H5),  7.56 (1H, dd, H4),  
3.37-3.41 (1H, m, H7),  3.31 (1H, t, H9a),  2.45-2.50 (1H, m, H9b),  2.33-2.39 
(1H, m, H11a),  2.32 (s, 3H, NCH3),  2.05-2.11 (1H, m, H10a), 1.94-2.00 (1H, m, 
H10b), 1.87-1.91 (1H, m, H11b). ES-MS: Found M+ 600.0, [Ag2(nicotine)2(NO3)]
+ 
requires M+ 600.0; found M+ 431.1, [Ag(nicotine)2]
+ requires M+ 431.1; found 
M+ 310.0, [Ag(nicotine)(CH3CN)]
+ requires M+ 310.0. IR (KBr mull): 2967, 2871, 
2797, 2398, 1753, 1597, 1388, 899, 807, 714 cm-1. 
 
9 
A solution of nicotine in acetonitrile (0.4 M, 3 mL) was added to silver(I) nitrate 
(66 mg, 0.4 mmol) dissolved in acetonitrile (4 mL). A crystalline product was 
obtained by the diffusion ofdiethyl ether into the solution. Yield 146 mg (74 %). 
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M.p. 141-142 ºC (dec.). Anal. Found: C, 48.78; H, 5.70; N, 14.27. Calc for 
C20H28AgN5O3: C, 48.59; H, 5.71; N, 14.17). 
1H NMR (300 MHz, CDCl3): 
δ 8.69 (1H, s, H2), 8.54 (1H, d, H6), 7.82-7.85 (1H, m, H5), 7.36-7.40 (1H, m, 
H4), 3.48 (1H, s, H7), 3.35 (1H, t, H9a), 3.16 (1H, t, H9b), 2.20-2.42 (1H, m, 
H11a), 2.26 (3H, s, NCH3), 1.97-2.01 (1H, m, H10a), 1.81-1.86 (2H, m, H10b, 
H11b). IR (KBr mull): 2976, 2770, 1762, 1576, 1390, 1035, 903, 807, 716 cm-1. 
 
10 
A solution of nicotine in acetonitrile (0.4 M, 1 mL) was added to silver(I) 
tetrafluoroborate (78 mg, 0.4 mmol) dissolved in acetonitrile (2 mL). A crystalline 
product was obtained by the diffusion of ethyl acetate into the solution. Yield 
126 mg (72 %). M.p. 135-140 °C (dec.). Anal. Found: C, 33.66; H, 4.28; N, 7.81. 
Calc for C10H14BF4N2Ag: C, 33.65; H, 3.95; N, 7.85. IR (KBr mull): 2943, 2781, 
1578, 1427, 1315, 1042(br), 905, 808, 718, 534, 523 cm-1. 
 
12 
Bis(2,2’-bipyridine)dichlororuthenium(II) (30.0 mg, 0.062 mmol) and nicotine 
(1 drop) were refluxed for two days in 3:1 ethanol:water (8 mL). The solution was 
cooled to room temperature and reduced in vacuo. A saturated aqueous solution 
of ammonium hexafluorophosphate was added until no further precipitation was 
observed. The fine red solid product was removed by filtration and washed with 
water (3 x 2 mL) and air dried. Yield 26 mg (55.5%). Anal. Found: C, 45.08; 




Complex 13 was synthesized by adapting the method of Calvert et al.42 (2,2’-
Bipyridine)chloro(2,2’:6’,2”-terpyridine)ruthenium(II) hexafluorophosphate (25 
mg, 0.04 mol) and nicotine (81 mg, 0.5 mmol) were dissolved in 1:1 
ethanol:water (12.5 mL). The solution was refluxed overnight with stirring. The 
solution was cooled, and reduced to half-volume in vacuo, and a solution of 
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saturated aqueous ammonium hexafluorophosphate was added until no further 
precipitation was observed. The red-brown product was removed by filtration and 
washed with water (3 x 2 mL). This product was purified by column 
chromatography on alumina eluting with 2:1 toluene:acetonitrile. Yield. 20 mg (53 
%). 1H-NMR (500 MHz, CD3CN): δ 8.76 (d, 1H, A6), 8.74 (d, 1H, A3), 8.57 (dd, 
1H, D3), 8.48-8.50 (m, 3H, B3 (1H) & C3 (2H)), 8.37 (t, 1H, A4), 8.25 (t, 1H, D4), 
8.07-8.10 (m, 2H, C4), 7.86-7.90 (m, 4H, A5 (1H) & B4 (1H) & C6 (2H)), 7.78 (s, 
1H, N2), 7.72 (d, 1H, N6), 7.57 (d, 1H, N4), 7.43-7.49 (m, 2H, C5), 7.37 (d, 1H, 
B6), 7.18 (dd, 1H, N5), 7.14 (t, 1H, B5). See diagram below for ring assignments. 
Pyrrolidine protons of nicotine were unassigned. C ring protons are not truly 
equivalent, which is observed as a broadening of those signals in the spectra. 
Anal. Found: C, 43.77; H, 4.00; N, 10.71. Calc for C35H33F12N7P2Ru.H2O: C, 





































Hexa(aqua)copper(II) perchlorate (74 mg, 0.2 mmol) and nicotine (39 mg, 0.24 
mmol) were dissolved in methanol (3 mL). A solution of 2,2’,6’,2’’-terpyridine (28 
mg, 0.12 mmol) dissolved in methanol (4 mL) was added dropwise with stirring. 
A purple-blue solid formed in the blue solution. The solid was removed by 
filtration, and recrystallisation from hot methanol was unsuccessful. Crystals of 
the desired product, suitable for X-ray crystallography, were obtained by slow 
diffusion of diethyl ether vapour into the filtrate. 
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15 
Copper(II) chloride (10 mg, 0.075 mmol) and quinine (32 mg, 1 mmol) were 
dissolved in 2:1 acetonitrile:methanol (5 mL). Crystals suitable for X-ray 
crystallography formed on standing overnight. Yield 29 mg (80 %). M.p. 166-168 
°C. Anal. Found: C, 54.07; H, 5.43; N, 8.47. Calc for 
C40H46Cl2Cu2N4O4.(CH3CN)2(H2O)2: C, 54.88; H, 5.86; N, 8.73. 
 
16 
Copper(II) bromide (14 mg, 0.065 mmol) and quinine (32 mg, 1 mmol) were 
dissolved in 2:1 acetonitrile:methanol (5 mL). Upon standing overnight a green 
powder formed, which redissolved when the solution was heated. The solution 
was allowed to stand overnight again, and green crystals suitable for X-ray 
crystallography formed. Yield 22 mg (67 %). M.p. 154-157 °C. Anal. Found: 
C, 52.13; H, 5.09; N, 8.26. Calc for C40H46Cl2Br2N4O4.(CH3CN)2: C, 52.02; 
H, 5.16; N, 8.27. 
17 
Hexa(aqua)cobalt(II) chloride (118 mg, 0.5 mmol) was dissolved in ethanol (2 
mL) and a solution of quinine (162 mg, 0.5 mmol) in ethanol (2 mL) was added. 
A light blue precipitate formed immediately, and small crystals formed over a 
period of three hours. These crystals were left overnight, after which they were of 
sufficient quality for preliminary X-ray crystallographic investigation. This 
investigation revealed the structure to be related to previously reported 
compounds; this fact in conjunction with the low quality of the crystals led to no 
further analysis being attempted. 
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7.3 Chapter 3 Experimental 
25 
Compound 25 was synthesized from nicotine by the method of Taylor55 with 
yields similar to those originally reported (~70 %). 
22 
Compound 22 was synthesized by the method of Schmidt and Neitemeier44 in 
variable yields (10-60 %). 
20 from 22 
The synthesis of 20 from 22 was attempted using the method of Schmidt and 
Neitemeier. The reaction was performed both in the presence and absence of 
diisopropylamine, as reported, by both syntheses resulted in none of the desired 
20. 
23 
Compound 23 was synthesized using the method of Rolf54 in high yields (>90 
%). 
27 
Compound 27 was synthesized by adapting the synthesis of 25. Cotinine 
(176 mg, 1 mmol) was dissolved in acetic acid (5 mL) and 30% hydrogen 
peroxide (1 mL) was added. The resulting solution was stirred overnight at 60 °C. 
The solvent was removed in vacuo to provide the product as a pale yellow oil. 
Yield 190 mg (99 %).  
Reaction of 27 with phosphorus oxychloride 
Compound 27 (19 mg, 0.1 mmol) was mixed with freshly distilled phosphorus 
oxychloride (2.5 mL). The solution was refluxed overnight with vigorous stirring 
under a nitrogen atmosphere. The solution was cooled, and carefully poured 
onto ice (5 mL). The resulting solution was neutralized with solid sodium 
bicarbonate then extracted with dichloromethane (3 x 10 mL). The combined 
organic phases were dried (Na2SO4) and the solvent removed in vacuo. Analysis 
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of the product by 1H-NMR revealed that the pyridine ring had not been 
substituted and that the five-membered ring had undergone an unidentified 
transformation. 
Reaction of 23 with phosphorus oxychloride 
Compound 23 (17 mg, 0.1 mmol) was mixed with freshly distilled phosphorus 
oxychloride (2.5 mL). The solution was refluxed overnight with vigorous stirring 
under a nitrogen atmosphere. The solution was cooled, and carefully poured 
onto ice (5 mL). The resulting solution was neutralized with solid sodium 
bicarbonate then extracted with dichloromethane (3 x 10 mL). The combined 
organic phases were dried (Na2SO4) and the solvent removed in vacuo. Analysis 
of the product by 1H-NMR revealed that the pyridine ring had not been 
substituted and that the five-membered ring had undergone an unidentified 
transformation. 
Reaction of 25 with phosphorus oxychloride 
Compound 25 (19 mg, 0.1 mmol) was mixed with freshly distilled phosphorus 
oxychloride (2.5 mL). The solution was refluxed overnight with vigorous stirring 
under a nitrogen atmosphere. The solution was cooled, and carefully poured 
onto ice (5 mL). The resulting solution was neutralized with solid sodium 
bicarbonate then extracted with dichloromethane (3 x10 mL). The combined 
organic phases were dried (Na2SO4) and the solvent removed in vacuo. No 
product was present 
28 
Compound 28 was synthesized by the method of Taylor55 in quantitative yield 
(>99 %). 
Reaction of 28 with phosphorus oxychloride 
Compound 28 (19 mg, 0.1 mmol) was mixed with freshly distilled phosphorus 
oxychloride (2.5 mL). The solution was refluxed overnight with vigorous stirring 
under a nitrogen atmosphere. The solution was cooled, and carefully poured 
onto ice (5 mL). The resulting solution was neutralized with solid sodium 
bicarbonate then extracted with dichloromethane (3 x 10 mL). The combined 
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organic phases were dried (Na2SO4) and the solvent removed in vacuo, but no 
product was present. Attempted extraction with common laboratory solvents also 
failed to provide any product. 
Reaction of 22 with acetic anhydride 
Compound 22 (18 mg, 0.1 mmol) was dissolved in acetic anhydride (2.5 mL), 
and the solution refluxed overnight with stirring under a nitrogen atmosphere. 
The solution was cooled and added to water (10 mL). The solution was 
neutralized with solid sodium carbonate and extracted with dichloromethane 
(3 x 10 mL). The combined organic phases were dried (Na2SO4) and the solvent 
removed in vacuo to provide a pale brown oil. Analysis of the product by 1H-NMR 
revealed only starting material. 
Reaction of 28 with acetic anhydride 
Compound 28 (18 mg, 0.1 mmol) was dissolved in acetic anhydride (2.5 mL), 
and the solution refluxed overnight with stirring under a nitrogen atmosphere. 
The solution was cooled and added to water (10 mL). The solution was 
neutralized with solid sodium carbonate and extracted with dichloromethane 
(3 x 10 mL). The combined organic phases were dried (Na2SO4) and the solvent 
removed in vacuo to provide a pale brown oil. Analysis of the product by 1H-NMR 
revealed only starting material. 
Reaction of 27 with acetic anhydride 
Compound 27 (18 mg, 0.1 mmol) was mixed with acetic anhydride (2.5 mL). The 
solution was refluxed overnight with vigorous stirring under a nitrogen 
atmosphere. The solution was cooled, and carefully poured onto ice (5 mL). The 
resulting solution was neutralized with solid sodium bicarbonate then extracted 
with dichloromethane (3 x 10 mL). The combined organic phases were dried 
(Na2SO4) and the solvent removed in vacuo. Analysis of the product by 
1H-NMR 
revealed that the pyridine ring had not been substituted and that the five-
membered ring had undergone an unidentified transformation. 
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Reaction of 23 with acetic anhydride 
Compound 23(19 mg, 0.1 mmol) was mixed with acetic anhydride (2.5 mL). The 
solution was refluxed overnight with vigorous stirring under a nitrogen 
atmosphere. The solution was cooled, and carefully poured onto ice (5 mL). The 
resulting solution was neutralized with solid sodium bicarbonate then extracted 
with dichloromethane (3 x 10 mL). The combined organic phases were dried 
(Na2SO4) and the solvent removed in vacuo. Analysis of the product by 
1H-NMR 
revealed that the pyridine ring had not been substituted and that the five-
membered ring had undergone an unidentified transformation. 
Attempted synthesis of 6-(triethylammonium)nicotine acetate 
22 (178 mg, 1 mmol) was dissolved in dry dichloromethane (10 mL) under an 
argon atmosphere. The solution was cooled to -25 °C and dry, freshly distilled 
triethylamine (1.4 mL, 10 mmol) was added dropwise. A solution of acetyl 
chloride (156 mg, 2 mmol) in dry dichloromethane (2 mL) was added dropwise 
over the course of 30 minutes, during which time the solution was maintained 
below -15 °C. The solution was maintained at -15 °C for a further 90 minutes, 
after which it was allowed to come to room temperature and stirred for a further 
3 hours. The solution was then treated with diethyl ether (20 mL) and the solid 
removed by filtration. The filtrate was concentrated in vacuo to provide a brown 
oil. Analysis of this revealed only starting material present. 
30 
30 was synthesized by the method of Seeman and Whidby35 in quantitative yield 
(>99 %). 
29 
29 was synthesized using the method of Acheson et al.47 Alternative purification 
is as follows. Following extraction of the reaction medium with chloroform, the 
organic phase was dried (Na2SO4) and the solvent removed in vacuo. The 
residue was dissolved in the minimum amount of water and added to a 
Sephadex column. The column was eluted with water, and the collected eluent 
was reduced in vacuo to provide the desired product as a brown oil. Subsequent 
elution of the column with 1 M sodium chloride solution provided a solution 
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containing the starting material, which could be recovered by reducing the 
solution in vacuo and extracting the solid with chloroform. 
20 from 29 
29 (192 mg, 1 mmol) and phosphorus pentachloride (312 mg, 1.5 mmol) were 
placed in a dry round-bottomed flask. Freshly distilled phosphorus oxychloride 
(5 mL) was added and the solution was refluxed overnight with vigorous stirring. 
The solution was cooled, and most of the phosphorus oxychloride was removed 
by distillation under reduced pressure. The residue was treated with ice water 
(10 mL), then neutralized with solid sodium carbonate. The neutral solution was 
then extracted with ethyl acetate (3 x 10 mL), and the combined organic phases 
were dried (Na2SO4) and reduced in vacuo. The resultant oil was purified by 
gradient column chromatography on silica, eluting with petroleum 
ether/chloroform. The desired product was obtained as a or pale brown oil. Yield 
31 mg (16 %). Spectroscopic data for the product matched literature values.47 
Attempted demethylation of 29 using Pd/C 
Compound 29 (38 mg, 0.2 mmol) and palladium on carbon (20 mg) were placed 
in a dry flask with a magnetic flea. The flask was subsequently evacuated and 
flushed with argon gas carefully several times. After the final evacuation dry 
dichloromethane (5 mL) was added, and the solution was then exposed to a 
hydrogen atmosphere. The solution was stirred under a hydrogen atmosphere 
overnight, then filtered through a Celite plug to remove the catalyst. After 
washing the plug with further dichloromethane the filtrate was reduced in vacuo. 
Analysis of the residue by 1H-NMR revealed only the starting material. 
Attempted demethylation of 29 using Pearlman’s Catalyst 
Compound 29 (38 mg, 0.2 mmol) and Pearlman’s Catalyst (20 mg) were placed 
in a dry flask with a magnetic flea. The flask was subsequently evacuated and 
flushed with argon gas carefully several times. After the final evacuation dry 
dichloromethane (5 mL) was added, and the solution was then exposed to a 
hydrogen atmosphere. The solution was stirred under a hydrogen atmosphere 
overnight, then filtered through a Celite plug to remove the catalyst. After 
 - 129 - 
 
washing the plug with further dichloromethane the filtrate was reduced in vacuo. 
Analysis of the residue by 1H-NMR revealed only the starting material. 
Demethylation of 30 using boron tribromide 
Compound 30 (38 mg, 0.2 mmol) was placed in a dry flask with a magnetic flea. 
Boron tribromide (5 mL) was added, and the solution was stirred overnight under 
argon. The solution was then cooled in an ice bath, and water was added 
carefully dropwise. After no further reaction was observed the resulting solution 
was neutralized with solid sodium bicarbonate. The solution was then extracted 
with dichloromethane (3 x 10 mL), and the organic phase was dried (Na2SO4) 
and reduced in vacuo. The residue was analysed by 1H-NMR, and revealed only 
starting material. 
 
Reaction of 29 with phosphorus tribromide 
Compound 29 (192 mg, 1 mmol) was dissolved in dry chloroform (15 mL). 
Phosphorus tribromide (1 mL) was added and the resulting solution was stirred 
overnight. The solvent was removed in vacuo and the residue dissolved in water 
(10 mL). The solution was neutralized with solid sodium carbonate and extracted 
with dichloromethane (3 x 10 mL). The combined organic phases were dried 
(Na2SO4) and the solvent removed in vacuo. The residue was analysed by 
1H-NMR, and revealed only starting material. The reaction was repeated in the 
absence of chloroform using 2 mL of phosphorus tribromide with the same result. 
 
Attempted synthesis of 32 from 29 using the method of Kato and co-
workers57 
Compound 29 (192 mg, 1 mmol), phosphorus pentoxide (355 mg, 2.5 mmol) and 
tetraethylammonium bromide (184 mg, 1.2 mmol) were dissolved in toluene 
(25 mL) and the solution was stirred at 95 °C for 1.5 hours. After cooling to room 
temperature the upper organic layer was removed. The lower layer was 
extracted with toluene (10 mL). The combined organic phases were washed with 
aqueous sodium bicarbonate solution, brine, then dried (Na2SO4). The solvent 
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was removed in vacuo, after which analysis by 1H-NMR revealed only the 
starting material.  
 
Attempted synthesis of 32 from 29 using the method of Sugimoto 
and co-workers58 
Freshly recrystallized N-bromosuccinimide (890 mg, 5 mmol) was added to a 
solution of triphenyl phosphine (1.31 g, 5 mmol) in absolute dioxane (50 mL) and 
then stirred for 30 minutes. A solution of 29 (192 mg, 1 mmol) in dioxane (10 mL) 
was added and the solution refluxed overnight. The solvent was removed in 
vacuo, dissolved in dichloromethane (50 mL), and basified with triethylamine. 
Chromatography on silica gel eluting with 1:1 petroleum ether:dichloromethane 
removed the reagents and by-products. Analysis of the residue by 1H-NMR 
revealed only starting material.  
 
33 
Nicotine (2 g, 12.3 mmol) was added carefully to 13 mL of glacial acetic acid and 
cooled to 0 °C. Benzyl bromide (4.21 g, 24.6 mmol) was added in a single 
portion. The solution was swirled to mix and then left to stand for 3 days. The 
solvent was then removed in vacuo and 5 mL water was added. The solution 
was neutralized with excess solid sodium carbonate and extracted with 
dichloromethane (3 x 30 mL). The organic phase was dried (Na2SO4) and the 
solvent then removed in vacuo. The residue was dissolved in 100:1 
CHCl3:MeOH and adsorbed onto an alumina column. Elution with CHCl3 
provided a forerun which proved to be unreacted benzyl bromide, followed by a 
band which was identified as a mixture of the desired product and starting 
materials. Elution with 100:1 CHCl3:MeOH provided a band which was only the 
desired product, as a dark brown oil. Elution with 1:1 CHCl3:MeOH gave a final 
band which consisted of a mixture of the desired product and starting materials. 
The second band was used and no further purification was attempted. Yield 1.72 
g (42 %). 1H-NMR (500 MHz, CDCl3): δ 9.55 (1H, d, H6), 9.36 (1H, s, H2), 8.38 
(1H, d, H4), 7.97 (1H, dd, H5), 7.66-7.68 (2H, m, H3’), 7.36-7.39 (3H, m, H4’, 
H5’), 6.29 (2H, dd, H1’), 3.51-3.54 (1H, m, H9a), 3.21 (1H, ddd, H7), 2.36-2.44 
 - 131 - 
 
(2H, m, H9b, H11a), 2.18 (3H, s, NCH3), 1.81-1.93 (2H, m, H10a, H10b), 1.60-
1.67 (1H, m, H11b). 13C-NMR (75 MHz, CDCl3): δ 145.91, 144.05, 143.70, 
143.42, 132.94, 129.93, 129.60, 129.50, 128.13, 66.92, 64.32, 56.62, 40.32, 
35.49, 23.03. ES-MS: Found M+ 253.1699, C17H21N2
+ requires M+ 253.1705. IR 
(KBr plates): 3422, 3024, 2947, 2361, 2341, 1634, 1456, 1205, 1151, 685 cm-1. 
34 
33 (1.7 g, 5.1 mmol) was dissolved in water (8 mL). Potassium ferricyanide 
(3.3 g, 10 mmol) and potassium hydroxide (1.55 g, 27.6 mmol) dissolved in water 
(13 mL) were added over 30 minutes under argon, keeping the temperature 
under 15 °C. Ethanol (2 mL) was added to help dissolve the starting material. 
After one day of stirring at room temperature further potassium ferricyanide 
(3.3 g, 10 mmol) and potassium hydroxide (1.55 g, 27.6 mmol) dissolved in of 
water (13 mL) were added and the mixture stirred for a further two days. The 
solution was filtered and then extracted with dichloromethane (3 x 20 mL). The 
solvent was dried (Na2SO4) and the solvent removed in vacuo. The residue was 
dissolved in 3:1 water:acetone (50 mL) and run through a short Sephadex 
column to remove any starting material. The solvent was removed in vacuo to 
provide the pure product as a brown oil. Yield 0.822 g (60 %). 1H-NMR (500 
MHz, CDCl3): δ 7.37 (1H, dd, H4), 7.33 (2H, d, H3’), 7.28-7.29 (3H, m, H4’ ,H5’), 
7.16 (1H, d, H2), 6.618 (1H, d, H5), 5.13 (2H, dd, H1’), 3.16 (1H, t, H9a), 2.74 
(1H, t, H7), 2.21 (1H, dd, H9b), 2.12 (3H, 2, NCH3), 2.01-2.08 (1H, m, H11a), 
1.83-1.90 (1H, m, H10a), 1.71-1.78 (1H, m, H10b), 1.60-1.67 (1H, m, H11b). 13C-
NMR (75 MHz, CDCl3): δ 162.61, 139.39, 136.54, 134.97, 128.78, 128.04, 
127.86, 127.81, 121.35, 120.89, 67.69, 56.59, 51.91, 40.08, 33.70, 22.24. ES-
MS: Found M+ 269.1653, [C17H20N2O.H]
+ requires M+ 269.1654. IR (KBr plates): 
3425, 3032, 2779, 1665, 1599, 1144, 1043, 835, 698 cm-1. 
Reaction of 34 with phosphorus oxychloride 
Freshly distilled phosphorus oxychloride (10 mL) was added to compound 34 
(26.8 mg, 0.1 mmol). The mixture was stirred vigorously at reflux overnight. After 
cooling the phosphorus oxychloride was removed by distillation under reduced 
pressure. The residue was dissolved in ice water (10 mL), neutralized with solid 
sodium carbonate and extracted with dichloromethane (3 x 10 mL). The 
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combined organic phases were dried (Na2SO4) and the solvent removed in 
vacuo. Analysis of the residue by 1H-NMR revealed only the starting material. 
Reaction of 34 with phosphorus tribromide 
Compound 34 (268 mg, 1 mmol) was dissolved in dry chloroform (15 mL). 
Phosphorus tribromide (1 mL) was added and the resulting solution was stirred 
overnight. The solvent was removed in vacuo and the residue dissolved in water 
(10 mL). The solution was neutralized with solid sodium carbonate and extracted 
with dichloromethane (3 x 10 mL). The combined organic phases was dried 
(Na2SO4) and the solvent removed in vacuo. The residue was analysed by 
1H-NMR, and revealed only starting material. The reaction was repeated in the 
absence of chloroform using 2 mL of phosphorus tribromide with the same result. 
Attempted bromination of 34 using the method of Kato and co-
workers57 
34 (268 mg, 1 mmol), phosphorus pentoxide (355 mg, 2.5 mmol) and tetraethyl 
ammonium bromide (184 mg, 1.2 mmol) were dissolved in toluene (25 mL) and 
the solution was stirred at 95 °C for 1.5 hours. After cooling to room temperature 
the upper organic layer was removed. The lower layer was extracted with 
toluene (10 mL). The combined organic phases were washed with aqueous 
sodium bicarbonate solution, brine, then dried (Na2SO4). The solvent was 
removed in vacuo, after which analysis by 1H-NMR revealed only the starting 
material.  
 
Attempted bromination of 34 using the method of Sugimoto and co-
workers58 
Freshly recrystallized N-bromosuccinimide (890 mg, 5 mmol) was added to a 
solution of triphenylphosphine (1.31 g, 5 mmol) in absolute dioxane (50 mL) and 
then stirred for 30 minutes. A solution of 34 (268 mg, 1 mmol) in dioxane (10 mL) 
was added and the solution refluxed overnight. The solvent was removed in 
vacuo, the residue redissolved in dichloromethane (50 mL), and basified with 
triethylamine. Chromatography on silica gel eluting with 1:1 petroleum 
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ether:dichloromethane removed the reagents and by-products. Analysis of the 
residue by 1H-NMR revealed only starting material.  
Attempted debenzylation of 34 using boron tribromide 
Compound 34 (268 mg, 1 mmol) was stirred with boron tribromide (5 mL) 
overnight at room temperature. The solution was carefully added to water 
(25 mL) and the solution neutralized with solid sodium carbonate. The solution 
was then extracted with dichloromethane (3 x 15 mL). The combine organic 
phases were dried (Na2SO4) and the solvent removed in vacuo. Analysis of the 
residue by 1H-NMR revealed only starting material. 
Attempted debenzylation of 34 using Pd/C in acetic acid 
Compound 34 (54 mg, 0.2 mmol) and palladium on carbon (20 mg) were placed 
in a dry flask with a magnetic flea. The flask was subsequently evacuated and 
flushed with argon gas carefully several times. After the final evacuation acetic 
acid (5 mL) was added, and the solution was then exposed to a hydrogen 
atmosphere. The solution was stirred under a hydrogen atmosphere overnight, 
then filtered through a Celite plug to remove the catalyst. After washing the plug 
with dichloromethane the filtrate was reduced in vacuo. Analysis of the residue 
by 1H-NMR revealed only the starting material. 
Attempted debenzylation of 34 using Pearlman’s Catalyst in acetic 
acid 
Compound 34 (54 mg, 0.2 mmol) and Pearlman’s Catalyst (20 mg) were placed 
in a dry flask with a magnetic flea. The flask was subsequently evacuated and 
flushed with argon gas carefully several times. After the final evacuation acetic 
acid (5 mL) was added, and the solution was then exposed to a hydrogen 
atmosphere. The solution was stirred under a hydrogen atmosphere overnight, 
then filtered through a Celite plug to remove the catalyst. After washing the plug 
with dichloromethane the filtrate was reduced in vacuo. Analysis of the residue 
by 1H-NMR revealed only the starting material. 
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Attempted debenzylation of 34 using Pd/C in trifluoroacetic acid 
Compound 34 (54 mg, 0.2 mmol) and palladium on carbon (20 mg) were placed 
in a dry flask with a magnetic flea. The flask was evacuated and flushed with 
argon gas carefully several times. After the final evacuation trifluoroacetic acid 
(5 mL) was added, and the solution was then exposed to a hydrogen 
atmosphere. The solution was stirred under a hydrogen atmosphere overnight, 
then filtered through a Celite plug to remove the catalyst. After washing the plug 
with dichloromethane the filtrate was reduced in vacuo. Analysis of the residue 
by 1H-NMR revealed only the starting material. 
Attempted debenzylation of 34 using Pearlman’s Catalyst in 
trifluoroacetic acid 
Compound 34 (54 mg, 0.2 mmol) and Pearlman’s Catalyst (20 mg) were placed 
in a dry flask with a magnetic flea. The flask was evacuated and flushed with 
argon gas carefully several times. After the final evacuation trifluoroacetic acid 
(5 mL) was added, and the solution was then exposed to a hydrogen 
atmosphere. The solution was stirred under a hydrogen atmosphere overnight, 
then filtered through a Celite plug to remove the catalyst. After washing the plug 
with dichloromethane the filtrate was reduced in vacuo. Analysis of the residue 
by 1H-NMR revealed only the starting material. 
Reaction of nicotine with 2-bromoethanol 
Nicotine (162 mg, 1 mmol) and 2-bromoethanol (125 mg, 1mmol) were dissolved 
in acetic acid (5 mL) and the solution stirred overnight. The solution was reduced 
in vacuo and the residue was dissolved in water (10 mL). The resulting solution 
was neutralized with solid sodium bicarbonate and then extracted with 
dichloromethane (3 x 10 mL). The combined organic phases were dried 
(Na2SO4) and the solvent removed in vacuo. Analysis of the residue by 
1H-NMR 
showed only nicotine. 
Reaction of nicotine with chloromethyl methyl ether 
Nicotine (162 mg, 1 mmol) and chloromethyl methyl ether (81 mg, 1 mmol) were 
dissolved in acetic acid (5 mL) and the solution stirred overnight at room 
temperature. The solution was reduced in vacuo and the residue was dissolved 
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in water (10 mL). The resulting solution was neutralized with solid sodium 
bicarbonate and then extracted with dichloromethane (3 x 10 mL). The combined 
organic phases were dried (Na2SO4) and the solvent removed in vacuo. Analysis 
of the residue by 1H-NMR showed only nicotine. 
Reaction of nicotine with 4-bromobenzyl bromide 
Nicotine (162 mg, 1 mmol) and 4-bromobenzyl bromide (250 mg, 1 mmol) were 
dissolved in acetic acid (5 mL) and the solution stirred overnight at room 
temperature. The solution was reduced in vacuo and the residue was dissolved 
in water (10 mL). The resulting solution was neutralized with solid sodium 
bicarbonate and then extracted with dichloromethane (3 x 10 mL). The combined 
organic phases were dried (Na2SO4) and the solvent removed in vacuo. Analysis 
of the residue by 1H-NMR showed only nicotine. 
35 
Nicotine (162 mg, 1 mmol) and 1-bromomethyl-4-nitrobenzene (216 mg, 1 mmol) 
were dissolved in acetic acid (5 mL) and the solution was stirred overnight at 
room temperature. The solution was then reduced in vacuo and the residue 
dissolved in water (10 mL). The resulting solution was neutralized with solid 
sodium bicarbonate and the extracted with dichloromethane (3 x 10 mL). The 
combined organic phases were dried (Na2SO4) and the solvent removed in 
vacuo to provide 35 as a brown oil.  
 
Attempted synthesis of 37 
Compound 37 (189 mg, 0.5 mmol) was dissolved in water (4 mL). Potassium 
ferricyanide (330 mg, 1 mmol) and potassium hydroxide (168 mg, 3 mmol) 
dissolved in water (10 mL) were added over 30 minutes under argon, keeping 
the temperature under 15 °C. Ethanol (2 mL) was added to help dissolve the 
starting material, which was observed coating the walls of the flask. After one 
day of stirring at room temperature further potassium ferricyanide (330 mg, 
1 mmol) and potassium hydroxide (168 mg, 3 mmol) dissolved in water (10 mL) 
was added and the mixture stirred for a further two days. The solution was 
filtered and then extracted with dichloromethane (3 x 10 mL). The reaction vessel 
 - 136 - 
 
was also rinsed with dichloromethane (10 mL). The solvent was dried (Na2SO4) 
and then removed in vacuo. Analysis of the residue by 1H-NMR revealed only 
starting material. 
39 
Nicotine (162 mg, 1 mmol) and 1-chloromethyl-4-methoxybenzene (157 mg, 
1 mmol) were dissolved in acetic acid (5 mL) and the solution was stirred 
overnight at room temperature. The solution was then reduced in vacuo and the 
residue dissolved in water (10 mL). The resulting solution was neutralized with 
solid sodium bicarbonate and then extracted with dichloromethane (3 x 10mL). 
The combined organic phases were dried (Na2SO4) and the solvent removed in 
vacuo to provide 39 as a brown oil.  
40 
Nicotine (162 mg, 1 mmol) and 1-bromomethyl-4-methylbenzene (185 mg, 
1 mmol) were dissolved in acetic acid (5 mL) and the solution was stirred 
overnight at room temperature. The solution was then reduced in vacuo and the 
residue dissolved in water (10 mL). The resulting solution was neutralized with 
solid sodium bicarbonate and the extracted with dichloromethane (3 x 10 mL). 
The combined organic phases were dried (Na2SO4) and the solvent remove in 
vacuo to provide 40 as a brown oil.  
 
Attempted synthesis of 41 
39 (160 mg, 0.5 mmol) was dissolved in water (4 mL). Potassium ferricyanide 
(330 mg, 1 mmol) and potassium hydroxide (168 mg, 3 mmol) dissolved in water 
(10 mL) were added over 30 minutes under argon, keeping the temperature 
under 15 °C. Ethanol (2 mL) was added to help dissolve the starting material, 
which was observed coating the walls of the flask. After one day of stirring at 
room temperature further potassium ferricyanide (330 mg, 1 mmol) and 
potassium hydroxide (168 mg, 3 mmol) dissolved in water (10 mL) were added 
and the mixture stirred for a further two days. The solution was filtered and then 
extracted with dichloromethane (3 x 10 mL). The reaction vessel was also rinsed 
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with dichloromethane (10 mL). The solvent was dried (Na2SO4) and the solvent 
removed in vacuo. Analysis of the residue by 1H-NMR revealed only nicotine. 
Attempted synthesis of 42 
40 (174 mg, 0.5 mmol) was dissolved in water (4 mL). Potassium ferricyanide 
(330 mg, 1 mmol) and potassium hydroxide (168 mg, 3 mmol) dissolved in water 
(10mL) were added over 30 minutes under argon, keeping the temperature 
under 15 °C. Ethanol (2 mL) was added to help dissolve the starting material, 
which was observed coating the walls of the flask. After one day of stirring at 
room temperature further potassium ferricyanide (330 mg, 1 mmol) and 
potassium hydroxide (168 mg, 3 mmol) dissolved in water (10 mL) were added 
and the mixture stirred for a further two days. The solution was filtered and then 
extracted with dichloromethane (3 x 10 mL). The reaction vessel was also rinsed 
with dichloromethane (10 mL). The solvent was dried (Na2SO4) and the solvent 
removed in vacuo. Analysis of the residue by 1H-NMR revealed only nicotine. 
Attempted demethylation of nicotine to nornicotine by reaction with 
boron tribromide 
Nicotine (324 mg, 2 mmol) was stirred with boron tribromide (5 mL) overnight at 
room temperature. The solution was carefully added to water (25 mL) and the 
solution neutralized with solid sodium carbonate. The solution was then 
extracted with dichloromethane (3 x 15 mL). The combine organic phases were 
dried (Na2SO4) and the solvent removed in vacuo. Analysis of the residue by 
1H-
NMR revealed only nicotine. 
Attempted demethylation of nicotine to nornicotine by reaction with 
refluxing trifluoroacetic acid 
Nicotine (324 mg, 2 mmol) was stirred with trifluoroacetic acid (5 mL) overnight 
at room temperature. The solution was carefully added to water (25 mL) and the 
solution neutralized with solid sodium carbonate. The solution was then 
extracted with dichloromethane (3 x 15 mL). The combine organic phases were 
dried (Na2SO4) and the solvent removed in vacuo. Analysis of the residue by 
1H-
NMR revealed only nicotine. 
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Attempted demethylation of nicotine to nornicotine using Pd/C in 
acetic acid 
Nicotine (324 mg, 2 mmol) and palladium on carbon (20 mg) were placed in a 
dry flask with a magnetic flea. The flask was evacuated and flushed with argon 
gas carefully several times. After the final evacuation acetic acid (5 mL) was 
added, and the solution was then exposed to a hydrogen atmosphere. The 
solution was stirred under a hydrogen atmosphere overnight, then filtered 
through a Celite plug to remove the catalyst. After washing the plug with 
dichloromethane the filtrate was reduced in vacuo. Analysis of the residue by 1H-
NMR revealed only nicotine. 
Attempted debenzylation of 34 using Pearlman’s Catalyst in acetic 
acid 
Nicotine (324 mg, 2 mmol) and Pearlman’s Catalyst (20 mg) were placed in a dry 
flask with a magnetic flea. The flask was evacuated and flushed with argon gas 
carefully several times. After the final evacuation acetic acid (5 mL) was added, 
and the solution was then exposed to a hydrogen atmosphere. The solution was 
stirred under a hydrogen atmosphere overnight, then filtered through a Celite 
plug to remove the catalyst. After washing the plug with dichloromethane the 
filtrate was reduced in vacuo. Analysis of the residue by 1H-NMR revealed only 
nicotine. 
2- and 6-aminonicotine 
2- And 6-aminonicotine were synthesized by the method of Chichibabin.45 
43 
Nicotine (100 mg, 0.62 mmol) was dissolved in acetone (10 mL) and benzyl 
bromide (210 mg, 1.24 mmol) was added. The solution was stirred overnight at 
50 °C, then cooled to room temperature. A pale yellow solid precipitated upon 
cooling, and was removed by filtration. The solid was washed with petroleum 
ether (5 mL) then diethyl ether (5 mL). Yield 50 mg (24 %). Spectroscopic data 
for the product matched literature values.64 
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Reaction of nicotine with 1,4-bisbromomethylbenzene 
Nicotine (324 mg, 2 mmol) was added to a solution of 1,4-
bis(bromomethyl)benzene (264 mg, 1 mmol) in acetone (20 mL). The solution 
was refluxed overnight. The solution was cooled and the solvent removed in 
vacuo to provide a brown tar. Analysis by 1H-NMR revealed multiple products 
indicating substitution at both nitrogens of the nicotine molecule. 
Reaction of nicotine with 1,3-bisbromomethylbenzene 
Nicotine (324 mg, 2 mmol) was added to a solution of 
1,3-(bisbromomethyl)benzene (264 mg, 1 mmol) in acetone (20 mL). The 
solution was refluxed overnight. The solution was cooled and the solvent 
removed in vacuo to provide a brown tar. Analysis by 1H-NMR revealed multiple 
products indicating substitution at both nitrogens of the nicotine molecule. 
Reaction of nicotine with 1,2-bisbromomethylbenzene 
Nicotine (324 mg, 2 mmol) was added to a solution of 
1,2-bis(bromomethyl)benzene (264 mg, 1 mmol) in acetone (20 mL). The 
solution was refluxed overnight. The solution was cooled and the solvent 
removed in vacuo to provide a brown tar. Analysis by 1H-NMR revealed multiple 
products indicating substitution at both nitrogens of the nicotine molecule. 
Reaction of nicotine with picolyl chloride hydrochloride in acetone 
Nicotine (324 mg, 2 mmol) was added to a solution of picolyl chloride 
hydrochloride (328 mg, 2 mmol) in acetone (20 mL). The solution was refluxed 
overnight. The solution was cooled and the solvent removed in vacuo to provide 
a brown tar. Analysis by 1H-NMR revealed multiple products indicating 
substitution at both nitrogens of the nicotine molecule. 
45 
Nicotine (200 mg, 1.24 mmol) and picolyl chloride hydrochloride (202 mg, 
1.24 mmol) were dissolved in acetic acid (10 mL) and stirred overnight at room 
temperature. The solvent was removed in vacuo and water (20 mL) was added. 
The resulting solution was neutralized with solid sodium bicarbonate then 
extracted with dichloromethane (3 x 20 mL). The combined organic phases were 
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dried (Na2SO4) and the solvent removed in vacuo to provide the desired product 
as a brown oil. Yield 337 mg (94 %).  
46 
45 (337 mg, 1.17 mmol) was dissolved in water (5 mL) and added to a solution of 
potassium ferricyanide (900 mg) and potassium hydroxide (500 mg) in water 
(10 mL). The solution was stirred overnight under argon, then extracted with 
chloroform (3 x 20 mL). The combined organic phases were dried (Na2SO4) and 
the solvent removed in vacuo to provide the desired product as a pale brown oil. 
Yield 179 mg (57 %).  
 
48 
The synthesis of 48 was based on the synthesis of 47 by Woodward, Wendler 
and Brutschy.65 Cinchonidine (2.94 g, 10 mmol) and benzophenone (9.1g, 50 
mmol) were dissolved in absolute toluene (50 mL) and potassium t-butoxide (2.8 
g, 25 mmol) was added. The solution was refluxed overnight under nitrogen, and 
then cooled to room temperature. The solution was poured onto ice (25 mL) and 
extracted with 10% hydrochloric acid (5 x 30 mL). The combined acid extracts 
were washed with diethyl ether (2 x 50 mL) and then added dropwise to an 
excess of ammonium hydroxide-ice. The off-white solid that precipitated was 
removed by extraction with diethyl ether (2 x 50mL). The combined diethyl ether 
extracts were dried (Na2SO4) and the solvent removed in vacuo to provide the 
desired product as an off-white solid. Yield 2.22 g (76 %). Slow evaporation of 
petroleum ether solution of the product provided crystals suitable for X-ray 
crystallography. NMR was consistent with two products (twice the number of 
expected peaks) and was not assigned. 
 
55 
Cinchonidine (100 mg, 0.34 mmol), triphenylphosphine (178 mg, 0.68 mmol) and 
carbon tetrabromide (124 mg, 0.37 mmol) were dissolved in toluene (10 mL), 
and the solution was stirred overnight at room temperature. The solution was 
extracted with dilute hydrochloric acid (2 M, 3 x 10 mL). The aqueous phase was 
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neutralized with saturated sodium bicarbonate solution and extracted with 
chloroform (3 x 15 mL). The combined organic phases were dried (Na2SO4) and 
the solvent removed in vacuo to provide 3.39 as a white solid. Yield 47 mg 
(47 %). M.p. 188-192 °C.  
 
56 
9-Amino-(9-deoxy)epi-quinine (56) was synthesized by literature methods.67 The 
yield of the reaction was increased from an approximately 1:1 ratio of 
product:starting material, to a 10:1 ratio, by increasing the amount of hydrazoic 
acid solution from 12 mL to 40 mL, and by the use of dry glassware and 
anhydrous solvents. Unfortunately the original paper gave no details on the 
chromatographic conditions used to purify the product, and although extensive 
work was done in this area, purification was not achieved. It is postulated that the 
product is unstable to column chromatography. 
Reaction of bis(benzonitrile)palladium chloride with 56 
Bis(benzonitrile)palladium chloride (38 mg, 0.1 mmol) in chloroform (1.5 mL) was 
added to crude 56 (32 mg, 0.1 mmol) in dichloromethane, with a fine yellow 
precipitate forming immediately. The solution was reduced in vacuo and water (3 
mL) was added. The precipitate was then filtered off as a yellow solid. Crude 
yield 38 mg. M.p. >330 °C. The solid was soluble only in DMF and DMSO. 1H-
NMR in d6-DMSO indicated the presence of a product in which the palladium had 
coordinated, as well as some starting material. Attempted recrystallisation by 
slow diffusion of various solvents into a DMF solution of the product failed to 
produce any solid material. 
58 
Compound 57 (100 mg, 0.31 mmol) and pyridine-2-carboxaldehyde (40 mg, 
0.37 mmol, 1.2 equivalents) were stirred in ethanol (10 mL) overnight. The 
solvent was removed in vacuo to provide a brown oil. 1H-NMR confirmed the 
presence of the desired product, as well as pyridine-2-carboxaldehyde and 
quinine. All attempts at purification of the product failed. 
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Attempted synthesis of 59 
Quinine (324 mg, 1 mmol) was stirred in anhydrous tetrahydrofuran under argon. 
Triethylamine (0.3 mL) and methanesulphonic acid (0.1 mL) were added and the 
solution was stirred overnight art room temperature. A product formed as a white 
solid which was removed by filtration and air dried. Analysis of the white solid by 
1H-NMR revealed only the starting material. 
 
60 
Cinchonidine (294 mg, 1 mmol) was stirred in anhydrous tetrahydrofuran under 
argon. Triethylamine (0.3 mL) and methanesulphonic acid (0.1 mL) were added 
and the solution was stirred overnight at room temperature. A white solid formed, 
and was removed by filtration. The white solid was dissolved in dichloromethane 
(10 mL) and extracted with water (2 x 10 mL). The organic phase was dried 
(Na2SO4) and reduced in vacuo, to provide the desired product as a white solid. 
Yield 357 mg (97 %).  
Attempted synthesis of 62 
60 (195 mg, 0.5 mmol) and sodium azide (162 mg, 2.5 mmol) in absolute DMF 
(4 mL) were stirred overnight at 80 °C under argon. A saturated aqueous 
solution of sodium bicarbonate (5 mL) was added and the resulting solution was 
extracted with dichloromethane (3 x 10 mL). The combined organic phases were 
reduced in vacuo  and 1:1:1 water:diethyl ether:chloroform mixture (20 mL) was 
added. The solution was shaken well and separated. The organic phase was 
dried (Na2SO4) and the solvent removed in vacuo. Analysis by 
1H-NMR and ES-
MS revealed only cinchonidine. 
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7.4 Chapter 4 Experimental 
63 
63 was synthesized by the method of Hartshorn70. Spectroscopic data for the 
product matched literature values.70 
64 
64 was synthesized by the method of Hartshorn70. Spectroscopic data for the 
product matched literature values.89 
65 
A solution of (2S)-proline (230 mg, 2 mmol) and sodium hydroxide (320 mg, 
8 mmol) in water (5 mL) was added dropwise to a solution of picolyl chloride 
hydrochloride (361 mg, 2.2 mmol) in water (5 mL) and heated to reflux with 
stirring overnight. The solution was cooled, extracted with petroleum ether 
(2 x 20 mL), and then acidified to pH 4-5 with concentrated hydrochloric acid. 
The solvent was removed in vacuo and the residue stirred overnight in refluxing 
chloroform. The solution was cooled, dried (Na2SO4), solids removed by 
filtration, and the solvent removed in vacuo to give the product as a brown oil. 
Yield 395 mg (96 %). 1H-NMR (500 MHz, CDCl3): δ 8.58 (1H, d, H6’), 7.69 (1H, 
dt, H4’), 7.36 (1H, d, H3’), 7.25-7.27 (1H, m, H5’), 4.21 (2H, dd, NCH2py), 3.79 
(1H, t, H2a), 3.46 (1H, p, H5b), 2.85 (1H, dd, H5a), 2.27 (2H, m, H3a, H3b), 1.92 
(2H, m, H4a,  H4b). 13C-NMR (75 MHz, CDCl3): δ 173.80 (COOH), 154.68 (C2’), 
149.42 (C6’), 137.26 (C4’), 123.55 (C3’), 123.32 (C5’), 67.89 (C2), 59.44 
(NCH2py), 54.39 (C5), 29.69 (C3), 24.21 (C4). ES-MS: Found M
+ 207.1136, 
C11H14N2O2 requires M
+ 207.1133. IR: 3387, 2991, 1632, 1595, 1441, 1393, 
1315, 1053, 999, 772 cm-1. 
66 
A solution of (2S)-proline (230 mg, 2 mmol) and sodium hydroxide (320 mg, 
8 mmol) in water (5 mL) was added dropwise to a solution of nicotinyl chloride 
hydrochloride (361 mg, 2.2 mmol) in water (5 mL) and heated to reflux with 
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stirring overnight. The solution was cooled, extracted with petroleum ether 
(2 x 20 mL), and then acidified to pH 4-5 with concentrated hydrochloric acid. 
The solvent was removed in vacuo and the residue stirred overnight in refluxing 
chloroform. The solution was cooled, dried (Na2SO4), solids removed by 
filtration, and the solvent removed in vacuo to give the product as a brown oil.  
67 
A solution of (2S)-proline (230 mg, 2 mmol) and sodium hydroxide (320 mg, 
8 mmol) in water (5 mL) was added dropwise to a solution of 
4-chloromethylpyridine hydrochloride (361 mg, 2.2 mmol) in water (5 mL) and 
heated to reflux with stirring overnight. The solution was cooled, extracted with 
petroleum ether (2 x 20 mL), and then acidified to pH 4-5 with concentrated 
hydrochloric acid. The solvent was removed in vacuo and the residue stirred 
overnight in refluxing chloroform. The solution was cooled, dried (Na2SO4), solids 
removed by filtration, and the solvent removed in vacuo to give the product as a 
brown oil.  
69 
(2S)-(-)-1,2,3,4-Tetrahydro-3-isoquinolinecarboxylic acid (177 mg, 1 mmol), 
2-chloromethylpyridine hydrochloride (180 mg, 1.1 mmol) and sodium hydroxide 
(0.3 g) were dissolved in water (5 mL). The solution was stirred and heated to 
reflux overnight. After cooling the solution was adjusted to pH ~7 and the 
solution left to stand for 30 minutes. The solution was filtered to remove the 
unreacted acid and the filtrate reduced in vacuo. The solid was stirred with 
dichloromethane (50 mL), then the organic phase was dried (Na2SO4) and 
reduced in vacuo to provide a sticky brown oil. This oil was dissolved in water 
(25 mL) and extracted with petroleum ether (4 x 40 mL) and then extracted with 
dichloromethane (3 x 30 mL). The combined dichloromethane fractions were 
dried (Na2SO4) and reduced in vacuo to provide the desired product as a sticky 
brown oil. Yield 160 mg (60 %). 1H-NMR (500 MHz, CDCl3): δ 8.60 (1H, d, H6’), 
7.75 (1H, dt, H4’), 7.44 (1H, d, H3’), 7.30 (1H, dd, H5’), 7.20-7.21 (2H, m, H5, 
H8), 7.04 & 7.15-7.18 (2H, m, H5, H8), 4.23 (1H, d, NCH2a), 4.10 (1H, d, H10a), 
4.08 (1H, d, NCH2a), 3.88 (1H, d, H10b), 3.84 (1H, t, H2), 3.22-3.30 (2H, m, H3a, 
H3b). 13C-NMR (75 MHz, CDCl3): δ 174.0 (COOH), 156.2 (C2’), 148.3 (C6’), 
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138.0 (C4’), 133.3 (C4), 132.9 (C9), 128.5 (C5), 127.3 (C8), 126.4 & 126.5 (C6, 
C7), 123.9 (C3’), 123.3 (C5’), 61.2 (C2), 59,5 (NCH2), 51.7 (C10), 29.7 (C3). ES-
MS: Found M+ 269.1188, C16H16N2O2 requires M
+ 269.1290. IR: 3395, 3013, 
2509, 1720, 1630, 1593, 1439, 1377, 1200, 766 cm-1. 
72 
Picolinic acid (123 mg, 1 mmol) and toluene (2 mL) were placed in a dry round-
bottomed flask, equipped with stir bar, under argon. The solution was stirred and 
sufficient triethylamine (~0.5 mL) was added dropwise to dissolve the solid. In 
some cases a sticky residue formed on the walls of the flask. The solution was 
cooled to 0 °C and ethyl chlorocarbonate (0.1 mL, ~1.1 mmol) was added 
dropwise. This addition was done with the syringe needle almost in the solution 
to reduce the reaction between ethyl chlorocarbonate and gaseous triethylamine. 
The solution was stirred for 15 minutes following completed addition. Alanine 
methyl ester hydrochloride (140 mg, 1 mmol) was dissolved in dry chloroform 
(5 mL) by the dropwise addition of triethylamine (~0.14 mL, ~1 mmol). The 
resulting solution was added dropwise to the cooled (0 °C) toluene solution. 
Following addition the solution was allowed to come to room temperature, and 
then stirred overnight. The solution was then extracted with water (15 mL), 3% 
sodium bicarbonate solution (20 mL) and again with water (15 mL), dried 
(Na2SO4) and the solvent was removed in vacuo, to provide the product as a 
pale brown oil. Yield 193 mg (93 %). 1H-NMR (500 MHz, CDCl3): δ 8.59 (1H, d, 
H6’), 8.49 (1H, d, NH), 8.18 (1H, dd, H4’), 7.83-7.87 (1H, m, H3’), 7.43-7.46 (1H, 
m, H5’), 4.78-4.84 (1H, m, CH), 3.79 (3H, s, OMe), 1.54 (3H, d, Me). 13C-NMR 
(75 MHz, CDCl3): δ 173.08 (C1), 163.82 (CONH), 149.29 (C2’), 148.13 (C6’), 
137.21 (C4’), 126.28 (C3’), 122.16 (C5’), 52.38 (OMe), 47.99 (C2), 18.32 (CH3). 
IR: 3383, 2955, 1744, 1676, 1518, 1435, 1352, 1173, 752, 621 cm-1. 
70 
72 (208 mg, 1 mmol) was dissolved in a 5 % lithium hydroxide solution in 3:1 
methanol:water (10 mL). The solution was cooled to 5 °C overnight. The solution 
was extracted with dichloromethane (3 x 10 mL), the organic phase was dried 
(Na2SO4) and the solvent removed in vacuo to provide the product as a white 
crystalline solid. Yield 190mg (98 %). Slow evaporation of a dichloromethane 
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solution provided crystals suitable for X-ray crystallography. 1H-NMR (500 MHz, 
CDCl3): 8.59 (1H, d, H6’), 8.50 (1H, d, NH), 8.20 (1H, d, H3’), 7.87 (1H, t, H4’), 
7.45-7.48 (1H, m, H5’), 4.81 (1H, p, CH), 1.62 (3H, d, Me). 13C-NMR (75 MHz, 
CDCl3): 176.26 (C1), 164.55 (CONH), 148.99 (C2’), 148.26 (C6’), 137.51 (C4’), 
126.61 (C3’), 122.51 (C5’), 48.29 (C2), 17.95 (CH3).  
73 
Picolinic acid (123 mg, 1 mmol) and toluene (2 mL) were placed in a dry round-
bottomed flask, equipped with stir bar, under argon. The solution was stirred and 
sufficient triethylamine (~0.5 mL) was added dropwise to dissolve the solid. In 
some cases a sticky residue formed on the walls of the flask. The solution was 
cooled to 0 °C and ethyl chlorocarbonate (0.1 mL, ~1.1 mmol) is added 
dropwise. This addition was done with the syringe needle almost in the solution 
to reduce the reaction between ethyl chlorocarbonate and gaseous triethylamine. 
The solution was stirred for 15 minutes following completed addition. Valine 
methyl ester hydrochloride (168 mg, 1 mmol) was dissolved in dry chloroform 
(5 mL) by the dropwise addition of triethylamine (~0.14 mL, ~1 mmol). The 
resulting solution was added dropwise to the cooled (0 °C) toluene solution. 
Following addition the solution was allowed to come to room temperature, and 
then stirred overnight. The solution was then extracted with water (15 mL), 3% 
sodium bicarbonate solution (20 mL) and again with water (15 mL), dried 
(Na2SO4) and the solvent was removed in vacuo, to provide the product as a 
pale brown oil. Yield 201 mg (85 %). 1H-NMR (500MHz, CDCl3): 8.60 (1H, dd, 
H6’), 8.52 (1H, d, NH), 8.18 (1H, dd, H3’), 7.83-7.87 (1H, m, H4’), 7.43-7.46 (1H, 
m, H5’), 4.74 (1H, ddd, H3), 3.77  (3H, d, OMe), 2.30-2.36 (1H, m, H4), 1.01-1.04 
(6H, m, H5).  
74 
73 (236 mg, 1 mmol) was dissolved in a 5 % lithium hydroxide solution in 3:1 
methanol:water (10 mL). The solution was cooled to 5 °C overnight. The solution 
was extracted with dichloromethane (3 x 10 mL), the organic phase was dried 
(Na2SO4) and the solvent removed in vacuo to provide the product as a white 
crystalline solid. Yield 203mg (91 %).  
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7.5 Chapter 5 Experimental 
82 
A solution of (2R,4R)-2-(2-pyridyl)-thiazolidine-4-carboxylic acid in 2:1 
methanol:water (0.333 M, 6 mL) was added to a solution of hexa(aqua)cobalt(II) 
nitrate (29 mg, 0.1 mmol) in water (2 mL). Upon standing crystals suitable for X-
ray crystallography were obtained. Yield 12 mg (20 %). M.p. 205-210 °C (dec.). 
Anal. Found: C, 37.02; H, 4.13; N, 11.92. Calc for C18H23CoN5O9.5S2: C, 36.99; 
H, 3.97; N, 11.98. IR (KBr mull): 3526, 3017, 2937, 2864, 2401, 1651, 1558, 
1479, 1385, 775 cm-1. 
83 
A solution of (2R,4R)-2-(2-pyridyl)-thiazolidine-4-carboxylic acid in 2:1 
methanol:water (0.333 M, 6 mL) was added to a solution of cobalt(II) bromide 
(22 mg, 0.1 mmol) in water (2 mL). Slow evaporation of the solvent resulted in 
crystals suitable for X-ray crystallography. Yield 13mg (23 %).  
84 
A solution of (2R,4R)-2-(2-pyridyl)-thiazolidine-4-carboxylic acid in 2:1 
methanol:water (0.333 M, 6 mL) was added to a solution of hexa(aqua)nickel(II) 
nitrate (29 mg, 0.1 mmol) in water (2 mL). Upon standing crystals suitable for X-
ray diffraction were obtained. Yield 30 mg (55 %). M.p. 223-226 °C (dec.). Anal. 
Found: C, 40.24; H, 3.65; N, 12.71. Calc for C18H19N5NiO7S2: C, 40.02; H, 3.55; 
N, 12.96. IR (KBr mull): 3184, 3092, 2930, 1624, 1603, 1384, 1300, 1227, 916, 
660, 419 cm-1. 
85 
A solution of (2R,4R)-2-(2-pyridyl)-thiazolidine-4-carboxylic acid in 2:1 
methanol:water (0.333 M, 6 mL) was added to a solution of nickel(II) sulphate 
heptahydrate (28.1 mg, 0.1 mmol) in water (2 mL). Upon standing crystals 
suitable for X-ray diffraction were obtained. Yield 25 mg (52 %). M.p. 229-232 °C 
(dec.). Anal. Found: C, 43.84; H, 4.09; N, 11.30. Calc for C18H20N4NiO5S2: 
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C, 43.66; H, 4.07; N, 11.31. IR (KBr mull): 3130, 2986, 2930, 2766, 1597, 1570, 
1477, 1443, 1387, 1350, 1294, 1151, 1088, 1056, 1024, 955, 843, 793 cm-1. 
86 
A solution of (2R,4R)-2-(2-pyridyl)-thiazolidine-4-carboxylic acid in 2:1 
methanol:water (0.333 M, 6 mL) was added to a solution of nickel(II) bromide 
trihydrate (27.2 mg, 0.1 mmol) in water (2 mL). Upon standing two different types 
of crystals formed, both of which were suitable for X-ray crystallography. The 
plate-like majority proved to have an identical unit cell to 85 and the structure 
was not pursued. A small rosette of crystals proved to have a different cell, and 
after several attempts a crystal suitable for X-ray crystallography was identified. 
Yield 8 mg (14 %). M.p. 220-230 °C (dec.). Anal. Found: C, 39.04; H, 3.50; 
N, 10.05. Calc for C18H19BrN4NiO4S2: C, 38.74; H, 3.43; N, 10.04. IR (KBr mull): 
3200 (br), 3101, 2885, 2361, 2341, 1626, 1607, 1479, 1429, 800 (br), 659 cm-1. 
87 
A solution of (S)-N-(picolinamide)alanine methyl ester (21 mg, 0.1 mmol) in 
acetonitrile (1 mL) was added to a solution of copper(II) nitrate trihydrate (12 mg, 
0.05 mmol) dissolved in acetonitrile (2 mL). The solution darkened immediately. 
Slow diffusion ofdiethyl ether into a 0.5 mL portion of this solution provided 
crystals suitable for X-ray diffraction. Yield 4 mg (80 %). M.p. 164-166 °C (dec.). 
Anal. Found: C, 39.81; H, 4.08; N, 13.75. Calc for C20H24CuN6O12: C, 39.77; H, 
4.01; N, 13.91. IR (KBr mull): 3163, 2231, 1695, 1510, 1076, 977, 957, 870, 802, 
733 cm-1. 
88 
A solution of (S)-N-(picolinamide)alanine methyl ester (21 mg, 0.1 mmol) in 
acetonitrile (1 mL) was added to a solution of silver(I) perchlorate (11 mg, 
0.05 mmol) dissolved in acetonitrile (2 mL). The solution was kept in the dark. 
Slow diffusion of ethyl acetate into a 0.5 mL portion, followed by almost complete 
evaporation of the solvent resulted in crystals suitable for X-ray crystallography. 
Yield >2 mg. M.p. undetermined. Anal. undetermined. 
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89 
A solution of (S)-N-(picolyl)proline (21 mg, 0.1 mmol) in methanol (1 mL) was 
added to a solution of cobalt(II) bromide (11 mg, 0.05 mmol) in methanol (2 mL). 
Slow evaporation of the solvent result in crystals suitable for X-ray 
crystallography. Yield undetermined.  
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Appendices 




Tables A1-A5 list the crystal data and X-ray experimental details for the 22 
crystal structures discussed in this thesis. Throughout the text, selected bond 
lengths and angles are discussed and listed under the appropriate figures, while 
the remaining distances and angles, as well as atomic coordinates, anisotropic 
displacement factors and hydrogen atom coordinates are available on request 
from the Department of Chemistry, University of Canterbury. 
 
Two different diffractometers were used in the collection of crystal structures 
reported in this thesis, and different software packages were used for the data 
collection, cell determination and data reduction. Both detectors employed 
graphite monochromatized Mo Kα (λ = 0.71073 Å) radiation. The first 
diffractometer used was a Siemens CCD area detector mounted on a P4 four-
circle diffractometer. Data collection and cell determination was performed with 
SMART90 and data reduction with SAINT.91 The second diffractometer used 
was an Bruker-Nonius APEX II system. Data collection, cell determination and 
data reduction were all performed with the APEX package of software.92 All 
structures had intensities corrected for Lorentz and polarization effects and for 
absorption using SADABS.93 All structures were solved by direct methods using 
SHELXS94 and refined on F2 using all data by full-matrix least-squares 
procedures using SHELXL-97.95 All non-hydrogen atoms were refined with 
anisotropic displacement parameters where possible. Aromatic and non-
terminal aliphatic hydrogen atoms were included in calculated positions with 
isotropic displacement factors 1.2 times the isotropic equivalent of their carrier 
atoms. Methyl protons were placed in calculated positions and allowed to rotate 
around the C-C axis, with isotropic displacement factors 1.5 times the isotropic 
equivalent of their carrier carbon atoms. Hydrogen atoms bonded to water 
molecules were located from the electron density map where possible and the 
O-H distance was restrained to 0.84 Å, with isotropic displacement factors 1.5 
times the isotropic equivalent of their carrier oxygen atoms. 
  
Table A1: Crystal data and X-ray experimental data for structures 1, 2, 3, 4 and 6. 
 
Compound 1 2 3 4 6 
Empirical Formula C24H30CoN8S4 C24H30NiN8S4 C24H30CuN8S4 C24H30CdN8S4 C24H30MnN8S4 
Formula Weight 617.73 617.51 622.34 671.20 613.74 
Temperature (K) 168(2) 168(2) 168(2) 168(2) 168(2) 
Crystal System Monoclinic Monoclinic Monoclinic Monoclinic Monoclinic 
Space Group C2 C2 P21 C2 C2 
Unit cell dimensions: a (Å) 19.059(9) 18.94(2) 7.478(2) 19.505(4) 18.514(7) 
                                  b (Å) 10.772(5) 10.805(13) 10.850(4) 10.818(2) 10.606(4) 
                                  c (Å) 7.434(3) 7.435(9) 18.236(6) 7.4438(16) 7.321(3) 
                                  α (°) 90 90 90 90 90 
                                  β (°) 107.09(3) 106.88(4) 97.757(4) 106.141(2) 93.943(3) 
                                  γ (°) 90 90 90 90 90 
Volume (Å3) 1458.9(11) 1456(3) 1466.0(8) 1508.8(5) 1434.2(9) 
Z 2 2 2 2 2 
Density (calculated) (Mg/m3) 1.406 1.409 1.410 1.477 1.421 
Absorption coefficient (mm-1) 0.903 0.982 1.059 1.029 0.781 
F(000) 642 644 646 684 638 
Crystal size (mm3) 0.50x0.50x0.35 0.50x0.50x0.50 0.44x0.31x0.26 0.50x0.50x0.20 0.50x0.50x0.50 
Theta range for data collection (°) 2.19 to 26.37 2.19 to 26.40 2.25 to 26.35 2.17 to 26.26 2.21 to 26.47 
Reflections collected 9430 26926 17924 9530 9042 
Independent reflections [Rint] 2969 [0.0148] 2800 [0.0189] 5838 [0.0393] 2894 [0.0211] 2612 [0.2079] 
Observed Reflections (for I>2σI) 2924 2750 5355 2890 2430 
Data / restraints / parameters 2629 / 1 / 189 2800 / 1 / 189 5838 / 1 / 346 2894 / 1 / 169 2612 / 114 / 188 
Goodness-of-fit on F2 1.079 1.048 1.084 1.044 1.056 
R1 (for I>2σI) 0.0263 0.0455 0.0400 0.0395 0.1139 
wR2 (all data) 0.0691 0.1177 0.1043 0.1048 0.2976 
Detector SMART/CCD SMART/CCD SMART/CCD SMART/CCD SMART/CCD 
 
  
Table A2: Crystal data and X-ray experimental data for structures 8, 9, 10, 7 and 14. 
 
Compound 8 9 10 7 14 
Empirical Formula C10H14AgN3O3 C20H28AgN5O3 C14H20AgBF4N4 C42H56N10NiOS2 C25H25Cl2CuN5O8 
Formula Weight 332.11 494.34 439.02 839.80 657.94 
Temperature (K) 170(2) 168(2) 168(2) 168(2) 168(2) 
Crystal System Orthorhombic Monoclinic Monoclinic Monoclinic Triclinic 
Space Group P212121 P21 P21 P21 P1 
Unit cell dimensions: a (Å) 9.925(2) 9.376(3) 7.602(4) 13.636(17) 8.626(4) 
                                  b (Å) 11.276(2) 11.393(3) 11.134(5) 18.11(2) 10.137(5) 
                                  c (Å) 11.284(2) 10.262(3) 11.034(5) 19.24(2) 16.484(8) 
                                  α (°) 90 90 90 90 87.313(6) 
                                  β (°) 90 94.509(4) 90.352(6) 106.96(5) 78.631(6) 
                                  γ (°) 90 90 90 90 85.403(7) 
Volume (Å3) 1262.8(4) 1092.9(6) 933.9(8) 4543(9) 1407.9(11) 
Z 4 2 2 4 2 
Density (calculated) (Mg/m3) 1.747 1.502 1.561 1.228 1.552 
Absorption coefficient (mm-1) 1.597 0.952 1.119 0.562 1.022 
F(000) 664 508 440 1784 674 
Crystal size (mm3) 0.50x0.35x0.30 0.42x0.21x0.13 0.50x0.40x0.20 0.40x0.35x0.15 0.12x0.11x0.04 
Theta range for data collection (°) 2.55 to 26.00 1.99 to 26.38 2.60 to 26.28 1.92 to 26.41 2.02 to 26.44 
Reflections collected 15118 13775 11193 58308 18001 
Independent reflections [Rint] 2475 [0.0199] 4388 [0.0299] 3652 [0.0212] 18300 [0.0653] 9198 [0.0601] 
Observed Reflections (for I>2σI) 2458 3998 3578 11489 5466 
Data / restraints / parameters 2475 / 0 / 155 4388 / 1 / 264 3652 / 1 / 248 18300 / 822 / 1026 9198 / 602 / 741 
Goodness-of-fit on F2 1.101 0.979 1.064 1.020 0.969 
R1 (for I>2σI) 0.0160 0.0212 0.0297 0.0772 0.0701 
wR2 (all data) 0.0410 0.0466 0.0771 0.2356 0.1742 
Detector SMART/CCD SMART/CCD SMART/CCD SMART/CCD SMART/CCD 
 
  
Table A3: Crystal data and X-ray experimental data for structures 15, 17, 48, 70, 82. 
 
Compound 15 17 48 70 82 
Empirical Formula C44H46Cl2Cu2N6O4 C20H24Cl2CoN2O2 C19H20N2O C9H10N2O3 C18H24CoN5O10S2 
Formula Weight 464.46 454.24 292.37 194.19 593.47 
Temperature (K) 168(2) 168(2) 93(2) 93(2) 93(2) 
Crystal System Monoclinic Tetragonal Monoclinic Orthorhombic Monoclinic 
Space Group P21 P41 C2 P212121 P21 
Unit cell dimensions: a (Å) 10.490(4) 9.336(14) 18.3643(16) 4.9239(10) 9.9472(5) 
                                  b (Å) 15.167(6) 9.336(14) 8.4333(7) 10.107(2) 10.2266(5) 
                                  c (Å) 13.510(5) 53.35(16) 20.4958(18) 18.813(4) 11.2600(6) 
                                  α (°) 90 90 90 90 90 
                                  β (°) 99.477(5) 90 102.400(2) 90 94.055(2) 
                                  γ (°) 90 90 90 90 90 
Volume (Å3) 2120.1(14) 4650(17) 3100.2(5) 936.2(3) 1142.57(10) 
Z 2 8 8 4 2 
Density (calculated) (Mg/m3) 1.455 1.460 1.253 1.378 1.725 
Absorption coefficient (mm-1) 1.179 1.106 0.078 0.105 1.001 
F(000) 968 2115 1248 408 612 
Crystal size (mm3) 0.44x0.38x0.35 0.28x0.21x0.01 0.64x0.35x0.10 0.41x0.40x0.09 0.49x0.46x0.19 
Theta range for data collection (°) 1.97 to 26.34 2.18 to 26.79 2.03 to 26.37 2.17 to 26.43 1.81 to 28.32 
Reflections collected 26477 59759 13451 19635 28798 
Independent reflections [Rint] 8302 [0.0505] 9741 [0.8181] 3340 [0.0341] 1155 [0.0246] 5649 [0.0254] 
Observed Reflections (for I>2σI) 7327 1242 2721 1115 5641 
Data / restraints / parameters 8302 / 1 / 527 9741 / 3 / 534 3340 / 1 / 397 1155 / 0 / 128 5649 / 10 / 343 
Goodness-of-fit on F2 1.122 0.525 0.976 1.061 1.034 
R1 (for I>2σI) 0.0456 0.0723 0.0364 0.0249 0.0245 
wR2 (all data) 0.0980 0.2362 0.0816 0.0671 0.0646 






Table A4: Crystal data and X-ray experimental data for structures 83, 84, 85, 86 and 87. 
 
Compound 83 84 85 86 87 
Empirical Formula C18H18BrCoN4O4S2 C18H19N5NiO7S2 C18H20N4NiO5S2 C18H19BrN4NiO4S2 C20H24CuN6O12 
Formula Weight 557.32 540.21 495.21 558.11 603.99 
Temperature (K) 93(2) 113(2) 113(2) 93(2) 93(2) 
Crystal System Orthorhombic Monoclinic Orthorhombic Monoclinic Monoclinic 
Space Group P21212 P21 P212121 P21 P21 
Unit cell dimensions: a (Å) 9.7103(9) 10.4057(6) 7.1909(5) 10.569(3) 7.3304(3) 
                                  b (Å) 23.214(3) 8.7019(5) 8.3294(5) 8.467(3) 13.7677(8) 
                                  c (Å) 10.2377(9) 12.1900(7) 32.5916(19) 11.937(4) 12.2355(7) 
                                  α (°) 90 90 90 90 90 
                                  β (°) 90 105.916(1) 90 106.280(6) 92.301(2) 
                                  γ (°) 90 90 90 90 90 
Volume (Å3) 2307.7(4) 1061.48(11) 1952.1(2) 1025.3(5) 1233.84(11) 
Z 4 2 4 2 2 
Density (calculated) (Mg/m3) 1.604 1.690 1.685 1.808 1.626 
Absorption coefficient (mm-1) 2.687 1.164 1.249 3.133 0.962 
F(000) 1120 556 1024 564 622 
Crystal size (mm3) 0.62x0.60x0.43 0.50x0.41x0.19 0.50x0.31x0.05 0.75x0.14x0.02 0.48x0.18x0.01 
Theta range for data collection (°) 1.99 to 33.58 2.04 to 26.39 2.50 to 26.39 2.28 to 25.00 1.67 to 30.71 
Reflections collected 28069 9232 17156 6170 21558 
Independent reflections [Rint] 8486 [0.0518] 4309 [0.0183] 3965 [0.0326] 3059 [0.0413] 6454 [0.0470] 
Observed Reflections (for I>2σI) 8120 4199 3706 2215 4936 
Data / restraints / parameters 8486 / 263 / 281 4309 / 1 / 318 3965 / 2 / 271 3059 / 33 / 277 6454 / 1 / 365 
Goodness-of-fit on F2 1.260 1.039 1.049 0.961 1.011 
R1 (for I>2σI) 0.1451 0.0262 0.0254 0.0530 0.0426 
wR2 (all data) 0.3543 0.0691 0.0623 0.1242 0.0889 






Table A5: Crystal data and X-ray experimental data for structures 88 and 89. 
 
Compound 88 89 
Empirical Formula C20H24AgClN4O10 C22H26BrCoN4O4.5 
Formula Weight 623.75 557.31 
Temperature (K) 93(2) 93(2) 
Crystal System Orthorhombic Tetragonal 
Space Group P212121 P42212 
Unit cell dimensions: a (Å) 8.3738(2) 14.8674(10) 
                                  b (Å) 14.8936(4) 14.8674(10) 
                                  c (Å) 19.9557(6) 12.9005(8) 
                                  α (°) 90 90 
                                  β (°) 90 90 
                                  γ (°) 90 90 
Volume (Å3) 2488.80(12) 2847.1(3) 
Z 4 8 
Density (calculated) (Mg/m3) 1.665 1.300 
Absorption coefficient (mm-1) 0.978 2.038 
F(000) 1264 1136 
Crystal size (mm3) 0.40x0.23x0.17 0.44x0.09x0.05 
Theta range for data collection (°) 2.46 to 26.35 1.58 to 26.37 
Reflections collected 28515 41976 
Independent reflections [Rint] 5067 [0.0293] 3261 [0.1091] 
Observed Reflections (for I>2σI) 4935 2610 
Data / restraints / parameters 5067 / 0 / 329 3261 / 242 / 301 
Goodness-of-fit on F2 1.045 1.555 
R1 (for I>2σI) 0.0167 0.1292 
wR2 (all data) 0.0418 0.3661 
Detector APEX II APEX II 
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